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Abstract 
This study investigated the immunotoxicology of silver nanoparticles using in vitro human 
cell cultures. THP-1 human monocytes, primary human monocytes isolated from 
peripheral blood, and PMA-stimulated macrophages derived from these monocytes, as 
well as HaCaT human keratinocytes, were exposed to 4 types of nanosilver or ionic silver 
for up to 24 hours.  
The investigated nanosilver included one laboratory synthesised material, one 
commercially available research material, and two test materials from the OECD’s 
Sponsorship Programme for the Testing of Manufactured Nanomaterials. They were 
characterised for their primary particle size distributions and morphology using TEM and 
DLS, as well as surface charge. The agglomerate size distributions and morphology were 
characterised in cell culture medium using DCS and cryo-TEM. 
Cytotoxicity of the nanosilver test materials to the immune cells and keratinocytes was 
assessed using the MTS viability assay, while cell death pathways were measured by flow 
cytometry using a double fluorescent stain of Annexin V-FITC and propidium iodide. The 
production of reactive oxygen species in nanosilver exposed immune cells was examined 
using H2DCF-DA (peroxides) and MitoSOX™ Red (superoxide), while the effects of 
oxidative stress were characterised by measuring levels of cellular glutathione and a 
biomarker of lipid peroxidation, 8-isoprostane. Immunomodulatory effects of nanosilver 
were assessed by profiling the cytokines released by immune cells using a multiplex 
fluorescent bead assay and ELISA. Uptake and intracellular localisation of nanosilver in 
immune cells was investigated by changes in flow cytometric side-scatter intensity and 
ultra-thin section TEM of monocytes and macrophages, as well as synchrotron X-ray 
fluorescence microscopy and SERS intensity mapping of macrophages. 
Nanosilver was cytotoxic to all cell types, with primary human immune cells and HaCaT 
keratinocytes being more sensitive than THP-1 cells. There was no difference in the 
sensitivity of THP-1 monocytes and macrophages. On a mass dose basis, the smaller sized 
nanosilver materials were more potent than larger sized material, and ionic silver was the 
most cytotoxic. Significant cytotoxicity occurred within the first 4 hours following 
exposure to nanosilver in all cell types, while at low doses the THP-1 cells recovered 
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gradually between 4 and 24 hours and even exhibited a hormetic effect in some cases. At 
high doses, cytotoxicity continued increasing for up to 12 hours following exposure. 
Cytotoxic doses of nanosilver caused cell death almost exclusively by necrosis in HaCaT 
keratinocytes, with less than 5% of cell death by apoptosis. The THP-1 monocytes also 
showed primarily necrotic cell death, but the proportion of apoptotic cells increased to 
between 10 and 20% of the total cell number as viability decreased. In contrast, THP-1 
PMA-stimulated macrophages primarily exhibited apoptotic cell death. As viability 
decreased, there were approximately 2- to 3-fold more apoptotic macrophages than 
necrotic. This may have been due to the greater ability of macrophages to withstand 
oxidative stress, due to their role in eliminating invading pathogens in vivo, allowing them 
to undergo programmed cell death. 
Interference due to the strong light-absorption properties of the nanosilver suspensions 
prevented effective measurement of intracellular ROS production using H2DCF-DA in a 
microplate format. When the H2DCF-DA assay was analysed by flow cytometry, there was 
no evidence that exposure to nanosilver increased intracellular ROS production under 
these conditions. In contrast, the immune cells loaded with MitoSOX™ Red, a probe which 
detects superoxide production in mitochondria, showed increased superoxide production 
with nanosilver exposure. Correspondingly, cellular GSH was depleted drastically in THP-1 
monocytes and macrophages exposed to nanosilver, and was proportional to the 
decrease in cell viability. The 8-isoprostane levels indicated that some types of nanosilver 
caused significant lipid peroxidation in these cells. 
Nanosilver exposure did not cause an increase in Th1 or Th2 specific cytokine expression 
in THP-1 or primary isolated human monocytes and PMA-stimulated macrophages in 
vitro. However, a significant increase in the pro inflammatory cytokines IL-8 and TNF was 
observed for THP-1 monocytes and PMA-stimulated macrophages, while in primary 
human monocytes, the pro inflammatory cytokine profile varied between donors. 
Increased IL-8 expression by THP-1 macrophages was independent of cytotoxicity and 
continued strongly for 24 hours following exposure to nanosilver. 
A summary of the effects of the nanosilver test materials on each cell type are shown in 
Table 0.1. 
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Table 0.1: Summary of nanosilver test material effects after 24 hours exposure of the cell 
types investigated. ND = not determined. 
Comparative sensitivity to nanosilver of cell types (based on EC50, μg/mL) 
Primary monocytes = primary macrophages > THP-1 monocytes = THP-1 macrophages 
Comparative cytotoxicity of nanosilver test materials (based on EC50, cm2/mL) 
HaCaT Keratinocytes: ABC Nanotech = NM-300K = Carey Lea's = Sigma 
THP-1 monocytes: ABC Nanotech = Carey Lea's > NM-300K = Sigma 
THP-1 macrophages: ABC Nanotech = Carey Lea's > NM-300K = Sigma 
Primary monocytes: ND 
Primary macrophages: ND 
Primary mode of cell death following nanosilver exposure 
HaCaT keratinocytes: Necrosis  
THP-1 monocytes: Necrosis 
THP-1 macrophages:  Apoptosis  
Comparative oxidative potential of nanosilver test materials 
 
Mitochondrial superoxide Glutathione Lipid peroxidation 
THP-1 monocytes: No significant difference 
No significant 
difference 
ABC Nanotech = NM-300K 
= Carey Lea's < Sigma 
THP-1 macrophages: 
ABC Nanotech > NM-300K 
= Carey Lea's = Sigma 
No significant 
difference 
ABC Nanotech = NM-300K 
= Carey Lea's < Sigma 
Cytokines stimulated by nanosilver (24 hours exposure) 
THP-1 monocytes: TNF, IL-8 
THP-1 macrophages: IL-6, IL-1β, IL-8 
Primary monocytes: TNF, IFN-γ, IL-8, IL-5 
Primary macrophages:  IL-10, IL-8, IL-1β, IL-9, IL-13, IL-17A  
 
Flow cytometric analysis of the changes in side-scatter intensity for THP-1 monocytes and 
PMA-stimulated macrophages indicated a dose dependent uptake of significant quantities 
of nanosilver, which mainly occurred within the first 4 hours of exposure. In an 
experimental first, synchrotron X-ray fluorescence microscopy showed a colocalisation of 
nanosilver agglomerates with the analysed THP-1 macrophages. A novel application of 
surface enhanced Raman scattering mapping was used to identify the cellular uptake of 
nanosilver agglomerates by immune cells grown on an aluminium foil substrate support. 
This new approach to nanosilver toxicology is currently limited by the size of the laser 
spot used to irradiate the samples. Ultra-thin section TEM of THP-1 monocytes and PMA-
stimulated macrophages showed agglomerates of nanosilver present in cellular vesicles 
and cytosol.  In one case, a macrophage was captured actively phagocytosing a large 
nanosilver agglomerate.  
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In conclusion, many common in vitro toxicology techniques were shown to be appropriate 
for investigating the immunotoxicology of nanosilver, although some modifications and 
improved protocols were necessary to overcome interferences due to the test materials. 
Exposure to nanosilver at high concentrations in vitro was shown to be hazardous to 
human immune and skin cells, causing cell death and increased oxidative stress. It is 
unclear whether ROS production is responsible for the cytotoxicity of nanosilver, but it is 
likely to be just one mechanism amongst a number of synergistic processes involving 
disrupted cellular thiol homeostasis, mitochondrial dysfunction, oxidative stress and 
membrane damage. This single cell type exposure system did not indicate a specific Th1 
or Th2 immune response to nanosilver exposure, but rather a strong pro inflammatory 
response in THP-1 cells and one donor of primary monocytes. This may pose an acute 
respiratory inflammation hazard to susceptible individuals exposed to large amounts of 
nanosilver, as in an accidental workplace spill. More complex immune system models, 
such as co-culture systems and animal models, are required to further investigate the 
immunostimulatory potential of nanosilver, and to be able to identify individuals that may 
be at risk from the identified pro inflammatory hazard.  
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List of abbreviations 
 
DCF-DA 2’,7’-dichlorofluroscein diacetate 
H2DCF-DA 2′-7′-dichlorodihydrofluorescein diacetate 
DCF 2′-7′-dichlorofluorescein 
ADME absorption, distribution, metabolism and excretion 
APC antigen presenting cell 
BSA bovine serum albumin 
BET Brunauer-Emmet-Teller gas adsorption isotherm 
CNT carbon nanotube 
cps counts per second  
cryo-TEM cryogenic transmission electron microscopy 
Tc cytotoxic T lymphocyte 
DCS differential centrifugation sedimentation 
DMSO dimethylsulfoxide  
DLS dynamic light scattering 
EC20 effective concentration causing 20% cytotoxicity 
EC50 effective concentration causing 50% cytotoxicity 
EC80 effective concentration causing 80% cytotoxicity 
ELISA enzyme-linked immunosorbent assay 
FBS fetal bovine serum 
FITC fluorescein isothiocyanate 
GIT gastrointestinal tract 
HCM HaCaT culture media  
HBSS Hank’s balanced salt solution 
IFN interferon  
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IL- interleukin- 
LPS lipopolysaccharide  
LT lymphotoxin  
MSR MitoSOX™ Red 
NAC N-acetylcysteine 
NP nanoparticle 
NMR nuclear magnetic resonance 
WPMN OECD Working Party on Manufactured Nanomaterials  
OECD Organisation for Economic Cooperation and Development 
pp percentage point 
PBMC peripheral blood mononuclear cell 
PMA phorbol-12-myristate-13-acetate 
PBS phosphate buffered saline 
PS phosphatidylserine  
PVP polyvinylpyrrolidone  
PEN Project on Emerging Nanotechnologies 
PI propidium iodide 
QNAR quantitative nanostructure-activity relationships 
QSAR quantitative structure-activity relationships 
QD quantum dot 
ROS reactive oxygen species 
GSH reduced glutathione 
RPM revolutions per minute 
SiN silicon nitride 
Ag+ silver ions 
nanosilver silver nanoparticles 
AgNO3 silver nitrate 
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Ag2S silver sulfide 
SEM standard error of the mean 
SOD superoxide dismutase 
SERS surface enhanced Raman scattering 
Th1 T-helper 1 
Th17 T-helper 17 
Th2 T-helper 2 
TCM THP-1 culture media 
TEM transmission electron microscopy 
TBE trypan blue exclusion 
TNF tumor necrosis factor 
UFP ultrafine particle 
UA uranyl acetate 
XFM X-ray fluorescence microscopy 
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1.1 Introduction 
Nanotechnology involves the manipulation of matter from the atomic to sub-micron 
scales to create materials with novel, useful properties compared to their bulk 
counterparts [1]. The most widespread and basic nanotechnologies involve the use of 
nanoparticles (NPs): particles with three dimensions below 100 nm in size [2]. At this 
scale, the surface area to volume ratio of these particles becomes large enough to cause 
changes in the material’s physical and chemical properties [3]. Methods to synthesize NPs 
from a wide range of constituents have advanced rapidly over the last decade, causing an 
explosion in the use of NPs in a variety of applications [4]. 
 
1.2 Consumer nanoparticles 
1.2.1 Growth in the use of nanoparticles 
Recent advances in synthesis have led to a rapid growth in the number of consumer 
products on the market claiming to contain NPs. The Project on Emerging 
Nanotechnologies (PEN) has reported that the number of consumer products claiming to 
contain NPs grew from 54 in 2005 to 1317 as of March 10, 2011, an increase of 
approximately 240 products per year since 2005 [5]. 
Although the PEN inventory is comprehensive, it only includes products that claim to 
contain NPs. As there are currently no labelling requirements for products containing NPs, 
it is likely that the true number is even higher. 
1.2.2 Lagging regulation 
The Royal Society and the Royal Academy of Engineers reported in 2004 that the 
increased use of NPs may pose risks to human health, primarily through workplace 
exposure, and the environment [6]. The report suggested that a dedicated research effort 
was required in cooperation with regulatory authorities for the continued safe use and 
development of products containing nanomaterials. However, the continued rapid 
development of consumer NPs has outstripped the capacity of national and supranational 
bodies to develop regulations governing the safe handling, use and disposal of these 
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novel materials. In 2010, Seaton et al. discussed the state-of-play in regards to our 
understanding of the hazards posed by exposure to NPs and “the early steps towards 
regulation and the difficulties facing regulators in controlling potentially harmful 
exposures in the absence of sufficient scientific evidence” [7]. Despite the early 
identification of the need for specific regulations governing the safe use of NPs backed by 
scientific understanding, there is still a long way to go in this area. 
1.2.3 Types of consumer nanoparticles 
The most common NP materials comprise: carbon, including carbon nanotubes (CNTs) 
and fullerenes (C60); titanium dioxide, used in paints, protective coatings and sunscreens; 
silica, widely used in cosmetics and food; zinc oxide, mainly used in sunscreens; and gold 
NPs, fluorescent NPs known as ‘quantum dots’, and magnetic iron oxide NPs, used in 
medical or biomedical applications [5]. But by far the greatest variety and number of 
consumer products claiming to contain NPs use some form of silver NPs (nanosilver): as of 
March 2011 PEN’s consumer inventory lists 313 products containing nanosilver, about one 
quarter of the total inventory. Along with this growth in the manufacture of NPs, and 
consumer products containing NPs, has come the need for research to establish their 
safety. 
 
1.3 Nanotoxicology 
1.3.1  “An emerging discipline” 
An influential journal article by Oberdörster et al. (2005) entitled ‘Nanotoxicology: An 
Emerging Discipline Evolving from Studies of Ultrafine Particles’ describes how the 
demand for safety testing of new, nanostructured materials was being met partly through 
the evolution of an established field of toxicology investigating the effects of ambient 
‘ultrafine’ particles (UFPs) [8].  Oberdörster defines nanotoxicology as the “science of 
engineered nanodevices and nanostructures that deals with their effects in living 
organisms”. The importance of this developing field became clear when, in 2007, a new 
scientific journal was published called Nanotoxicology, with its major focus being “how 
11 
 
we can use [the science of nanotoxicology] to make nanomaterials safe in order to allow 
nanotechnology to reach its full potential in a safe and sustainable manner” [9]. 
Nanotoxicology was identified as an important field of research due to a number of 
biokinetic factors inherent to nanomaterials compared to bulk materials: NPs can be 
deposited in all areas of the airways and can translocate to systemic distribution by 
different mechanisms; there is evidence for translocation of NPs along neuronal axons, 
especially to the olfactory bulb, following inhalation; NPs can be taken up through the 
gastrointestinal tract (GIT); NPs in blood can be distributed widely to many organs 
including the spleen, liver, bone marrow and heart [8]. This ability for NPs to be widely 
distributed to different organs through multiple entry portals made it essential to identify 
whether novel human health hazards would follow exposure to NPs. 
1.3.2 The OECD’s Working Party on Manufactured Nanomaterials 
In 2007 the Organisation for Economic Cooperation and Development’s (OECD) Working 
Party on Manufactured Nanomaterials (WPMN) initiated the Sponsorship Programme for 
the Testing of Manufactured Nanomaterials. Test materials and sponsor countries for the 
programme are shown in Table 1.1 [10]. 
This programme set out to subject a representative set of manufactured NPs to a battery 
of tests including physicochemical characterisation, environmental degradation, 
ecotoxicology and mammalian toxicology in order to “create an understanding of the kind 
of information on intrinsic properties that may be relevant for exposure and effects 
assessment of nanomaterials through testing” [11]. A major benefit of this approach was 
the international collaboration and discussion that was facilitated around the crucial 
aspects of testing nanotoxicology to enable the safe use of manufactured nanomaterials. 
1.3.3 Testing nanotoxicology 
Despite the evolution of nanotoxicology from a pre-existing field of research, much of the 
practical and theoretical infrastructure to enable the reliable investigation of the safety of 
engineered NPs has had to be significantly adapted and redesigned from traditional 
toxicological practices. An important aspect that was largely overlooked in early 
nanotoxicology testing was the physicochemical characterisation of the NPs being 
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investigated. Suddenly, biological scientists, used to the relatively predictable behaviour 
of small molecule therapeutics or chemicals, were forced to consider the aggregation and 
agglomeration, solubility, exposure media interactions, size, shape, surface area and 
porosity, and how to reproducibly deliver a consistent dose of the NPs being tested, and 
how these factors might affect any observed toxicological endpoints. This has required 
interdisciplinary collaboration between toxicologists, materials scientists, physicists and 
chemists, as flagged in 2004 by Donaldson et al. [12], in order to design protocols and the 
minimum particle characterisation data required for useful nanotoxicological 
investigations.  
Table 1.1: Test materials and contributing countries for the OECD WPMN’s Sponsorship 
Programme for the Testing of Manufactured Nanomaterials. SWCNT = single-walled 
carbon nanotubes, MWCNT = multi-walled carbon nanotubes, EC = European Commision, 
BIAC = Business and Industry Advisory Committee. 
 Lead sponsor Co-sponsor Contributor 
Fullerenes (C60) Japan, USA - Denmark, China 
SWCNTs Japan, USA - 
Canada, France, Germany, 
EC, China, BIAC 
MWCNTs Japan, USA Korea, BIAC 
Canada, France, Germany, 
EC, China, BIAC 
Nanosilver Korea, USA 
Australia, Canada, Germany, 
Nordic Council of Ministers 
France, Netherlands, EC, 
China, BIAC 
Iron NPs China BIAC 
Canada, USA, Nordic 
Council of Ministers 
TiO2 
France, 
Germany 
Austria, Canada, Korea, 
Spain, USA, EC, BIAC 
Denmark, Japan, UK, China 
Al2O3 - - Germany, Japan, USA 
CeO USA, UK/BIAC 
Australia, Netherlands, 
Spain 
Denmark, Germany, Japan, 
Switzerland, EC 
ZnO UK/BIAC Australia, USA, BIAC  
Canada, Denmark, 
Germany, Japan,  
Netherlands, Spain, EC 
SiO2 France, EC Belgium, Korea, BIAC Denmark, Japan 
Dendrimers - Spain, USA - 
Nanoclays BIAC - Denmark, USA, EC 
Gold South Africa USA Korea, EC 
 
In 2005 and 2006, the journal of the Society of Toxicology, USA, (Toxicological Sciences) 
published 8 review articles as part of its ‘Forum Series’ examining the implications of, and 
catalysing discussion and collaboration around nanotoxicology, the safety of 
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nanomaterials, and regulatory responses [13-20]. At the same time, Oberdörster et al. 
were considering the critical elements of a nanotoxicological screening strategy [21]. The 
critical aspects of a nanotoxicology screening strategy identified were: physicochemical 
characterisation and dose metrics of NPs; acellular assays; in vitro assays and in vivo 
assays focussed on likely exposure routes, including the inhalational, oral, dermal, and 
intravenous routes. 
1.3.3.1 Physicochemical characterisation 
Central to nanotoxicology is the need to understand how the physical and chemical 
characteristics of NPs affect their toxicity. Not only is thorough characterisation essential 
to determine which properties of NPs determine their toxicity for the purposes of safety 
regulations, test materials must be characterised as received, as administered and during 
exposure for all toxicology investigations in order to adequately interpret the results and 
to retrospectively compare different studies. Key properties to be characterised include: 
particle size distribution; aggregation state and agglomeration behaviour; particle shape, 
or aspect ratio; crystal structure, as some crystal forms of a material may be more toxic 
than others; chemical composition, including impurities or contaminants; specific surface 
area; surface chemistry, such as coatings or functionalisation, and charge; and porosity 
[21, 22].  
1.3.3.2 In vitro nanotoxicology 
In vitro models have been utilised for a considerable period of time to screen potentially 
toxic chemicals and materials, thereby reducing the amount of animal testing in general 
and identifying materials with the highest potential for harm to subject to further testing. 
In addition, in vitro investigations allow the elucidation of the mechanisms behind toxicity 
at the cellular level [23]. 
The primary endpoint of interest for in vitro toxicology is cytotoxicity, the ability of a 
compound to cause cell death by disrupting essential cellular processes. This is usually 
achieved by measuring cellular metabolism or membrane integrity. Determining the basal 
cytotoxicity of a compound is useful for planning further in vivo investigations to calculate 
a likely dose to elicit the toxic effects being investigated, as well as determining an 
14 
 
appropriate sub-lethal dose range for mechanistic studies in vitro. In addition to 
cytotoxicity, common in vitro toxicological endpoints for nanotoxicology include: mode of 
cell death; DNA damage; reactive oxygen species (ROS) generation and oxidative stress; 
and intercellular signalling, usually by measuring the production of cytokine molecules 
[24]. 
In vitro studies can be targeted at cell types that are derived from organs and tissues that 
have been observed to be primary or secondary targets of toxicity from in vivo testing. 
There are a number of human and animal cell lines used as in vitro models of organs such 
as the lung, liver, kidney, immune system, skin, nerves, and reproductive organs [25]. An 
important consideration for in vitro models based on immortalised or cancer-derived cell 
lines is that they may behave differently to primary cells, and so primary cells derived 
from the same organ should also be tested where possible. Another, more complex, type 
of in vitro model is a co-culture system, where more than one cell type are cultured 
together to give results that reflect the exposure effects on intercellular communication 
[26]. These co-culture models can be even more useful for mechanistic studies, but are 
usually very complex and difficult to work with. Ultimately, in vitro testing complements 
in vivo testing, and vice versa, in an iterative manner. 
1.3.3.3 In vivo nanotoxicology 
To gain an understanding of the effects of nanomaterials in living organisms, including 
humans, it is important to conduct exposure tests on model animal systems to see the 
whole of organism responses. In vivo investigations are usually undertaken on materials 
that have been identified as potentially hazardous through in vitro testing, as described 
above. This is due to the cost and time involved in animal testing, as well as 
considerations of the animal welfare principles of replacement, reduction and 
refinement; i.e. the fewer animals required for toxicology testing, the better. 
In vivo models are most useful in nanotoxicology for investigating the exposure routes 
through which NPs will enter the body and their subsequent toxico-/particokinetic 
parameters of absorption, distribution, metabolism and excretion (ADME), as well as 
long-term chronic exposures which are practically impossible to achieve using in vitro 
systems [27]. 
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In vivo studies have long been used in the pharmaceutical industry for drug development 
and testing, and in regulatory toxicology for screening chemicals and establishing safe 
exposure limits. As such, there exist well-established, internationally accepted protocols 
for these kinds of investigations which have been adapted for use in nanotoxicology 
testing. For example, a laboratory at the Korean Environment and Merchandise Testing 
Institute has recently conducted 28 and 90 day in vivo inhalational and oral nanosilver 
exposure tests [28-31] which they based on the OECD test guidelines 407, 408, 412 and 
413 [32-35]. By combining the thorough characterisation of NP test materials, as 
described above, with internationally accepted in vivo test protocols, high quality 
nanotoxicology data can be produced. 
1.3.3.4 In silico 
While in vitro and in vivo testing is essential to gain an understanding of nanotoxicology, 
the enormous number of different kinds of nanomaterials being produced, in 
combination with a range of surface functionalisations and coatings, means that it would 
be physically impossible to test every NP on the market [36]. To overcome this problem, 
along with high-throughput in vitro screening of NPs, researchers are turning to 
computational modelling, sometimes known as ‘in silico’ screening or testing, to predict 
which kinds of NPs could pose significant hazards in order to prioritise the physical toxicity 
testing of these materials [37]. 
The major approach to this kind of modelling is known as ‘quantitative structure-activity 
relationships’ (QSAR), and has previously been used as a method to assess experimental 
data in order to better understand the mechanistic bioactivity of structurally related small 
molecules, usually for drug development. Recently, there has been a move towards using 
rigorously validated QSAR models based on in vitro experimental data in a predictive 
capacity, in order to identify novel chemicals that may exhibit a desired activity by a 
process of ‘virtual screening’ of existing chemical databases and virtual libraries using 
expert systems [38]. 
This approach has been of considerable interest to toxicologists in the international 
regulatory environment, as it has allowed chemical regulators to identify and prioritise 
chemical substances for further toxicological testing to fill gaps in risk assessment data 
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sets, for both human health and environmental effects and fate [39, 40]. As the field of 
nanotoxicology has developed over the last decade, the potential application of QSAR 
modelling to predict biological interactions and hazards of NPs has been part of the 
discussion from an early stage and has been repurposed as ‘quantitative nanostructure-
activity relationships’, or QNAR [41]. 
Meng, George and Nel advocated in 2009 for a predictive QNAR approach to 
nanotoxicology based around the oxidative stress potential of test materials, as ROS 
generation is a common feature of many different kinds of NPs [41]. ROS generation 
potential can be examined in acellular test systems, reducing the cost and time to identify 
possibly hazardous materials, so this method is advocated as a way to speed up and 
prioritise the most relevant materials for in vitro and in vivo investigations of 
nanotoxicology. 
One of the first QNAR models developed for predicting nano-bio-interactions was 
described by Fouchers et al. in 2010 [42]. They utilised two data sets produced earlier by 
other laboratories as case studies to construct their models: in case study 1, Weissleder et 
al. (2005) screened fluorescent magnetic nanoparticles with 146 different combinations 
of surface functionalisation in a range of cell types for specific cellular targeting [43]; and 
in case study 2, Shaw et al. (2008) screened 50 combinations of different NP cores with a 
variety of surface coatings and functionalisations in a range of cell types against a number 
of toxicological endpoints, for the purposes of developing structure-activity relationships 
[44]. Fouchers et al. were successful in developing QNAR models to predict the uptake of 
NPs in case study 1 and the biological activity of NPs in case study 2, showing that this 
approach to predictive modelling for nanotoxicology has serious potential. Other studies 
have investigated different methods for predicting the biological interactions of a range of 
NPs, all with a degree of success, by using: a combination of physicochemical 
characteristics; theoretical redox potential energies; or modelling of cellular uptake of NPs 
[45-47]. 
By combining in vitro, in vivo, and in silico (or QNAR) techniques for nanotoxicology 
testing, it should be possible to develop a testing regime in order to rapidly identify NPs 
that could present serious hazards to human health and the environment, and design 
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better materials that can be used for their beneficial properties without the same risks. 
Through collaboration and data sharing, as described by Fouchers et al. [42], the results of 
in vitro nanotoxicology testing can be utilised to develop QNAR models and inform in vivo 
testing, which can then further inform more targeted and specific in vitro tests, and the 
evolution of more robust computational models to build our understanding of the 
dangers presented by some NPs and how best to avoid them.  
1.3.4 Hazards of nanoparticles 
As discussed in the reviews of Oberdörster et al. (2005) and Donaldson et al. (2004), the 
study of UFPs provides a starting point for assessing the potential hazards to humans from 
exposure to NPs [8, 12]. Since the mid 2000’s, there have been a number of in vitro and in 
vivo nanotoxicological investigations published which build on this knowledge, and have 
started to illuminate an understanding about how NPs interact with biological systems 
and what hazards they pose. 
1.3.4.1 Exposure routes and target organs  
When considering nanotoxicology, any potential NP hazards will depend on the route 
through which exposure occurs. Figure 1.1 shows the major exposure routes and portals 
of entry for NPs, as suggested by Oberdörster et al. [8]: inhalation of airborne NPs; oral 
ingestion of NPs; dermal application of NPs; and injection of NPs, whether by intravenous 
or subcutaneous routes. Once NPs have arrived at a particular portal of entry, they 
interact with the biological environment present and adsorb any biomolecules that may 
be present, depending on the size, surface coating and functionalisation of the NPs. This 
interaction in biological media has been termed the NP ‘protein corona’ [48]. Depending 
on which portal of entry the NPs encounter, there will be a different mix of biomolecules 
present, giving the NPs a different corona. It has been suggested that this may be a critical 
factor in the translocation and distribution of NPs in exposed humans [49].  
For any exposure route and portal of entry, a major secondary target organ for all types of 
NPs is the liver [49-55]. This is due to the prominent role played by the liver of clearing 
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particulate matter from the blood, along with the spleen which is also a major secondary 
target organ for NP exposure [56, 57]. For inhalational exposure, major targets include 
alveolar epithelial cells and alveolar macrophages, which can migrate to the mucocilliary 
elevator after phagocytosing NPs, which in turn leads to the GIT. Additionally, inhalational 
exposure can lead to the translocation of NPs along neural cells to the olfactory bulb [58]. 
For oral NP exposure, other major targets include the stomach and intestinal villi [59]. 
Secondary targets from dermal exposure to NPs will depend on the context of the 
exposure. Exposure of damaged skin directly to NPs, as in nanosilver impregnated 
bandages for wound infection control, could lead to NP translocation directly to the 
circulation and lymphatic system, with similar secondary targets as above, as well as cells 
of the skin such as keratinocytes, melanocytes and fibroblasts [60]. However, this is much 
less likely in the case of intact skin, such as in the application of sunscreen or cosmetics 
containing NPs. There is still considerable debate about the ability of NPs to penetrate 
intact human skin, due to the limitations of test models involving rodent or pig skin, which 
have different structures and thicknesses to human skin, and the difficulties of observing 
NP migration when tested on human subjects [61-65]. 
Figure 1.1: Exposure routes and distribution of nanoparticles in humans. Reproduced with 
permission from Environmental Health Perspectives [8]. 
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While many secondary target organs and systems have been shown to be susceptible to 
NP exposure through a number of entry portals and exposure routes, it is important to 
note that the rate and volume of translocation of NPs are still not well characterised, and 
may vary widely depending on the type of NP and the exposure route. Only a small 
percentage of inhaled NPs will ever translocate to the brain, and most orally ingested NPs 
are likely to be excreted in faeces, but for intravenously administered NPs, it would be 
expected that a very large proportion of the dose will end up in the liver and the spleen 
[66]. The rate and differential amount of translocation of NPs to relevant secondary 
targets will play a significant role in any hazards that this exposure might present. 
1.3.4.2 General hazards 
As mentioned previously, the study of UFPs in air pollution and nuisance dusts provided a 
significant platform of knowledge about the possible hazards of exposure to NPs. A major 
hazard from exposure to UFPs is inflammation driven by increased oxidative stress [67, 
68], especially in the airways following inhalation, which was shown to be related to the 
particle surface area [69]. Differences in toxicity for UFPs have also been observed 
depending on their surface reactivity, which can determine their oxidative stress potential 
[70]. These observations translate directly to the hazards of manufactured and incidental 
NPs [71]. 
As well as generalised inflammation in the lung following UFP and NP exposure, NPs have 
been shown to increase cellular oxidative stress after being taken up by a range of cell 
types, such as mouse immune cells [72], lung epithelial cells [73] and rat alveolar 
macrophages [74]. The potential for NPs to produce ROS is one of the most widely studied 
mechanisms for NP cytotoxicity [75].  
Apart from increased oxidative stress and ROS production, there are other potential 
hazards associated with NP exposure. Some NPs have been shown to induce DNA damage 
after cellular uptake [76]. Through their interaction with biomolecules, NPs may be able 
to induce auto-immune disorders by exposing ‘cryptic epitopes’ of common endogenous 
proteins, by refolding  them around the surface of the NPs [77, 78]. When these refolded 
proteins come into contact with immune cells, they may be mistaken for pathogens, 
causing an adverse immune reaction. 
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These hazards potentially apply to all forms of NPs, but some NPs composed of toxic or 
reactive materials may present their own specific hazards. 
1.3.4.3 Composition specific hazards 
Many engineered and incidental NPs are either insoluble or non-toxic in composition, but 
some significant applications of NPs do use toxic materials. Some of the most widely used 
toxic NPs are ‘quantum dots’ (QDs), very small (1-5 nm) fluorescent particles used for 
biomedical imaging in animals, with potential use for medical imaging in humans [79]. 
These QDs are most commonly composed of very small crystals of the semiconductor 
cadmium selenide or cadmium telluride, with a coating of zinc sulfide [80], and QDs have 
also been synthesised as indium arsenide crystals with an indium phosphide-zinc selenide 
double shell [81]. Elements like cadmium and arsenic are highly toxic, so if any dissolved 
ions of these materials are able to leach out of the QD cores when they interact with 
biological systems, they clearly pose a significant toxicity hazard [82]. This may be a 
serious risk as NPs are taken up by most cells and have been observed to localise in 
endosomes and lysosomes, which present a highly acidic environment likely to dissolve 
the NPs, at least to some extent [83]. 
This has been termed the ‘Trojan horse’ effect, originally used in reference to drug-
delivery using viral capsules. Other types of NPs that may pose a hazard due to the Trojan 
horse effect include silver and zinc oxide. Zinc oxide is poorly soluble in basic or neutral 
pH solutions, but is highly soluble in acidic conditions such as those present in cellular 
endosomes [84], and overexposure to zinc ions has been observed to induce cytotoxicity 
[85]. Nanosilver is also highly soluble in acidic environments, and silver ions have a high 
affinity for thiol-bonds. Silver ions will bind to and disrupt sulfur containing molecules 
that are prevalent in intracellular environments with cytotoxic results, such as reduced 
glutathione and any biomolecules with cysteine residues [86]. As such, the intracellular 
dissolution of nanosilver has the potential to deliver a large dose of toxic silver ions to 
cells. This property of silver is also central to its role as an antimicrobial, for which it is 
being used in a wide array of nanosilver-containing consumer products. 
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1.4 Silver is an antimicrobial 
Silver has been used by humans for various purposes for thousands of years, including 
currency, tableware, jewellery, and medicinal purposes. Silver’s antimicrobial properties 
have long been recognised, mostly through the use of silver salts such as silver nitrate 
(AgNO3) or, more recently, silver sulfadiazine for topical infection-control of burns and 
ulcers [87].  
1.4.1 Mechanistic understanding 
Experiments by Gibbard in 1937 showed that the antimicrobial activity exhibited by 
different kinds of silver was primarily due to the action of silver ions [88]. The 
mechanisms behind the strong antimicrobial properties of silver ions are still somewhat 
uncertain [89]. One of the most studied mechanisms is the disruption of the cellular 
respiratory chain [90, 91] leading to the generation of ROS [92, 93], caused by the affinity 
of silver ions for thiol groups present in the cysteine residues of many important 
intracellular proteins and enzymes [87]. This affinity for sulfur containing compounds can 
also cause the depletion of intracellular glutathione stores [94], which would have a 
synergistic effect on oxidative stress when combined with increased ROS production, as 
mentioned above. 
1.4.2 Silver socks 
While silver has historically been used for its antimicrobial properties in a limited number 
of applications described above, the availability of nanosilver in a range of different forms 
has spawned a dazzling array of new antimicrobial products [89]. These include: odour 
resistant socks and other clothing items; antifungal washing machines; methicillin-
resistant Staphylococcus aureus (MRSA)-resistant bed-sheets; nanosilver sticking plasters; 
plush children’s toys; food storage containers; cosmetics; so-called ‘health-food’ or 
‘immune-boosting’ supplements; wall paint; air sanitiser sprays and filters; vacuum 
cleaners; baby bottles; toothpaste and toothbrushes; kitchenware; fridges; personal 
grooming implements; water filters; door knobs; and keyboards [5]. Almost any item that 
can be coated in nanosilver has been, and these products are chiefly marketed at people 
who believe they are at risk from every-day contact with ‘germs’ and are, to a large 
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Figure 1.2: Patient showing symptoms of 
generalised argyria. Areas exposed to 
sunlight appear darker. Reproduced with 
permission from White, Powell and Russel-
Jones (2003). 
degree, unnecessary gimmicks. In contrast, nanosilver has also found use in many medical 
applications for infection control, like surgical face-masks, nanosilver imbued catheters 
and medical implants, including replacement joints, bone cement and heart-valves [95, 
96]. 
1.4.3 Overexposure: silver hazards 
This proliferation of products containing nanosilver has caused concern about the risk of 
increasing human and environmental exposure to this novel material [89]. Apart from any 
nano-specific hazards associated with exposure to nanosilver, overexposure to silver can 
cause a number of problems for humans and, especially, for the environment. 
The most common result of overexposure to silver in humans is argyria, a greyish 
discolouration of the skin as shown in Figure 1.2 [97]. Argyrosis is a similar discoloration 
of the eyes, usually caused by the use of silver containing eye-drops [98]. While 
disfiguring and generally irreversible, this 
condition is not life threatening. It results 
from the deposition of silver protein 
complexes in the skin’s basement 
membrane after chronic exposure to silver 
in various forms [99, 100]. Exposure to UV 
light can cause these deposits to be 
reduced to metallic silver, causing the skin 
to darken even further [101]. More serious 
health effects have been reported in 
extreme cases, involving fatty 
degeneration of the liver when exposed to 
AgNO3 [102] and possible kidney damage 
[101, 103].  
Historically, argyria has been observed in 
cases of workplace exposure, such as silver 
smelters and refiners, silver electroplaters 
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and finishers, manufacturers of metal powders and silver salts, and photographic 
processing workers, but this has become much less common with improved occupational 
safety and hygiene practices [99, 103-105]. Argyria cases have also been reported 
historically in relation to medical applications of silver including: silver-containing nose- or 
eye-drops and mouthwash; anti-smoking remedies; and treatment for burns [106-110]. 
More recently, there have been cases of argyria caused by the use of ‘colloidal silver’ 
preparations as a form of dietary supplement or ‘immune-booster’ [97, 111, 112]. 
While there are numerous examples of humans being overexposed to silver, and despite 
the possibly debilitating psychological implications of severe generalised argyria, the 
clinical relevance of these cases is low, except in the possibility of being a confounding 
factor in the diagnosis of other more serious diseases or conditions such as cyanosis 
[113]. In contrast, environmental exposure to silver can have serious consequences for 
the health of ecosystems, as silver is much more toxic to bacteria and aquatic organisms 
than mammals [114]. 
Since the late 1960s there has been concern about the impact of silver pollution on the 
environment and aquatic ecosystems [115]. By far the largest sources of silver pollution 
are mining operations, mostly in the form of leachate from tailings, refining and landfill 
[116]. Industrial sources of silver pollution have also been of concern in specific cases, 
such as photographic processing around the San Francisco Bay, California USA [116, 117]. 
Ionic silver (Ag+) is considered among the most toxic heavy metals to aquatic organisms, 
comparable with mercury and chromium [118]. Lethal concentrations of Ag+ for 
representative species of aquatic plants, invertebrates and fish lie between 1.2 to 4.9 
μg/L, while adverse effects are observed between 0.17 and 0.6 μg/L [114]. 
However, the chemical nature of silver is such that it is rarely present in a free ionic form 
in aqueous environments, whether natural waterways or wastewater streams [119]. The 
silver that does enter aquatic environments will mostly be in the form of insoluble sulfur 
or chloride complexes, which become deposited in sediments and pose a much lower 
hazard to fish than Ag+ [120]. The toxicity of silver sulfide-spiked sediments to crustacea 
(e.g. Hyalella azteca) and aquatic worms (e.g. Lumbriculus variegates) that live in and 
feed off these sediments has also been found to be relatively low [121, 122]. These 
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factors, combined with the increased recycling and recovery of silver from waste streams 
[123], as well as the dramatic collapse in the photographic film processing industry 
brought about by digital photography, means that the hazards of environmental 
degradation due to industrial silver pollution are generally under control, excluding major 
pollution events due to mining. 
1.4.4 Nanosilver: environmental and human health concerns 
While the consequences of over-exposure to silver for humans and the environment, as 
outlined in section 1.4.3, appear to be relatively innocuous and amenable to various 
forms of mitigation, the rapid rise in the production and use of nanosilver may pose 
additional hazards to conventional forms of silver used in the past [89, 124].  
1.4.4.1 Environmental exposure 
Silver NPs have the potential for very different interactions with wastewater treatment 
and aquatic environments than other forms of silver due to their solid, metallic nature. 
Particles taken up by organisms can act as a kind of ‘Trojan horse’ to deliver a significant 
amount of silver which, once inside the organism, can be broken down by low pH levels to 
highly toxic Ag+ [125]. Studies of the toxicity of nanosilver to a number of aquatic 
organisms have shown a range of adverse effects, such as abnormalities in zebrafish 
embryos, disruption of gill function in some fish, toxicity to invertebrates and algae, and 
inhibition of bacterial communities [126, 127]. 
The risk of adverse effects from nanosilver to ecosystems and wastewater treatment 
plants depends on the level of exposure. If silver NPs can persist in these environments 
and remain suspended to a sufficient degree, then the potential exposure for sensitive 
aquatic organisms may be quite high, considering the highly toxic nature of silver ions. 
Studies have shown that nanosilver impregnated fabrics can lose large amounts of silver 
NPs when being washed [128, 129]. It has been estimated that of all silver emissions into 
wastewater in Europe for the year of 2010, up to 15% would be in the form of nanosilver 
from antibacterial consumer goods, although this calculation does not include emissions 
from nanosilver manufacturing processes [130]. There is the potential for significant 
amounts of nanosilver from consumer products and manufacturing processes to end up 
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in wastewater treatment plants, but the magnitude of any hazards from this pollution 
depends on how the nanosilver interacts with the processes and environments present. 
In 2010, Kim et al. identified silver sulfide (Ag2S) nanoparticles in the final-stage sludge 
from a municipal wastewater treatment plant [131]. They suggested that the reducing, 
sulfur rich environment of the wastewater treatment process was transforming Ag+ and 
nanosilver in the wastewater stream to Ag2S nanoparticles. A further investigation by 
Kaegi et al. (2011) found that nanosilver spiked into a pilot wastewater treatment plant 
had transformed to Ag2S within 2 hours [132], while Tiede et al. (2010) found that for 
nanosilver spiked into sewage sludge samples, more than 90% of the nanoparticles 
became adsorbed to the sludge fraction within 6 hours [133]. Nevertheless, both of these 
studies found that some nanosilver either escaped in the wastewater treatment effluent 
shortly after being injected, or remained suspended in the supernatant fraction of the 
treatment environment in nanoparticle form. This, combined with studies showing that 
natural organic matter is capable of stabilising single silver NPs in suspension implies that 
there remains a significant possibility for exposure of aquatic organisms to nanosilver, but 
the extent of this exposure still remains to be quantified [134, 135]. 
1.4.4.2 Human exposure 
Parallel to the significant probability for exposure of aquatic organisms to nanosilver 
outlined above, the increase in consumer and medical products containing nanosilver 
poses a significant threat for the exposure of humans to these materials, especially in a 
workplace environment where these products, and the nanosilver itself, are 
manufactured [136]. A number of studies have examined the potential inhalational 
exposure of both workers and consumers to aerosolised nanosilver, and have found 
significant exposure risks from liquid-phase nanosilver manufacturing processes, during 
reaction and cleaning phases of nanosilver manufacturing, during use of nanosilver-
containing consumer aerosol sprays, and during handling by researchers of nanosilver 
powder in fume-hoods  [137-140]. This is likely to be the most common and potentially 
hazardous exposure route [141]. 
In light of this significant exposure potential to humans across the life-cycle of nanosilver 
containing products, the hazards related to different exposure routes have been a topic of 
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significant research involving in vitro cell line-based and in vivo rodent-based models. 
Inhalational and oral exposure studies in rats have described the systemic distribution of 
nanosilver to a range of tissues and organs. Takenaka et al. (2001) found significant 
translocation of silver to the liver and lung-associated lymph nodes of rats at 1 and 4 days 
after a 6 hour acute inhalational exposure [142]. The previously mentioned studies at the 
laboratory led by Professor Il Je Yu, at the Korean Environment and Merchandise Testing 
Institute, conducted 28 and 90 day inhalational and oral nanosilver exposure tests in 
Sprague-Dawley rats [28-31]. Ji et al. (2007) and Sung et al. (2009), in 28 and 90 day 
inhalational exposures in rats respectively, observed no significant effects on gross health 
indicators, haematology or blood chemistry. However, the shorter study showed silver 
translocation to the liver and the olfactory bulb, and the longer study showed dose-
dependent increases in silver concentration in the lungs, blood, liver, olfactory bulb, 
kidneys and brain [28, 29]. Oral exposure studies over 28 and 90 days by Kim et al. (2008, 
2010) also showed dose-dependent silver increases in the testes, kidneys, liver, brain, 
lungs, stomach and blood, for both exposure periods. No differences in gross health 
indicators or haematology were observed, but there was an increase in blood alkaline 
phosphatase and cholesterol consistent with impaired liver function, which was 
supported by histology [30, 31]. Although these studies only measured total silver in 
tissues and did not discriminate what form it was present in (i.e. whether as silver NPs, 
dissolved silver or silver complexes), it appears that there is significant potential for 
nanosilver to be systemically distributed through the blood to many organs and tissues 
following inhalational exposure. Furthermore, complementary studies suggest that silver 
NPs likely undergo significant chemical modification when absorbed orally, including 
within the GIT lumen itself, making the nature of systemically distributed silver in these 
cases ambiguous [53, 59, 143]. While it seems that there is still significant debate around 
the mechanisms and extent of the translocation of inhaled NPs to the systemic circulation 
and secondary target organs, in numerous studies of a range of NPs of different 
composition in humans and rodents, there remains significant potential for exposure to 
these tissues and organs depending on NP composition, size, aggregation and surface-
chemistry and charge of the NPs [26, 50, 51, 144-150]. 
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The studies described above identify the lungs, liver, kidneys and immune system as likely 
targets for inhalational and oral exposure to nanosilver. Additionally, skin cells are a 
significant target for nanosilver applied topically for infection control. A number of in vitro 
studies have been undertaken investigating the toxicological effects and hazards of 
nanosilver on cell lines specific to these target organs and systems, as well as the 
mechanisms behind any observed effects. Among the cell lines investigated in these 
studies are: the A549 human adenocarcinoma alveolar epithelial cell line [151-162]; 
NR8383 rat alveolar macrophages [74, 163], J774.A1 and RAW 264.7 mouse macrophages 
[162, 164-166], U937 human monoblastic leukemia cell line [167, 168] and THP-1 human 
acute monocytic leukemia cell line [161, 169, 170]; BRL-3A rat liver cell line [163, 171], 
HepG2 and Huh-7 human hepatoma cell lines [153, 161, 172-177]; as well as primary 
human keratinocytes and HaCaT immortalised human keratinocytes [86, 178-183]. 
Common toxicological outcomes observed in these studies include: significant cytotoxicity 
at high concentrations; increased ROS generation and oxidative stress, although the 
causality of this increase remains unclear; cell-cycle disruption; induction of apoptosis; 
DNA damage; significant cellular uptake of NPs; and stimulation of proinflammatory 
cytokines. There still remains considerable debate over the role of Ag+ and particle 
dissolution when considering in vitro investigations of silver nanotoxicology. 
The mechanisms behind the observed cytotoxicity of nanosilver are still debated, but it is 
commonly believed that ROS generation plays a central role, leading to mitochondrially-
mediated apoptosis, DNA damage and cell death [184]. An observed consequence of 
nanosilver exposure in vitro is the depletion of intracellular reduced glutathione (GSH), 
which is responsible for counteracting ROS within the cell [185]. It is unclear, however, 
whether this is solely due to the generation of ROS by the nanosilver, or if the nanosilver 
itself can deplete GSH stocks by binding directly to the thiol groups, for which silver has a 
high affinity. It is likely that the observed oxidative stress upon exposure to nanosilver is a 
combination of direct ROS generation, binding and depletion of GSH, and disruption of 
the mitochondrial respiratory chain, leading to further ROS generation. More research is 
required to tease apart the causality of these events in in vitro models due to the 
significant complexity involved. 
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1.5 The immune system: a target for human nanoparticle exposure 
Following exposure, NPs will encounter human immune cells shortly after entering the 
body, due to their ability to translocate into the circulation, and many organs and tissues, 
from different exposure routes [186-188]. These immune cells include: alveolar 
macrophages in the lungs; Langerhans cells in the skin; Kupffer cells in the liver; microglial 
cells in the brain; lymphocytes in the blood; monocytes in the spleen and blood; and 
other tissue-resident macrophages [57]. 
It is the role of immune cells to engulf foreign particulates in tissues, organs or the 
circulation, in order to destroy pathogens as part of the innate immune response, and 
also present and recognise antigens as part of the adaptive immune response [57]. These 
processes occurr to a large extent in the liver and the spleen, respectively, two organs 
that have been shown to accumulate NPs following exposure in a number of in vivo 
nanotoxicology studies [29, 31, 53, 189].  
Materials that interact with the immune system can have either immunostimulatory or 
immunosuppressive effects, with different consequences and risks for both outcomes. 
The effects of NPs on the human immune system have therefore been an area of 
increasing interest and research recently [190, 191]. 
1.5.1 Immunostimulation 
One of the most common results of immunostimulation is inflammation, an innate 
immune response. This occurs when macrophages sense an injury or infection and 
produce ROS to destroy any pathogens that may be present, such as bacteria, as well as 
emitting signalling molecules known as cytokines that recruit other immune cells, like 
neutrophils, which then produce more ROS and can lead to the damage of surrounding 
tissue [57]. 
Many NPs have been shown to cause inflammation or have proinflammatory effects by 
stimulating immune cells to produce cytokines such as interleukins (IL) -1, -6 and -8 and 
tumor necrosis factor (TNF) [192-196]. Acute or chronic inflammation can be dangerous, 
especially in vulnerable populations, so the ability of NPs to cause severe acute 
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inflammation or chronic low-level inflammation is a priority area of research for 
developing safe exposure limits. 
As well as stimulating innate immune responses, NPs may also stimulate acquired 
immunity, possibly causing an allergic reaction or leading to auto-immune disease. When 
NPs interact with a biological environment, they become coated in a range of 
biomolecules, e.g. proteins which form the protein corona mentioned previously [197, 
198]. It is also possible for NPs to be coated in other kinds of molecules, if they are used in 
food or food packaging for example, before encountering a human. If these NPs are then 
taken up by antigen-presenting immune cells and interpreted as pathogens, they may 
either provoke an allergic response in the case of food-associated molecules or an auto-
immune response if endogenous proteins are mistakenly recognised as pathogens due to 
their interaction with the NPs [77]. Research around NP-based vaccines has shown that 
some NPs may act as an adjuvant to stimulate an acquired immune response in this way 
[199, 200]. 
1.5.2 Immunosuppression 
Immunosuppression can occur through a range of mechanisms affecting any of the 
immune system components or cell types. Well-known examples include: irradiation with 
ultraviolet light, as one might experience on a sunny day at the beach, is known to 
suppress immunity in the skin; drugs are used to suppress the immune systems of organ 
transplant recipients to prevent transplant rejection; and sufferers of HIV can experience 
immunosuppression if not treated as the virus attacks immune cells [201-203]. In these 
cases the immune system is suppressed either by destroying particular types of immune 
cells, preventing the production or maturation of immune cells, or interfering with 
immune function and signalling, causing the immune system to become dormant or 
inactive [57]. 
If particular types of NPs interact with the human immune system to preferentially target 
a certain kind of immune cell or depress immune signalling, this may pose the hazard of 
immunosuppression. This could expose vulnerable populations to opportunistic 
secondary infections, such as pneumonia, or reduced tumor surveillance. There is some 
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evidence of NPs having immunosuppressive effects, although research in this area is still 
quite sparse [204-207]. 
Despite the possible dangers of inappropriate immunomodulation by NPs, there are also 
potential therapeutic benefits. If some NPs can behave as adjuvants then they may have 
applications in vaccination development, while other NPs exhibiting immunosuppression 
through anti-inflammatory or anti-allergenic effects may have applications in treating 
diseases of chronic or acute inflammation, such as asthma. More research is essential to 
better understand the immunomodulatory behaviour of NPs in order to most effectively 
utilise this ‘double-edged sword’. 
 
1.6 The in vitro immunotoxicology of nanosilver 
The immunotoxicology of nanosilver is still a relatively unexplored area, despite the 
widespread use of nanosilver and the recent increased research output examining various 
toxicological aspects of nanosilver exposure to humans and the environment. The 
mammalian immune system is highly complex in its structure, organisation and response 
to stimulus, and the human immune system has some different characteristics to that of 
common animal (rodent) models used in nanotoxicological testing. While it is important 
to test the response of such a complex system to NP exposure using in vivo models in 
order to see an integrated response, it can be difficult to tease apart the various 
mechanisms at play and then translate this to humans. To achieve a more complete 
understanding of how the immune system will react to nanosilver exposure, in vitro 
models of specific immune components can be utilised to explore individual responses 
and their causes [208]. But in order to understand these in vitro models, it is imperative to 
understand the physical and chemical properties of the test materials as well. 
1.6.1 Characterisation of nanosilver for in vitro immunotoxicology 
As discussed previously, the physicochemical characterisation of NPs used for in vitro or in 
vivo toxicology testing is paramount to being able to draw robust conclusions about the 
nature of the nano-bio-interactions taking place [209]. 
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Important characteristics to define for the toxicological investigation of nanosilver in vitro 
include: particle size distribution, aggregation state, agglomeration behaviour in cell 
culture medium, surface coatings and chemistry, surface charge, and surface area [210]. 
1.6.1.1 Size, shape and agglomeration behaviour 
There have been a number of studies examining the toxicology of nanosilver in vitro, with 
varying characterisation of the physicochemical properties of the nanosilver test 
materials, as reviewed by MacCuspie et al. (2011) [211]. All studies reported the size of 
the nanosilver investigated, although few presented a size distribution. The most common 
sizing techniques were transmission electron microscopy (TEM) and dynamic light 
scattering (DLS) [211]. TEM is useful for determining a primary particle size distribution, if 
a thorough dispersion can be cast onto a TEM grid to allow measurement of individual 
particles. The benefit of TEM is that it also allows characterisation of particle shape, with 
nanosilver showing almost exclusively a spherical aspect in the literature, except where 
specialised forms of nanosilver were investigated, such as silver nanowires [157]. DLS is a 
very popular particle sizing technique due to the relative affordability of the instruments 
and uncomplicated nature of measurements. DLS also has drawbacks that are rarely 
acknowledged in nanotoxicology literature; for polydisperse samples, such as nanosilver 
dispersed in cell culture media and has undergone a degree of agglomeration, the larger 
particles or agglomerates scatter much more intensely than the individual particles, 
making the measurement almost useless [211]. Most literature investigating the 
toxicology of nanosilver presents relatively limited size distribution characterisation, and 
almost no characterisation of particle agglomeration behaviour in exposure media. 
There have been a number of investigations into effective techniques for characterising 
NP size distribution which are not widely reflected in nanotoxicological investigations yet. 
Techniques such as differential centrifugal sedimentation, which can provide a more 
robust measure of size distribution for polydisperse samples than DLS, field flow 
fractionation [212, 213], particle tracking [214], and cryogenic TEM [22] may provide 
better size distribution information than the most widely used combination of TEM and 
DLS, especially for agglomerated samples in exposure media. However, these techniques 
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may not be as widely available to all laboratories, highlighting the need for better 
collaboration between toxicologists and materials scientists. 
1.6.1.2 Surface charge and surface area 
The surface charge of NPs, also known as zeta potential, is important to characterise for 
toxicological investigations as it can influence the stability of dispersions and how the 
particles might interact with their surroundings in a biological environment [77]. The zeta 
potential of nanosilver in water is a fairly widely reported characteristic in 
nanotoxicological investigations, possibly because most DLS instruments also measure 
zeta potential. However, as with DLS measurements, an accurate zeta potential 
measurement depends on the stability of the NP suspension, a fact that is rarely 
acknowledged. Once NPs are introduced to a biological medium, their surfaces will be 
covered with biomolecules, changing their surface charge. A number of studies also 
report zeta potential measurements in the exposure media, but this measurement may 
be of dubious quality due to the effect of large charged biomolecules present in the 
suspension that can influence the reading [215]. It would be more useful to characterise 
how NP surface charge influences the formation of a protein corona in different biological 
environments relevant to exposure pathways, and how this effects NP-cell interactions. 
Some laboratories are investigating the formation of protein coronas, but this is at a stage 
where it is difficult to generalise mechanistic interpretations across different systems and 
NPs [198, 216]. 
Surface area has been shown to be a very important factor when considering 
nanotoxicology. However, there are still many investigations in the literature that do not 
report surface area characterisation, especially in the topic of nanosilver. This may be due 
to the nature of nanosilver test materials, which are to a large degree manufactured and 
distributed in suspension. The most commonly used technique for measuring particle 
surface area, the Brunauer-Emmet-Teller (BET) gas adsorption isotherm, only works on 
dry powders. As such, it would be difficult to produce an accurate and relevant surface 
area measurement for nanosilver if it needed to be somehow taken out of suspension, 
dried and degassed before being measured. It is likely that these processing steps would 
alter the material to a degree such that any surface area measurement would be 
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unrepresentative of the as-manufactured sample, because nanosilver can sinter and form 
hard aggregates very easily. Specific surface area values for nanosilver test materials can 
be calculated from size distribution and particle shape data, such as can be determined 
using TEM [217]. There exists a technique to directly measure the specific surface area of 
particle suspensions using nuclear magnetic resonance (NMR) which was described in 
1987 [218] and for which there is commercial instrumentation available [219], but it 
appears that this technique has escaped the notice of nanotoxicology researchers to date. 
Depending on the reliability of measurements by this technique in terms of particle-
media interactions, it may be possible to use NMR surface area measurements to assess 
NP aggregation in exposure media over time. This is an area that requires further 
research, as this remains a serious problem in NP characterisation for in vitro 
nanotoxicology studies. 
1.6.2 Cell culture for the immunotoxicology of nanosilver in vitro 
As mentioned previously, there have been a range of investigations into the interaction of 
nanosilver with immune cells in vitro, derived from humans, mice and rats including: 
NR8383 rat alveolar macrophages [74, 163], J774.A1 and RAW 264.7 mouse macrophages 
[162, 164-166], U937 human monoblastic leukemia cell line [167, 168] and THP-1 human 
acute monocytic leukemia cell line [161, 169, 170]. The cell types used in this research 
project are discussed in detail below. 
1.6.2.1 The THP-1 cell line 
The THP-1 human acute monocytic leukemia cell line provides a good model system to 
investigate immunotoxicology as it is versatile, in that it can be transformed to a 
macrophage-like cell by incubating with phorbol-12-myristate-13-acetate (PMA) under 
normal cell culture conditions [220], and easily sub-cultured as the monocytes do not 
attach to cultureware. While this is an immortalised cancer cell line, it still exhibits most 
of the characteristics of primary monocytes, i.e. active phagocytosis, α-naphthyl butyrate 
esterase activity, and lysozyme production [221]. It has been observed that PMA-
stimulated THP-1 cells behave more like native macrophages than other monocytic cell 
lines, and are therefore useful in examining the functions and interactions of 
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macrophages in vitro [222], and as such it is a relatively widely used cell line for 
immunotoxicological investigations. 
Some studies have examined the effect of low levels of Ag+ on THP-1 cells [223-225], 
while others looked at the inflammatory responses of THP-1 cells to silver nanoparticles 
and the effect of particle agglomeration [161, 169, 170, 226]. It has been generally 
observed that exposure to silver, in the form of nanosilver or Ag+, causes dose-dependent 
cytotoxicity and proinflammatory responses in THP-1 cells. 
1.6.2.2 Peripheral blood mononuclear cells 
Peripheral blood mononuclear cells (PBMCs), primarily lymphocytes and monocytes, can 
be isolated from human blood by a number of techniques in order to be used for in vitro 
immunotoxicological testing [227, 228]. Given that blood donations for medical purposes 
must be depleted of these immune cells before they can be used for transfusions, 
following ethical approval these cells can be accessed relatively easily for experiments as 
they would otherwise simply be disposed of. Establishing consistent cultures of primary 
immune cells is quite difficult [229-231], so it is important to have reliable access to these 
unwanted cells. 
As the immune cell lines described previously are derived from cancerous cells, they can 
have altered behaviour when compared with primary human immune cells. Therefore, 
there is significant interest in conducting research on PBMCs as a comparison with 
experiments conducted using immortalised cell lines. There have been a limited number 
of investigations into nanosilver immunotoxicology using PBMCs, mostly examining 
cytotoxicity or proliferation and the release of inflammatory cytokines, in some cases 
compared with THP-1 cells [170, 232-234]. Generally, PBMCs appear more sensitive to 
nanosilver than THP-1 cells, and also produce a proinflammatory response. 
1.6.2.3 HaCaT human keratinocyte cell line 
It has been established that the immune system is a target for nanosilver exposure 
through oral, inhalational and intravenous entry portals, but a major use of nanosilver is 
in infection control for wounds, especially burns [86, 178, 235]. This makes skin cells 
another major target for nanosilver exposure, in particular keratinocytes which will be 
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proliferating under these conditions. Whilst keratinocytes are not immune cells, they do 
release immunomodulatory cytokines and chemokines when exposed to UV light and 
chemicals [236].  
The HaCaT human keratinocyte cell line is widely utilised for in vitro investigations of skin 
cell toxicology. It was established in 1988 by Boukamp et al. and is a spontaneously 
transformed, immortalised cell line, but it is not cancerous and retains normal 
differentiation [237]. These properties make this cell line a convenient model for 
toxicological investigations and have been used in a number of studies examining the 
interaction of nanosilver with skin cells, mostly in terms of cytotoxicity and proliferation, 
as well as cytokine release [182, 183, 238-240]. Nanosilver has also been shown to cause 
dose-dependent cytotoxicity in HaCaT cells and stimulate IL-6 release. 
1.6.3 In vitro testing considerations 
Important considerations for in vitro nanotoxicology testing have been examined a 
number of times in order to produce the most reliable and useful data [24, 25, 241]. As 
well as particle characterisation, which has been covered previously, some important 
considerations are: dosimetry, i.e. how does the nominal NP concentration in exposure 
media relate to cellular dose; and which toxicological endpoints are most relevant. 
1.6.3.1 In vitro NP dosimetry 
Dosimetry for in vitro nanotoxicological testing is still one of the most poorly understood 
and controlled aspects of nanotoxicology. The amount of NPs added to the culture system 
does not necessarily relate linearly to the cellular dose of NPs, with factors such as 
volume and height of exposure media in the wells of the multiwall plate, cell-growth 
surface area, particle agglomeration and rate of cellular uptake all affecting the ultimate 
cellular dose. 
Several methods to improve dosimetry for in vitro nanotoxicological investigations have 
been proposed, although this area still requires a great deal of further research [242-246]. 
A computational model to assess dosimetry, known as ISDD, has been developed by 
Hinderliter et al. (2010) but this approach has not yet been widely adopted. The majority 
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of in vitro nanotoxicology investigations simply report mass concentrations of NPs 
delivered to cultured cells and very few studies assess the rate of particle uptake. 
1.6.3.2 In vitro immunotoxicology endpoints 
The most common endpoint investigated in any in vitro toxicology experiment is 
cytotoxicity. This is usually accomplished using a tetrazolium dye-based assay, which cells 
metabolise to a coloured formazan dye [247]. By measuring the absorption of the dye at a 
particular wavelength, the proportion of living cells can be determined by comparison 
with an untreated control [184, 232].  
In parallel with cytotoxicity is the mode of cell death. There are two major routes of cell 
death, apoptosis, an energy-dependent ‘programmed’ death, or necrosis, where cells are 
split open by cellular trauma releasing their internal components into the surrounding 
environment. This is commonly assessed using dual cellular stains that bind to different 
components of the cells and are quantified using flow cytometry. This allows the 
proportion of viable (unstained) apoptotic and necrotic cells to be assessed following NP 
exposure [169]. 
ROS generation has been identified as a major contributor to cytotoxicity for nanosilver 
[74] and is widely investigated. Many studies have used the oxidation of a cell permeable 
probe, 2′-7′-dichlorodihydrofluorescin diacetate (H2DCF-DA), to the fluorescent product 
2′-7′-dichlorodihydrofluorescein (DCF) in order to assess the redox status of cells, or a 
fluorescent molecule called MitoSOX Red to measure mitochondrial superoxide 
production, either by flow cytometry or spectrofluorometric plate reader [169, 248, 249]. 
In addition to measuring ROS production, cellular oxidative stress as the direct result of 
excess ROS production, has also been assessed through the measurement of lipid 
peroxidation, caused by the oxidation of cellular membranes due to excessive ROS, and 
glutathione depletion, a major intracellular antioxidant [184, 250].  
Cytokine signalling is central to determining the immunomodulatory effects of NPs and 
has also been widely studied; usually using enzyme-linked immunosorbent assays (ELISA). 
The most commonly studied are the pro inflammatory cytokines, such as IL-1, IL-6, IL-8 
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and TNF, which have all been shown to be induced by nanosilver [167, 168, 226, 232, 
233].  
1.6.4 Intracellular localisation of nanosilver 
Many studies have shown that NPs are taken up by cells through various mechanisms 
[251]. The intracellular localisation of these NPs to specific organelles once taken up by 
cells may determine their level and mechanisms of cytotoxicity. 
Thin section TEM has long been utilised to examine the ultrastructure of resin-embedded 
cells [252], and in the case of nanosilver intracellular localisation it is a fairly useful tool, 
as the silver NPs provide good contrast in TEM micrographs. Several studies using TEM 
have shown that nanosilver is generally localised to vacuoles within the cell cytoplasm, 
and has not been found to be located in the nucleus [74, 161, 181]. 
A different approach has also been developed to probe the localisation of silver and gold 
nanoparticles within cells utilising surface enhanced Raman scattering (SERS). This 
technique was examined for its uses in probing the internal structure of cells, but it also 
functions as a tool to examine where nanosilver localises inside cells for toxicological 
purposes [253-255]. The interaction of the metallic surface of silver NPs with closely 
associated biomolecules produces a very large enhancement of infra-red spectroscopy 
(Raman) signals when irradiated with an appropriate wavelength laser. These signals can 
be used to determine the chemical bonds present in these molecules, and the spike in 
signal over background noise can be used to locate the particles within the cells [256, 
257]. The application of this technique for probing live cells is still in its infancy, and is yet 
to be widely adopted. It has not been used previously for the purposes of nanotoxicology. 
 
1.7 Conclusions 
Nanotoxicology is a rapidly developing field of research dedicated to promoting the safe 
use of nanomaterials through understanding their potential hazards and risks. The recent 
growth in the use of nanosilver for its antibacterial properties in medical and consumer 
products gives cause for concern about the potential exposure of humans and the 
environment to this novel material. This in turn has prompted a similar growth in the 
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number of nanotoxicological investigations into the safety of nanosilver, both in vitro and 
in vivo, which have characterised its ability to: translocate from oral and inhalational 
exposure routes to the systemic circulation and accumulate in secondary target organs, 
such as the liver and the spleen; be cytotoxic and produce ROS to increase oxidative 
stress; be proinflammatory; and have genotoxic potential [29, 31, 171, 258-260]. 
The human immune system is a secondary target following exposure to nanosilver due to 
its role in clearing particulate matter from the circulation. There have been a limited 
number of studies examining the immunotoxicology of nanosilver, and this is an area of 
research that requires more work to understand the potential immunomodulatory effects 
likely from exposure to nanosilver. 
The THP-1 acute monocytic leukemia cell line provides a useful in vitro model to examine 
the interactions of nanosilver with monocytes and macrophage-like cells, in order to 
assess NP-induced cytotoxicity, cell death, ROS production, oxidative stress and cytokine 
signalling. 
This kind of in vitro investigation is important to advance the mechanistic understanding 
of how nanosilver interacts with immune cells, to better interpret more complex 
experimental systems, such as the immunotoxicology of nanosilver in vivo. 
 
1.8 Scope and project outline 
This project investigated the utility of an in vitro model based on the THP-1 human acute 
monocytic leukemia cell line to assess the immunotoxicology of four kinds of nanosilver 
(including two OECD WPMN test materials) and silver ions. Endpoints investigated in this 
project included: cytotoxicity, the relative potency of different nanosilver and the timeline 
of any cytotoxic events; cell death pathways, the ratio of apoptotic to necrotic cells upon 
exposure to nanosilver; intracellular ROS production and oxidative stress of cells exposed 
to nanosilver, through lipid peroxidation and reduced glutathione depletion; cytokine 
signalling by immune cells exposed to nanosilver to assess the mode of immune 
response; and the intracellular localisation of nanosilver within phagocytic immune cells. 
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Some of these endpoints were also assessed in primary human immune cells isolated 
from peripheral blood and human keratinocytes of the HaCaT cell line. 
The aim of this project was to investigate the relative utility of a number of common 
toxicological and immunological techniques to assess the cytotoxic and immunotoxic 
effects of a range of types of nanosilver to human cell cultures, including immortalised 
and primary cell lines of epithelial and immune cells. It was hypothesised that different 
kinds of nanosilver would show dose-dependent cytotoxicity of varying potency 
depending on the respective physicochemical characteristics, and that human immune 
cells exposed to nanosilver would show an immune response through the stimulation of 
specific cytokines. 
The outcomes of this project will help to increase the understanding of immune 
responses to nanosilver exposure and the mechanisms behind observed responses. It will 
also serve to assess the utility, practicality, and reliability of common in vitro toxicological 
techniques when investigating the immunotoxicology of nanosilver. 
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2 General materials and methods 
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2.1 Carey Lea’s colloidal nanosilver synthesis 
This project involved the repeated, in-house synthesis of a citrate capped nanosilver 
preparation (9.2 ± 3.5 nm diameter). The synthesis of nanosilver by the ‘Carey Lea’s 
colloidal silver’ method was undertaken using a method based on that described by Frens 
and Overbeek [261]. ACS reagent grade (>99% pure) silver nitrate, trisodium citrate 
dihydrate and iron sulfate heptahydrate were all purchased from Sigma-Aldrich.  
3.5 mL of a 40% w/w solution of trisodium citrate was mixed with 3 mL of a 30% w/w 
solution of iron sulfate heptahydrate. This mixture was added dropwise to 2.5 mL of a 
10% w/w solution of silver nitrate in a small glass beaker over a period of approximately 
two minutes while being stirred with a magnetic stirrer. The resulting suspension was 
stirred for a further 15 minutes before being decanted into a 15 mL plastic centrifuge 
tube. This was centrifuged at 1400 g for 10 minutes, after which the supernatant was 
decanted. The pellet of nanosilver was resuspended in 5 mL of milliQ water and then 
reprecipitated with 5 mL of 40% trisodium citrate and centrifuged again for 10 minutes at 
1400 g. The above wash step was repeated twice more for a total of three washes, and 
the nanosilver was resuspended in 10 mL of milliQ water. This resulted in a concentrated 
dark red/brown dispersion and was used within four weeks of synthesis. 
 
2.2 Particle characterisation 
Four types of nanosilver were investigated in this project: ‘Sigma’ silver nanopowder was 
purchased from Sigma Aldrich, with an advertised particle diameter of “< 100 nm”; 
laboratory synthesised ‘Carey Lea’s’ colloidal silver as described in section 2.1; ‘NM-300K’ 
was obtained through the European Commission’s Joint Research Centre as part of the 
OECD Working Party on Manufactured Nanomaterials (WPMN) Sponsorship Programme 
for the Testing of Manufactured Nanomaterials phase 1, produced by RAS GmbH in 
Germany with an advertised particle diameter of 15 nm in a 10.16% w/w dispersion 
containing 4% each of polyoxyethylene glycerol trioleate and ‘Tween 20’, coated with 
polyvinylpyrrolidone (PVP); and an ‘ABC Nanotech’ produced dispersion also obtained as 
part of the OECD WPMN test program, made in Korea with an advertised particle 
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diameter of 10 to 15 nm in an aqueous solution with citrate capping, similar to the Carey 
Lea’s nanosilver [11]. 
Nanosilver was characterised using three techniques: transmission electron microscopy 
(TEM); dynamic light scattering (DLS); and differential centrifugation sedimentation (DCS), 
also known as disc centrifugation. 
2.2.1 Transmission electron microscopy 
Nanosilver was characterised using a Tecnai 12 transmission electron microscope (FEI, 
Netherlands) at an operating voltage of 120 KV, and images were captured using a 
Megaview III CCD camera with AnalySIS camera control software (Olympus) at CSIRO 
Materials Science and Engineering, Parkville, Victoria, Australia. 
2.2.1.1 Semi-automated particle size analysis from TEM micrographs 
TEM samples for particle size analysis were prepared by pipetting a 4 µL aliquot of the 
relevant nanosilver suspension in water on a nitrogen glow-discharged, 300-mesh, copper 
TEM grid, covered with amorphous carbon film. Excess liquid was wicked from the grid 
and then allowed to air dry. Grids were imaged at two magnifications and sub-sampled at 
a number of different locations to obtain a representative sample of each type of 
nanosilver. 
Particle size distribution data was obtained from these TEM images using ImageJ image 
analysis software. This process broadly followed that set out by Dune Sciences, Inc [262]. 
TEM images of well dispersed nanosilver particles were thresholded to produce a binary 
image and remove any background. The thresholded images were then ‘despeckled’ to 
remove any noise that may have been present from the image background. The resulting 
images were analysed using the built-in particle analyser function in ImageJ. The area 
projected by the particles in each image was measured, and particle diameters were 
expressed as            where A is the projected particle area in the TEM image, i.e. 
assuming the particles were spheres. Each image was calibrated using the scale-bar as 
determined by the TEM software based on magnification. 
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2.2.1.2 Cryo-TEM 
Cryo-TEM samples were prepared to examine particle agglomeration in cell culture media 
by pipetting a 4 µL aliquot of the relevant nanosilver suspension in media onto a nitrogen 
glow-discharged 300-mesh copper TEM grid covered with lacy formvar-carbon film 
(ProSciTech, Queensland, Australia). After 30 seconds the grids were blotted with filter 
paper then plunged into liquid ethane cooled with liquid nitrogen. This caused the cell 
culture media containing nanosilver to form vitreous ice which is effectively transparent 
to electrons, providing a good model of the agglomeration state of the nanosilver in the in 
vitro culture conditions. The frozen grids were stored in liquid nitrogen until required. 
They were examined using a Gatan 626 cryoholder (Gatan, California, USA) to keep them 
below -170 °C to prevent the samples from de-vitrifying. 
2.2.2 Dynamic Light Scattering 
DLS was performed on nanosilver suspensions in water to determine a primary particle 
size distribution. All measurements were performed on a Zetasizer Nano ZS (Malvern) at 
the Nanometrology section of the National Measurement Institute, Lindfield, New South 
Wales, Australia. Each sample was prepared by weighing the appropriate amount of 
nanosilver and diluting with milliQ water for a final silver concentration by weight of 200 
µg/mL, 24 hours before measurement. Aliquots of 1 mL per sample were loaded into 
polystyrene cuvettes for analysis. 
The instrument used a 633 nm He-Ne laser with a scattering angle of 173°. Each 
measurement was performed in triplicate at a temperature of 20 °C. 
The autocorrelation functions derived from DLS measurements were fitted using the 
cumulants method. A sub-set of logarithmically-spaced, quadratically-weighted points, 
normalized by baseline subtraction, was selected from each autocorrelation function for 
which the Z-average effective sphere hydrodynamic diameter and polydispersity index 
were calculated using Zetasizer Software v6.2 (Malvern). 
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2.2.3 Differential centrifugation sedimentation 
DCS or disc centrifugation analysis was undertaken on nanosilver that hadbeen incubated 
in cell culture media containing 10% fetal bovine serum for at least 24 hours prior to 
analysis. Measurements were performed on a DC24000 Disc Centrifuge (CPS Instruments, 
Inc., Florida, USA). 15 mL of a gradient solution containing 24% w/w sucrose dissolved in 
RPMI-1640 culture media was loaded into the disc and spun at 24000 RPM for 60 minutes 
to equilibrate. An aliquot of 100 µL, at a concentration of 200 µg/mL for ABC Nanotech, 
NM-300K and Carey Lea’s, and 600 µg/mL for Sigma, was directly injected onto the disk 
for each sample. A standard consisting of polystyrene beads with a diameter of 390 nm 
was used to calibrate the system before each measurement. Particles are assumed to be 
spherical and have uniform density for diameter calculations. 
2.2.4 Specific surface area and particle number density 
The specific surface area for each type of nanosilver was calculated from size distribution 
data: TEM derived data was used for ABC Nanotech, NM-300K and Carey Lea’s; DCS 
derived data was used for Sigma nanosilver. Calculations relied on the raw binned data 
used to generate the plots shown in section 3.2. Specific surface area per unit volume (m-
1),   , was calculated using:      
  
  
 where    is the number of particles in bin ‘i’ and 
   is the mass fraction of particles in bin ‘i’, which is defined for spherical particles as 
   
  
   
   
   
 where    is the particle diameter at the centre of bin ‘i’. The specific surface 
area per unit volume,   , was converted to the surface area per unit mass (m
2/kg) by 
dividing    by the density of silver, 10 500 kg/m
3 [263]. The above equations are 
described in Holdich [217]. 
The particle number mass density for each type of nanosilver was also calculated using 
the same size distribution data. The particle mass distribution (kg),  , was calculated 
using:      
 
 
     
  where    is the density of silver. The inverse of    was 
calculated to determine the particle number mass density (particles/kg). 
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2.3 Cell culture 
This project involved the culturing, and incubation with nanosilver, of five cell types: THP-
1 human monocytes, and PMA-stimulated macrophages derived from them; primary 
human monocytes isolated from peripheral blood, and PMA-stimulated macrophages 
derived from them; and HaCaT human keratinocytes. All cell cultures and cell culture 
exposures were kept in a humidified incubator at 37 °C with a 5% CO2 atmosphere. All cell 
culture media and solutions for exposures and culturing were kept at 37 °C using a water 
bath unless otherwise stated. Cell culture and exposure experiments were performed 
under aseptic conditions in a class 2 biohazard containment hood, and materials were 
sterilised by spraying with 70% v/v ethanol in water. Cells were cultured in Cellstar® 75 
cm2 filter-cap polystyrene culture flasks (Greiner Bio-One, catalogue number 658 175) and 
exposures were carried out in Cellstar® 96-well polystyrene, flat bottomed microplates 
(Greiner Bio-One, catalogue number 655 180). 
2.3.1 THP-1 human acute monocytic leukemia cell line 
The THP-1 cell line (donated by Department of Epidemiology and Preventative Medicine, 
Monash University, Melbourne, Australia) was cultured in RPMI-1640 cell culture media, 
without L-glutamine, with 25 mM HEPES (Sigma-Aldrich, catalogue number R5886). The 
culture media was freshly prepared for culturing and experiments by supplementing with 
4.5 g/L D-glucose (AnalaR, BDH), 1 mM sodium pyruvate (ReagentPlus®, Sigma-Aldrich), 2 
mM L-glutamine (BioXtra, Sigma-Aldrich), 0.05 mM β-mercaptoethanol (BioReagent, 
Sigma-Aldrich), 100 mg/L gentamycin sulfate (BioReagent, Sigma-Aldrich), and 10% v/v 
heat inactivated fetal bovine serum (FBS) (Australian origin, SAFC Biosciences, Sigma-
Aldrich Corportation). This supplemented media will henceforth be referred to as THP-1 
culture media (TCM). The cells were cultured to a cell density of between 1 and 2 x 106 
cells/mL before being subcultured into fresh TCM at a dilution factor of 1 in 10, usually 
once a week, with a doubling time of approximately 22 hours.  
For nanosilver exposure experiments, THP-1 cells were harvested from cultures at a cell 
density of between 0.5 and 1 x 106 cells/mL. The cell suspension was aspirated from the 
culture flask using a 25 mL sterile graduated pipette and transferred to either a 10 or 50 
mL centrifuge tube. This was centrifuged at 200 g for 5 minutes to pellet the cells. The 
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supernatant was discarded and the cell pellet resuspended in 5 mL of fresh TCM. An 
aliquot of 50 µL was then taken and stained with 50 µL of 0.4% w/v trypan blue solution. 
The stained cell suspension was then counted, within 5 minutes of staining, to determine 
the concentration of viable cells using KOVA Glasstic haemocytometer slides (Hycor) and a 
Leitz Diaplan optical microscope. The 5 mL of suspended THP-1 cells were then made up 
with fresh TCM to a concentration of 106 cells/mL. This suspension was seeded into 96-
well microplates: 100 µL of cell suspension (105 cells) for monocyte experiments and 80 
µL (0.8 x 105 cells) for macrophage experiments. 
Phorbol ester stimulation for 24 hours was used to differentiate THP-1 monocytes into 
macrophage-like cells [220]. A 100 nM solution of phorbol-12-myristate-13-acetate (PMA) 
was prepared by diluting 25 µM PMA dissolved in dimethylsulfoxide (DMSO) (ACS grade, 
Amresco) by a factor of 1:250 in fresh TCM. 20 µL of this working solution was then 
pipetted into the wells of a 96-well plate already containing 80 µL of THP-1 cell 
suspension, to produce a final PMA concentration of 20 nM, or 12.3 ng/mL. These 
conditions gave the best balance between not over-stimulating the differentiated 
macrophages, as shown by Park et al. (2007) [264], and ensuring at least 80% of 
stimulated THP-1 cells became adherent within 24 hours, as shown by Tsuchiya et al. 
(1982) [220]. 
Once the THP-1 cells had been added to 96-well plates, and had PMA added in the case of 
macrophage experiments, the plates were incubated for 24 hours (at 37 °C and 5% CO2). 
Following this incubation the supernatant was aspirated from macrophage-containing 
wells, leaving behind differentiated macrophages which had attached to the culture 
surface, and replaced with fresh TCM immediately before exposure to nanosilver. 
Macrophage differentiation was confirmed by examining cellular morphology using light 
microscopy.  
2.3.2 Peripheral blood mononuclear cells 
Primary human monocytes were isolated from ‘buffy-coat’ material sourced from the 
Australian Red Cross Blood Service (Melbourne, Australia), which is a by-product of blood 
donations containing immune cells (under RMIT University Human Research Ethics 
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Committee project number 29/08). Two isolation techniques were investigated, 
separation by attachment and separation by density gradient. 
2.3.2.1 Monocyte attachment method 
The separation by attachment method was adapted from Zuckerman et al. [229]. BD 
Vacutainer® CPT glass molecular diagnostics tubes (BD, New Jersey) containing Ficoll™ 
medium and 0.1 mL of 0.1 M sodium citrate were used to separate leukocytes from any 
remaining erythrocytes in the buffy-coat. After centrifuging the tubes at 1500 g for 15 
minutes at room temperature, the interphase band containing the leukocytes was 
removed along with the serum and collected in a 50 mL centrifuge tube. This was 
centrifuged at 300 g for 5 minutes and the supernatant was discarded. The cell pellet was 
resuspended in 25 mL of warm phosphate buffered saline (PBS) (made from PBS tablets 
(Sigma-Aldrich) and milliQ water, sterilised at 121 °C) and centrifuged again at 300 g for 5 
minutes to remove any residual platelets. This wash step was repeated for two washes. 
Following this, the leukocytes were resuspended in 25 mL of TCM and counted to 
determine the concentration as described in section 2.3.1. The leukocyte suspension was 
diluted to a concentration of approximately 5 x 106 cells/mL in warm TCM and 15 mL of 
this suspension was added to 75 cm2 culture flasks and incubated at 37 °C for 90 minutes 
to allow the monocytes to attach. 
Following the attachment step, the supernatant was decanted from each flask, and the 
flasks were gently washed twice with 5 mL of PBS. The flasks were then incubated with ice 
cold 5 mM EDTA in PBS for 10 minutes to detach the monocytes. The flasks were tapped 
gently and a serological pipette was used to thoroughly wash the cell attachment surface 
to remove as many monocytes as possible. The detached monocytes were collected in a 
50 mL centrifuge tube and centrifuged at 200 g for 5 minutes. The cell pellet was 
resuspended in 5 mL of TCM and the protocol described in section 2.3.1 was then 
followed from the cell counting stage. 
2.3.2.2 Density gradient method 
The separation of monocytes by density gradient method was adapted from Danciger et 
al. [228]. A Histopaque (Sigma-Aldrich) gradient was used to separate leukocytes from the 
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buffy-coat: 15 mL of Histopaque was added to a 50 mL centrifuge tube and 15 mL of 
buffy-coat was layered carefully over the top. The tubes were centrifuged at 400 g for 30 
minutes at room temperature. The serum layer was aspirated carefully using a serological 
pipette and discarded. The leukocyte layer at the interphase was carefully collected in a 
fresh 50 mL centrifuge tube. 15 mL of leukocytes were then diluted with 35 mL of 1 mM 
EDTA in PBS and centrifuged at 200 g for 10 minutes at room temperature. The cell pellets 
were collected in one fresh 50 mL centrifuge tube, diluted with 40 mL of 1 mM EDTA in 
PBS and centrifuged again at 200 g for 10 minutes. This wash step was repeated once and 
the remaining cell pellet was resuspended in 40 mL of TCM without phenol red. The cells 
were counted as described in section 2.3.1 and made up with TCM to a concentration of 
approximately 5 x 106 cells/mL. 
Iso-osmotic Percoll was prepared by adding 7.5 mL of 10x PBS to 92.5 mL of Percoll 
(Amersham). A 46% Percoll gradient was prepared by combining 92 mL of iso-osmotic 
Percoll to 108 mL of TCM with phenol red and 25 mL of this gradient was divided across 
eight 50 mL centrifuge tubes. 25 mL of the leukocyte suspension was carefully layered 
over the top of the 46% Percoll gradient and the tubes were centrifuged at 550 g for 30 
minutes at room temperature. The monocytes formed a layer at the interphase and were 
collected with a serological pipette. 15 mL of collected monocytes were diluted with 35 
mL of 1 mM EDTA in PBS and centrifuged at 400 g for 10 minutes. The cell pellet was 
resuspended in 20 mL of TCM and the protocol described in section 2.3.1 was then 
followed from the cell counting stage. 
2.3.3 HaCaT human keratinocyte cell line 
The HaCaT human keratinocyte cell line (donated by Professor Peter Parsons at QMIR, 
Brisbane, Australia) was cultured in RPMI-1640 media supplemented with 5% v/v heat 
inactivated FBS and 1% v/v penicillin-streptomycin-glutamine (Invitrogen), henceforth 
referred to as HaCaT culture media (HCM). HCM was refreshed every 3 to 4 days.  
Once the cells reached confluence, usually a week after seeding, spent media was 
aspirated and the cells were washed with trypsin-EDTA solution for subculturing. The cells 
were then incubated with 3 mL of trypsin-EDTA solution for 3 minutes (at 37 °C and 5% 
CO2). Cells were detached from the flask with gentle tapping and the cell suspension was 
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harvested into a 15 mL centrifuge tube containing 3 mL of HCM. This was centrifuged at 
400 g for 5 minutes and the supernatant was discarded. The cells were resuspended in 1 
mL of HCM, and 250 µL of this suspension was seeded into a 75 cm2 culture flask 
containing 20 mL of fresh HCM. The cells had a doubling time of approximately 18 hours. 
For nanosilver exposure experiments, the media was aspirated from a confluent culture 
flask of HaCaT cells which was then washed with 3 mL of warm trypsin solution. The cells 
were then incubated with 3 mL of trypsin for 5 minutes at 37 °C. The flask was gently 
tapped to free the cells, and cell detachment was confirmed by light microscopy. The cell 
suspension was harvested into a 15 mL centrifuge tube containing 3 mL of fresh HCM to 
inactivate the trypsin. The cells were centrifuged at 400 g for 5 minutes, the supernatant 
discarded and the pellet resuspended in 2 mL of fresh HCM. An aliquot of 50 µL was 
stained with trypan blue and counted as described in section 2.3.1. The cell suspension 
was made up with fresh HCM to a concentration of 4 x 104 cells/mL. This suspension was 
seeded into 96-well plates with a volume of 100 µL to give 4 x 103 cells per well. Plates 
were kept at room temperature for 30 minutes to allow the cells to distribute evenly 
across the bottom of the wells before attaching, and then incubated as described in 
section 2.3 for 24 hours before exposure to nanosilver. 
2.3.4 Nanosilver exposures 
Concentrated stock suspensions of nanosilver in milliQ water were prepared for cell 
culture exposures. Small amounts of each kind of nanosilver were weighed out in 5 mL 
polypropylene specimen tubes, and milliQ water was added to make a final silver 
concentration by mass of 20 mg/mL, or in the case of silver nitrate 2 mg/mL of Ag+. These 
tubes were then sterilised by sonicating in an ultrasonic bath (150 W) for 10 minutes. 
Working suspensions of each type of nanosilver were prepared 24 hours before exposure. 
Specific volumes of each nanosilver stock solution were added to fresh TCM or HCM for 
the relevant cell type at room temperature and mixed thoroughly by inversion to give the 
desired final concentration by mass of silver. 
For THP-1 cells and peripheral blood monocytes and macrophages, 100 µL of each 
nanosilver working suspension was pipetted into the appropriate wells of a 96-well plate 
already containing 100 µL of TCM and the relevant number of cells, as prepared the day 
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before. For HaCaT cells, HCM in the 96-well plates was aspirated immediately before 
being replaced with 200 µL of the appropriate nanosilver working suspension. Nanosilver 
working suspensions were mixed thoroughly by inversion immediately before being 
pipetted into the 96-well plates. Plates were then incubated as described above for the 
desired period of time before being analysed for a range of endpoints. 
 
2.4 Data analysis of in vitro toxicological endpoint assays 
Raw data was analysed and manipulated using Microsoft® Office Excel® 2007 (Microsoft 
Corporation), data visualisation, correlation and regression analysis was performed using 
Origin® 8.5 (OriginLab Corporation), and statistical significance testing, and additional 
correlation and regression analysis was performed using GaphPad Prism® 5 (GraphPad 
Software, Inc.). 
 
2.5 Cell viability assay 
2.5.1 Trypan blue exclusion assay 
Trypan blue is a cellular stain that is excluded by the cell membranes of viable cells, and 
can be used to distinguish between viable and non-viable cells by light microscopy [265]. 
For suspended cells (THP-1 monocytes), the samples were simply diluted 1:1 with 0.4% 
w/v trypan blue solution and then pipetted into a haemocytometer to count the number 
of live and dead cells. For attached cells, (THP-1 macrophages) the sample supernatant 
was removed and collected in a microfuge tube. The sample wells were then washed 
twice with PBS and these washings were transferred to the same microfuge tube. 
Following washing, the samples were incubated with 100 µL of TrypLE Express 
(Invitrogen) for 5 minutes at 37 °C before being dislodged by repeated pipetting and 
transferred to the same microfuge tube. Samples were then centrifuged at 200 g for 5 
minutes and resuspended in 200 µL of PBS. Samples were then stained and counted as 
described above. 
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2.5.1.1 Data analysis for the trypan blue exclusion assay  
Cell counts were manually entered into Excel® for analysis. Percent viability was 
calculated for each sample by dividing the number of viable, unstained, cells by the total 
number of viable and dead cells. The replicates for each specimen were averaged and the 
SEM was calculated using the formula described in section 2.5.2.1. The viability as a 
percentage of control was calculated by dividing the percent viability of each exposed 
specimen by the percent viability of the unexposed control specimen. The uncertainty in 
the viability as a percent of control was calculated using the following formula: 
       
    
  
 
 
  
    
  
 
 
 where     is the viability as a percent of control of that 
specimen,    is the percent viability of the exposed specimen,    is the percent viability of 
the control,      is the SEM of the exposed specimen and      is the SEM of the 
control. 
2.5.2 MTS viability assay 
The main assay used to determine cell viability in this project used a system called 
CellTiter 96® Aqueous Non-Radioactive Cell Proliferation Assay (Promega), or the MTS 
assay. The MTS reagent is reduced by viable cells through interaction with dehydrogenase 
enzymes to produce a soluble formazan dye which absorbs light strongly at 490 nm [266]. 
The amount of light absorbed is directly proportional to the number of viable cells 
present. 
MTS reagent (40 µL) was added to samples in 96-well plates 4 hours before the desired 
exposure time-point. Plates were incubated in the dark under conditions described in 
section 2.3 for 4 hours. Following incubation with MTS, the 96-well plates were 
centrifuged at 1400 g for 30 minutes. After centrifugation, 150 µL of each sample was 
carefully transferred, taking care not to disturb nanosilver in the bottom of each well, to 
clean 96-well plates. This step was taken to remove as much interference due to the 
nanosilver as possible. The supernatants were then analysed using a FlexStation 3 
(Molecular Devices) spectrophotometric plate reader in which absorbance at a 
wavelength of 490 nm was recorded. 
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To calculate the viability of each sample, the average absorbance of two wells containing 
only MTS and TCM or HCM (i.e. no cell blank) was subtracted from all MTS-containing 
samples. Then the average absorbance of two wells containing cells and nanosilver (no 
MTS) was subtracted from the respective MTS-containing samples at each concentration 
of nanosilver. This controlled for both non-cell based absorbance by MTS reagent and any 
interference due to the nanosilver. Finally, the absorbance of each sample was divided by 
the absorbance of the control wells (no nanosilver) to produce the viability as a 
percentage of control. 
2.5.2.1 Data analysis for the MTS viability assay 
For the optimisation of the MTS viability assay in THP-1 and HaCaT cells, raw absorbance 
data from the FlexStation 3 microplate reader were imported into Excel® for analysis. 
Absorbance values for replicates of each specimen and the corresponding blanks were 
averaged and the blanks, containing culture media and MTS reagent but no cells, were 
subtracted from the corresponding specimens. The uncertainty at each data point was 
calculated by combining the standard error of the mean (SEM) of each specimen and the 
corresponding blank by the following formula:        
      
   where  is the 
uncertainty,      is the standard error of the mean for the specimen and      is the 
standard error of the mean of the blank. The SEM was calculated by     
 
  
 where   is 
the specimen standard deviation and   is the number of replicate wells in the specimen. 
The blank corrected absorbance values were then plotted against cell number or 
incubation time accordingly. 
To measure cell viability by the MTS viability assay for nanosilver exposures, each 
experiment contained: replicates of the specimens exposed to different concentrations of 
each type of nanosilver, including unexposed controls; blanks which were exactly the 
same as the specimens except TCM was added instead of the MTS reagent; and MTS 
blanks which contained just TCM and MTS, no cells. After importing raw data, averaging 
replicates and calculating SEM as described above, the absorbance of each blank was 
subtracted from the corresponding specimen and the absorbance of the MTS blank was 
subtracted from each specimen to give the final corrected absorbance. The viability of 
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each specimen as a percent of control was then calculated by dividing the absorbance of 
the exposed specimen by the absorbance of the unexposed control. Uncertainty was 
calculated using the formulas described above and in section 2.5.1.1. 
The viability as a percent of control for each test material and each exposure time-point 
was fitted against the nanosilver concentration in Origin® 8.5 using the non-linear four 
parameter logistic dose response curve function, defined by the formula: 
     
     
              
 
where    and    are the bottom and top asymptotes respectively,       is the centre of 
the curve, or inflection point,   is the slope of the curve, or the hill-slope,   is the viability 
as a percent of control and   is the nanosilver concentration. No weighting was applied to 
the data points. The resulting fitted curves were used to calculate concentrations of 
nanosilver causing 20%, 50% and 80% cytotoxicity, i.e. where   = 80, 50 and 20. 
To produce the contour plots of cell viability over time against nanosilver concentration, 
viability as a percent of control data from each independent experiment was combined 
and fitted as described above, producing one fitted curve per time-point and test 
material. For each test material, the fitted curves at all time-points were transformed 
using Origin® 8.5 to XYZ matrices with 21 Y-steps and 100 X-steps using the Renka-Cline 
gridding algorithm [267]. The resulting matrices were plotted as colour-fill contour maps 
to visualise the change in cell viability with time as nanosilver concentration increased. 
To compare the relative potency of each test material in the different cell lines tested 
here, the surface area concentration of each test material causing 50% cytotoxicity (EC50) 
in the different cell lines were subtracted from one another to give the concentration 
difference. Due to the different potencies of the test materials within each cell line, in 
order to compare between the different test materials the calculated concentration 
differences were normalised by dividing by the sum of the EC50s in each case. 
 
 
 
54 
 
2.6 Flow cytometry 
Flow cytometry was used to perform a number of assays for a range of in vitro endpoints, 
which are described below. Flow cytometry was performed using a BD FACSCanto II flow 
cytometer (BD Biosciences) running BD FACSDiva™ software. 
2.6.1 Apoptosis and necrosis 
Cell death pathways of cells exposed to nanosilver were measured using a double stain kit 
containing Annexin V- fluorescein isothiocyanate (FTIC) conjugate and propidium iodide 
(PI) (Beckman Coulter, California, USA). Annexin V binds specifically to phosphatidylserine, 
a cell membrane component that is only found on the inside of cells except during 
apoptosis [268]. PI binds to DNA and RNA but is excluded from cells with an intact cell 
membrane. Therefore, cells stained positively for Annexin V-FITC alone will be undergoing 
the early stages of apoptosis, while those stained with both Annexin V-FITC and PI will be 
necrotic. 
Experiments to measure apoptosis and necrosis in cells exposed to nanosilver were 
performed according to the kit manufacturer’s instructions [269]. Following exposure of 
the cells to nanosilver, the supernatant from each sample was aspirated, after mixing by 
pipette, and collected in a Falcon™ polystyrene flow cytometer tube (BD Biosciences). For 
attached cells the samples were then rinsed with ice cold PBS, which was also collected in 
the flow cytometer tube, and incubated with 100 µL of TrypLE Express for 5 minutes at 37 
°C before being dislodged by repeated pipetting and collected in the same flow cytometer 
tube. 1 mL of ice cold TCM was added to each tube and the samples were centrifuged at 
200 g for 5 minutes at 4 °C. Supernatants were discarded following centrifugation and cell 
pellets were resuspended in 100 µL of binding buffer (a high [Ca2+] buffer included with 
the kit). The samples were then incubated with Annexin V-FITC conjugate and PI for 15 
minutes on ice in the dark. Following staining, 400 µL of binding buffer was added to each 
sample and the samples were kept on ice to be analysed by flow cytometry within 30 
minutes. 
Flow cytometry analysis of these samples required the simultaneous measurement of the 
fluorescence due to PI and Annexin V conjugated FITC. The spectral output of these two 
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fluorophores overlaps slightly so it was necessary to adjust the flow cytometer settings to 
compensate for this effect. This was achieved by analysing samples that had been stained 
with only one of each of the fluorophores to determine the amount of compensation 
required. For each sample, 10,000 events were collected. 
2.6.1.1 Data analysis for apoptosis and necrosis assay 
Cell counts from apoptosis and necrosis flow cytometry experiments were divided into 
four quadrants depending on the fluorescence intensity of the two fluorophores: double 
negative, viable; Annexin V positive only, apoptotic; double positive, necrotic; and PI 
positive only, debris. Out of 10,000 events, the number of events in each quadrant was 
exported from the BD FACSDiva™ software and imported into Excel® for analysis. The 
percent totals of each category, excluding debris, were calculated for every sample by 
dividing the count observed by the total counts of viable, apoptotic and necrotic events 
combined. Replicates for each specimen were averaged and the SEM calculated as 
described in section 2.5.2.1. 
The rate of change of the percent total counts of viable, apoptotic, and necrotic cells over 
time for THP-1 monocytes and PMA-stimulated macrophages was calculated by linear 
regression using Origin® 8.5 at all concentrations for each type of nanosilver. The rate of 
change of the percent total counts of apoptotic and necrotic cells as the proportion of 
viable cells decreased was also calculated using linear regression. 
2.6.2 Cytokine expression profile screening 
The expression of a range of cytokines including interleukins-1β, 2, 4, 5, 6, 8, 9, 10, 12 
p70, 13, 17A, 22, tumor necrosis factor, lymphotoxin, and interferon-γ were examined 
using the Human Th1/Th2/Th9/Th17/Th22 13plex FlowCytomix Multiplex fluorescent 
bead assay kit (eBioscience). Supernatants were harvested from nanosilver exposure 
experiments and stored at -80 °C for later cytokine analysis, which was undertaken 
according to the kit manufacturer’s directions [270]. Following preparation, samples were 
stored overnight at 4 °C and analysed by flow cytometry the following day. 
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2.6.2.1 Data analysis for cytokine expression profile screening 
The median fluorescence intensity of every bead population for each sample, with 10,000 
total events, was exported from the BD FACSDiva™ software and imported into Excel® for 
analysis. The average median fluorescence of the blank samples was subtracted from 
each sample to give the corrected fluorescence for every bead population. This corrected 
fluorescence data was imported into Origin® 8.5 and the standard curves for each 
cytokine, corresponding to the relevant bead population, were fitted using a 5-parameter 
logistic curve defined by the formula:  
       
         
    
 
  
 
  
 
  
where      and      are the top and bottom asymptotes respectively,    is the centre of 
the curve, or inflection point,   is the slope of the curve, or the hill-slope,   is the 
symmetry factor,   is the fluorescence and   is the concentration of cytokine protein in 
pg/mL. The data was weighted by the variance proportional to    algorithm.  The fitted 
standard curves were used to calculate the cytokine concentrations in each sample. 
Replicates of each specimen were averaged and the SEM was calculated as described in 
section 2.5.2.1. 
2.6.3 Reactive oxygen species 
Two kinds of fluorescent probes were used to detect the generation of ROS in vitro: 2’,7’-
dichlorodihydrofluroscein diacetate (H2DCF-DA) (Sigma-Aldrich) for peroxides and 
MitoSOX™ Red (MSR) (Invitrogen) for superoxide anion. All experiments were carried out 
using TCM as described in section 2.3.1 except that the RPMI-1640 media did not contain 
phenol red indicator, as this interfered with the fluorescence measurements. 
2.6.3.1 H2DCF-DA 
A 100 mM H2DCF-DA stock solution in DMSO was stored at -20 °C for use in all 
experiments. A 10 µM loading solution was prepared by diluting the stock solution in PBS 
immediately before loading the cells. THP-1 macrophages were prepared as described in 
section 2.3.1. After aspirating TCM containing PMA, the macrophage wells were filled 
with 100 µL of the H2DCF-DA loading solution and incubated in the dark for 30 minutes. 
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At the same time, following harvesting and centrifugation as described in section 2.3.1, 
THP-1 monocytes were incubated in 3 mL of the H2DCF-DA loading solution in the dark for 
30 minutes. After loading, the cells were washed once with PBS and then the exposure 
protocol as described in sections 2.3.1 and 2.3.4 was resumed. Following nanosilver 
exposure, the THP-1 monocytes were harvested from the microplates into flow cytometer 
tubes, while the macrophages were harvested using TrypLE Express as described in 
section 2.6.1, and 200 µL of cold PBS was added to all tubes. Cells were exposed to H2O2 
as a positive control and cells were also loaded with 2’,7’-dichlorofluroscein diacetate 
(DCF-DA), the fluorescent product of H2DCF-DA, as a fluorescence control. The samples 
were analysed by flow cytometry for intensity of fluorescence, with 10,000 events being 
recorded for each sample.  
2.6.3.2 MitoSOX™ Red 
A 5 mM MSR stock solution in DMSO was prepared fresh from powder stored at -20 °C for 
each experiment. A 2.5 µM loading solution was prepared by diluting the stock solution in 
Hank’s balanced salt solution (HBSS) (Sigma-Aldrich). Loading the cells with MSR, 
exposure to nanosilver, and harvesting the exposed cells was performed as described in 
section 2.6.3.1, except that the cells were finally washed once by centrifuging at 200 g for 
5 minutes and resuspended in 400 µL of cold HBSS. Positive controls were prepared at the 
same time as the NP exposures by adding a superoxide generating system to the cells, 20 
µL of 3.33 mM xanthine, 20 µL of 1 mM EDTA in PBS, 55 µL of 10 mM potassium 
phosphate buffer at pH 7.4 and 5 µL of 4 U/mL xanthine oxidase, instead of the nanosilver 
suspension. All other conditions were identical. The samples were analysed by flow 
cytometry for intensity of fluorescence, with 10,000 events being recorded for each 
sample.  
2.6.3.3 Data analysis for H2DCF-DA and MitoSOX™ Red flow cytometric assays 
For the H2DCF-DA and MitoSOX™ Red assays analysed by flow cytometry, the median 
fluorescence intensity of 10,000 events for each sample was exported from the BD 
FACSDiva™ software and imported into Excel® for analysis. Replicates for each specimen 
were averaged, and the average fluorescence of the exposed specimens was divided by 
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the average fluorescence of the unexposed controls to give fluorescence as a percent of 
control. Uncertainty was calculated as described in sections 2.5.1.1 and 2.5.2.1. 
2.7 Oxidative stress assays 
2.7.1 H2DCF-DA 
As well as using H2DCF-DA to examine intracellular ROS production (predominately 
detecting peroxides) by flow cytometry, it was also analysed using a spectrophotometric 
plate reader. The same procedure as described in section 2.6.3.1 was used, except that 
instead of transferring samples to flow cytometry tubes following nanosilver exposure, 
the microplates containing samples were measured directly in a FlexStation 3 
spectrophotometric plate reader, after the samples were prepared in a clear bottomed 
black microplate. 
2.7.1.1 Data analysis for H2DCF-DA microplate assay 
Raw fluorescence data was exported from the FlexStation 3 microplate reader and was 
imported into Excel® for analysis. Replicates of each specimen and blanks were averaged 
and the SEM was calculated as described in section 2.5.2.1. Average fluorescence of the 
blanks was subtracted from the corresponding H2DCF-DA and DCF-DA loaded specimens 
to give the corrected fluorescence, and uncertainty was calculated as described in section 
2.5.2.1. Corrected fluorescence values for each specimen were expressed as a percent of 
the unexposed control and uncertainty was calculated as described in section 2.5.1.1, and 
fluorescence as a percent of control was plotted against time for each specimen. 
2.7.2 Glutathione depletion 
Levels of intracellular reduced glutathione (GSH) decrease in cells under oxidative stress. 
The GSH levels in THP-1 human monocytes and PMA-stimulated macrophages exposed to 
nanosilver or Ag+ were measured using the Amplite™ Fluorimetric Glutathione GSH/GSSG 
Ratio Assay kit (AAT Bioquest, Inc). The kit was used as outlined in the manufacturer’s 
instructions. Samples were prepared and exposed to nanosilver as described in sections 
2.3.1 and 2.3.4. Following 24 hours of exposure, 100 µL of supernatant was removed from 
each sample and replaced with 100 µL of ice cold lysis buffer, consisting of 1% w/v triton 
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X-100 in PBS with 0.6% w/v sulfosalicylic acid. The microplates were then placed on an 
orbital plate shaker for 2 minutes and samples added immediately to the kit reagents in 
fresh microplates. Cells exposed to H2O2 were used as a positive control. After developing 
the samples for 60 minutes, fluorescence was recorded using a FlexStation 3 
spectrophotometric plate reader.  
2.7.2.1 Data analysis for glutathione depletion assay 
Raw fluorescence data was exported from the FlexStation 3 microplate reader and was 
imported into Excel® for analysis. The average fluorescence of the blank samples was 
subtracted from each well to give the corrected fluorescence. Corrected fluorescence 
data was imported into Origin® 8.5 and the standard curve data was fitted using the 5-
parameter logistic formula described in section 2.6.2.1. The fitted standard curve was 
used to calculate the GSH concentration for each sample. The calculated GSH 
concentrations were averaged for each specimen and divided by the unexposed control 
specimen to give GSH levels as percent of control. Uncertainty was calculated as 
described in sections 2.5.1.1 and 2.5.2.1. Results from two independent experiments 
were combined by averaging the calculated percent control GSH levels at the same 
concentration for each type of nanosilver. The change in GSH levels as cell viability 
decreased was calculated by a linear regression of the combined results for percent 
control GSH levels against the results of a parallel MTS viability assay experiment under 
the same conditions. 
2.7.3 Lipid peroxidation 
Lipid peroxidation is a consequence of oxidative stress in cells. This was assessed in THP-1 
human monocytes and PMA-stimulated macrophages exposed to nanosilver and Ag+ by 
measuring levels of 8-isoprostane, a biomarker of lipid peroxidation. This was done using 
an 8-isoprostane EIA kit (Cayman Chemical Company) according to manufacturer’s 
instructions. Samples were prepared and exposed as described in sections 2.3.1 and 
2.3.4. Following 24 hours exposure, 100 µL of supernatant was removed from each 
sample and 50 µL of 6 M KOH was added. The microplate was then covered with a 
protective film and incubated at 40 °C in air for 60 minutes. The samples were then 
neutralised to a pH of approximately 7.5 with 20 µL of 6 M HCl and 140 µL of 1 M KH2PO4. 
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The samples were then immediately analysed using the kit mentioned above. Cells 
exposed to H2O2 were used as a positive control. The developed kit microplates were 
measured using a FlexStation 3 spectrophotometric plate reader.  
2.7.3.1 Data analysis for lipid peroxidation assay 
Raw absorbance data was exported from the FlexStation 3 microplate reader and was 
imported into Excel® for analysis. The average absorbance of the blank wells was 
subtracted from each well, and the average absorbance of the non-specific binding wells 
was then subtracted from the average of the maximum binding wells to give B0, the 
maximum absorbance where no 8-isprostane was present. The absorbance of each well 
was then divided by B0 to give the binding ratio B/B0 which was proportional to the 
concentration of 8-isprostane in each well. This data was then imported into Origin® 8.5 
and the standard curve data was fitted using a 5-parameter logistic curve of the formula 
described in section 2.6.2.1, with the same weighting. The fitted standard curve was used 
to calculate the 8-isprostane concentration for each sample. 
The 8-isoprostane concentration for samples in each column was expressed as a percent 
of control by dividing by the unexposed control sample. Replicates for each specimen 
were then averaged and the SEM calculated as described in section 2.5.2.1. Results for 
two independent experiments were combined by calculating the average percent control 
of 8-isoprostane for each specimen. The change in 8-isoprostane levels as cell viability 
decreased was assessed by plotting combined results for percent control 8-isoprostane 
against the results of a parallel MTS viability assay experiment under the same conditions. 
 
2.8 Specific cytokine expression by enzyme-linked immunosorbent assay 
Specific levels of expression of the cytokines interleukin-8 and tumor necrosis factor were 
measured for THP-1 human monocytes and PMA-stimulated THP-1 macrophages, and 
human peripheral blood monocytes and PMA-stimulated macrophages following 
exposure to nanosilver or Ag+ using enzyme-linked immunosorbent assay (ELISA) BD 
OptEIA kits (BD Systems). Supernatants were collected from a number of exposure 
experiments described above and frozen for later analysis of cytokine expression. All 
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ELISAs were performed according to the manufacturer’s instructions and developed 
plates were measured using a FlexStation 3 spectrophotometric plate reader. 
2.8.1 Data analysis for ELISA cytokine assays 
Raw absorbance and luminescence data was exported from the FlexStation 3 microplate 
reader and was imported into Excel® for analysis. The average absorbance or 
luminescence of the blank samples was subtracted from each sample to give the 
corrected absorbance or luminescence. This data was imported into Origin® 8.5 and the 
standard curves were fitted using the 5-parameter logistic curve described in section 
2.6.2.1, with the same weighting. The fitted standard curves were used to calculate the 
cytokine concentrations in each sample. Samples were corrected for dilution, replicates of 
each specimen were averaged and the SEM was calculated as described in section 2.5.2.1. 
Cytokine concentrations for each specimen were expressed as percent of control by 
dividing by the unexposed control specimen cytokine concentration, and uncertainty was 
calculated as described in section 2.5.1.1. The change in IL-8 and TNF levels as cell 
viability decreased was calculated by a linear regression of the percent control cytokine 
results against the results of a parallel MTS viability assay experiment under the same 
conditions. 
 
2.9 Intracellular localisation and uptake of nanosilver 
The challenging aspect of assessing the intracellular localisation and uptake of nanosilver 
was addressed using four independent techniques:  flow cytometric side-scatter analysis, 
synchrotron X-ray fluorescence microscopy, ultra-thin section TEM, and SERS intensity 
mapping. These techniques are described below. 
2.9.1 Flow cytometric side-scatter analysis 
When cells internalise NPs their optical properties can change dramatically due to the 
increased scattering of light by the NP agglomerates. The uptake of nanosilver by THP-1 
monocytes and PMA-stimulated macrophage was assessed using the flow cytometric 
method described by Suzuki et al. (2007) [271]. The mean side-scatter intensity of cells 
analysed by flow cytometry to assess cell death pathways, as described in section 2.6.1, 
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was collected for each sample to assess the uptake of each type of nanosilver. The 
average mean side-scatter intensity of each specimen was plotted against the 
corresponding nanosilver concentration and linear regression was used to determine any 
relationship between nanosilver dose and side-scatter intensity. 
2.9.2 Synchrotron X-ray fluorescence microscopy 
Samples of PMA-stimulated THP-1 macrophages were prepared as described in section 
2.3.1 except that 24-well culture plates were used instead of 96-well microplates in order 
to accommodate a silicon nitride (SiN) window (window area 2 mm2, thickness 500 nm) 
for each sample. Accordingly, the volumes of cell suspension and TCM were modified to 
give the same number of cells per mm2 of growth area. Following exposure to nanosilver 
or Ag+ as described in section 2.3.4, the SiN windows were removed from TCM and 
immediately fixed for 2 hours in 2.5% w/v glutaraldehyde in 0.1 M sodium cacodylate 
buffer containing 2 mM CaCl2. The samples were then washed in cacodylate buffer and 
post-fixed with 1% w/v osmium tetroxide in cacodylate buffer. After washing again in 
cacodylate buffer to remove excess osmium tetroxide, the samples were dehydrated in a 
graded series of ethanol baths for 10 minutes each, starting with 50% v/v in water, then 
70%, 90% and finishing with 100% absolute ethanol. 
These samples were then analysed at the Australian Synchrotron using the X-ray 
fluorescence microscopy beamline. The X-ray beam spot size was determined by the 
beamline scientists to be 350 nm wide in the X direction and 250 nm wide in the Y 
direction. An incident beam energy of 10 keV X-rays was selected which induced K-shell 
ionisations in elements with atomic numbers below 30 and L-shell ionisations in silver 
atoms. Specimens were oriented at 90° to the incident X-ray beam and scanned at steps 
of 300 nm in the X direction and 200 nm in the Y direction, with a dwell time of 2.5 
seconds per pixel. A silicon-drift diode detector (Vortex, SII NanoTechnology) was oriented 
at 75° to the incident X-ray beam to detect the entire X-ray fluorescence spectrum for 
each pixel. 
Elemental maps for each specimen were generated from the data sets by the beamline 
scientists using the MAPS software suite (v1.6.5) by fitting the recorded spectrum at each 
pixel to determine the X-ray fluorescence signal from each element, which is proportional 
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to the amount of that element within the beam-sample interaction volume. The 
procedure fitted the contribution to the recorded signal from the K emission lines of Si, P, 
S, Cl, Ar, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu and Zn, as well as the L emission lines of Ag. 
The elemental maps for each specimen were processed using ImageJ image analysis 
software to produce colocalisation images by merging the maps of different elements. 
2.9.3 Ultra-thin section transmission electron microscopy 
Samples of THP-1 monocytes and PMA-differentiated THP-1 macrophages were prepared 
and exposed to nanosilver or Ag+ as described in sections 2.3.1 and 2.3.4. Following 24 
hours of exposure, samples were collected in centrifuge tubes. Macrophages were 
detached from the culture surface by incubating for 5 minutes at 37 °C with TrypLE 
Express. Three wells of each sample were pooled to provide an adequate number of cells. 
Samples were then washed with PBS and centrifuged at 200 g for 5 minutes, after which 
the supernatant was discarded and the cell pellets were resuspended in 100 µL of warm 
TCM. 
After being washed and resuspended, 100 µL of 37 °C 12% w/v gelatine was added to 
each sample and gently mixed using a vortexer. The gelatine was set by placing the 
samples in ice for 10 minutes. The samples in gelatine were then fixed by adding 1 mL of 
2% w/v paraformaldehyde and 2% w/v glutaraldehyde in 0.1M cacodylate buffer on top of 
the gelatine, and incubating overnight at 4 °C. After fixing, the samples were cut into 
approximately 1 mm3 cubes using a scalpel. These were then dehydrated in a series of 
ethanol baths for 10 minutes, twice at each concentration, beginning with 70% ethanol in 
water, then 90% ethanol in water, absolute ethanol and finishing with 3 washes in fresh 
anhydrous ethanol. 
Following dehydration, the samples were infiltrated with PROCURE 812 resin (ProSciTech). 
The resin was prepared according to the manufacturer’s instructions for the ‘medium’ 
hardness recipe. After the final drying step, the ethanol was replaced with 1 mL of a 50% 
w/w resin in absolute ethanol mixture and allowed to infiltrate the samples on a sample 
rotator for 2 hours. The sample containers were then left open overnight to allow the 
ethanol to slowly evaporate. The following morning, the resin/ethanol mixture was 
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replaced with pure resin and allowed to infiltrate for 8 hours before being replaced with 
fresh resin and left overnight. This was repeated twice before the samples were 
embedded in resin in a flat embedding mould. The embedding resin was cured at 60 °C 
for 2 days. Once cured, the embedded samples were trimmed and sectioned at 70 nm 
thickness using an ultramictrotome at CSIRO Materials Science and Engineering, Clayton, 
Victoria, Australia. The sections were placed on copper TEM grids for transmission 
electron microscopy. 
Prior to TEM analysis, the sections were stained with uranyl acetate (UA) and triple lead 
(consisting of equal parts lead nitrate, citrate and acetate) to enhance contrast. Both UA 
and triple lead solutions were centrifuged at 1000 g for 10 minutes prior to staining. TEM 
grids containing ultrathin sections of embedded specimens were suspended on a drop of 
5% w/v UA in 70% v/v ethanol in water for 10 minutes, in the dark. Following staining 
with UA, the grids were rinsed in 30 °C degassed distilled water (boiled for 5 minutes 
immediately prior to use) and then in absolute methanol. The grids were then suspended 
on a drop of triple lead solution (prepared as described in Sato (1968) [272]) for 10 
minutes in a glass Petri dish in the dark. Prior to lead staining, the Petri dish had been 
depleted of CO2 by arranging NaOH pellets around the interior circumference and 
covering the dish with a lid. After lead staining, the grids were rinsed three times in 30 °C 
degassed distilled water and finally in absolute methanol. The grids were then coated 
lightly with carbon on the side containing the sections using a carbon coater at CSIRO 
Materials Science and Engineering, Clayton. TEM analysis was then undertaken using the 
instrument described in section 2.2.1, but at an accelerating voltage of 80 kV. Results are 
displayed as annotated micrographs of cells within the ultra-thin sections. 
2.9.4 Surface enhanced Raman spectroscopy 
Surface enhanced Raman spectroscopy (SERS) was undertaken on nanosilver in the THP-1 
exposure system at CSIRO Materials Science and Engineering, Clayton, using an inVia 
Raman microscope (Renishaw, UK) with StreamLine Plus mapping hardware and WiRE 3.0 
control software. 
The THP-1 macrophages were cultured on small circles of aluminium foil (sterilised with 
70% ethanol in water) in a 24-well plate and exposed to nanosilver in TCM (as described 
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in section 2.9.2). Following 24 hours of exposure, the aluminium foil was carefully 
removed from the exposure media and placed in a fresh 24-well plate where it was 
immersed in room temperature HBSS. The samples were analysed using a 50-times 
magnification long-working distance objective lens of the infrared microscope described 
above. Specimens were irradiated with a 300 mW, 830 nm wavelength near-infrared laser 
at 1% intensity with collection times of 0.2 s per pixel, and the detector collected the 
intensity of the portion of the Raman spectrum between 1150 and 60 cm-1 wavenumbers 
at each pixel. Specimens were scanned with steps in both X- and Y-directions of 1 µm. 
Optical micrographs of each scanned cell were captured using a digital camera 
microscope attachment and the Raman signal intensity at 230 cm-1 was overlayed on the 
optical micrograph of each specimen using the WiRE 3.0 software. 
Raman spectra were also collected for each type of nanosilver incubated in TCM for 48 
hours, as described in section 2.3.4. A small drop of approximately 100 µL of each 
nanosilver suspension was placed on an aluminium foil support and allowed to settle for 
10 minutes. The specimens were then irradiated with the same 830 nm near-infrared 
laser described above at 1% intensity with a collection time of 0.5 s. The Raman spectra 
intensity for each specimen was collected between 2000 and 100 cm-1 wavenumbers. 
 
 
66 
 
 
3 Physicochemical characterisation of 
nanosilver in an in vitro test system 
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3.1 Introduction 
Thorough characterisation of the physical and chemical properties of nanomaterials 
before, during and after any toxicological testing is imperative in order to properly 
interpret and understand the data produced [273]. To help spread this message, a set of 
minimum nanomaterial characterisation requirements for use in toxicological studies 
were proposed by the MINChar Initiative, a resource arising from a workshop hosted at 
the Woodrow Wilson International Centre for Scholars and coordinated by a number of 
researchers from industry, academia and government organisations, in October 2008. 
They include four major categories which are described in Table 3.1 [274]. 
Table 3.1: MINChar initiative recommended minimum characterisation parameters for 
nanotoxicological investigations. 
What does it look like? Size distribution 
 Aggregation and agglomeration state 
 Shape 
What is it made of? Chemical composition and crystal structure 
 Surface composition 
 Purity and levels of impurities 
Factors affecting interactions with 
surroundings 
Surface area 
 Surface chemistry, reactivity, 
hydrophobicity 
 Surface charge 
Overarching considerations Stability: storage, handling, preparation, 
delivery 
 Context: how properties are affected by 
different media 
 Dose metrics: mass, surface area, number 
concentration 
 
By far the most common characteristic of NPs investigated by researchers is that of 
particle size. There are a number of techniques to determine the particle size distribution 
of a sample of NPs, some of the most common being electron microscopy (both scanning 
and transmission) and dynamic light scattering. Electron microscopy is useful for 
examining the shape of NPs but is poorly suited to providing a statistically relevant and 
representative size distribution, as it can only examine a relatively small number of 
particles at once and is open to a number of biases which can be difficult to control. To 
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achieve effective particle size analysis by TEM, it must be possible to disperse the NPs 
evenly over a formvar-coated TEM grid, as image processing techniques to determine 
particle size cannot distinguish individual particles from agglomerates.  
On the other hand, DLS can provide a statistically robust size distribution for well 
dispersed NPs in a liquid suspension, but it provides no information about particle shape 
and is ineffective in analysing polydisperse or unstable dispersions. DLS is therefore useful 
for determining a primary particle size distribution for NPs that are close to spherical in 
shape and not agglomerated in suspension, but it is not suited to analysing the 
agglomeration behaviour of NPs in biological environments such as the in vitro test 
system used in this project [211]. 
An alternative size distribution characterisation method that can be used for 
agglomerated, polydisperse or monodisperse suspensions of NPs is differential centrifugal 
sedimentation, also referred to as disc centrifugation. This method uses a hollow disc 
filled with a sucrose gradient solution that is spun at speeds of 20 000 to 30 000 
revolutions per minute (RPM), with a light-based detection system at the edge of the disc. 
A sample of NP suspension is injected into the centre of the disc and the detection system 
records the time taken for the particles to reach the edge. By calibrating the system with 
particles of known size, shape and density, this technique can accurately characterise 
many different kinds of particle distributions in solution, including agglomerations of 
particles in biological environments. However, it is important to note that this technique 
relies on assumptions about particle shape and density to calculate an apparent size 
distribution using a modified version of Stokes law, which may not reflect the true size of 
any agglomerates or coated particles. 
One other technique that is useful for characterising NPs in biological environments is 
cryogenic transmission electron microscopy, or cryo-TEM. Cryo-TEM involves plunge-
freezing samples in suspension on copper TEM grids into liquid ethane, cooled by liquid 
nitrogen: a process which creates disordered, or ‘vitreous’, ice that is transparent to 
electrons. These samples are examined at cryogenic temperatures using a liquid nitrogen-
cooled sample-holder, as described in section 2.2.1.2. For examining NPs in cell culture 
media, this technique gives a good qualitative insight into agglomeration behaviour, such 
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as the range of agglomerate sizes, the density of any agglomerates, and how much space 
there is between particles. 
This project utilised TEM and DLS to investigate the primary particle size distribution of 
the four types of nanosilver described in section 2.2, and DCS and cryo-TEM to investigate 
the agglomeration behaviour of these specimens after being incubated in TCM (as 
described in section 2.3) at room temperature for 24 hours. 
 
3.2 Results 
3.2.1 TEM primary particle sizing 
A series of TEM micrographs were taken of the nanosilver ‘Sigma’, ‘Carey Lea’s’, ‘NM-
300K’ and ‘ABC Nanotech’ dispersed over formvar-coated copper TEM grids in order to 
characterise their primary particle size distributions. This was successful for all nanosilvers 
except Sigma, as this particle was a highly agglomerated powder that resisted dispersion 
for the purposes of TEM imaging. Representative images of the four types of nanosilver 
are shown in Figure 3.1. The highly agglomerated state of Sigma nanosilver is clearly 
visible.  
These images were processed using the free image analysis software package ImageJ, as 
described in section 2.2.1.1. This process is outlined in Figure 3.2. Image ‘A’ shows the 
result of the thresholding process, which works best for images with a high contrast 
between particles and background, and is ideal for heavy elements such as silver. Image 
‘B’ shows the result of the particle analysis script on the thresholded image; the particles 
that were recognised are shown as numbered outlines for visual inspection.  
The measurements performed on the analysed particles included: area; circularity; Feret’s 
diameter, the maximum distance between two opposite points on the particles 
circumference; aspect ratio; roundness; and solidity. Only objects with circularity greater 
than 0.1 and area greater than 1 nm2 were included in the analysis. The area measure was 
used to calculate the diameter of each particle by assuming that the particles were 
perfectly spherical. The other measurements were used to screen the collected data for 
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Figure 3.1: TEM micrographs of nanosilver used for particle sizing. A: ABC Nanotech. B: 
NM-300K. C: Carey Lea’s. D: Sigma. Scale bar 200 nm. 
B 
C D 
A 
Figure 3.2: Imaging processing for TEM particle sizing. A: Thresholded and despeckled 
image from Figure 3.1, A. B: Image A after particle analysis showing particle outlines. 
Scale bar 200 nm. 
B A 
artefacts of the particle analysis process, such as particle agglomerates, that would skew 
the results. Any objects with a circularity of less than 0.8 (1 being perfectly circular), an 
aspect ratio greater than 1.5, a solidity less than 0.9 and a roundness of less than 0.8, 
were excluded from the particle size distribution. Particles with a very small area, less 
than about 10 nm2, were also excluded to avoid any artefacts from image background 
noise introduced by the thresholding process. 
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Figure 3.3: Particle size distributions of nanosilver determined by TEM micrograph 
analysis. 
The calculated particle diameters for each type of nanosilver were divided into 70 bins 
between 0 and 5000 nm, increasing exponentially by the formula              to 
match with the data from DLS analysis, using the Origin 8.5 statistical analysis software 
package, in order to form size distributions as shown in Figure 3.3. ABC Nanotech and 
Carey Lea’s appear to have similar size distributions, with Carey Lea’s showing a slightly 
wider distribution, while NM-300K’s has a more irregular distribution skewed towards 
larger particles. The mean diameter and standard deviation determined from each 
distribution are also shown in Figure 3.3. As analysis of Sigma nanosilver from the TEM 
micrographs obtained would have required measuring over a thousand particles 
manually, due to the agglomerated nature of the sample, a laborious process prone to 
numerous biases, no particle size distribution data was produced for this material. 
The TEM micrographs in Figure 3.1 show that the three smaller types of nanosilver, ABC 
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Nanotech, NM-300K and Carey Lea’s, are all approximately spherical, whereas the larger 
nanosilver, Sigma, has a more irregular shape. The spherical nature of the nanosilver 
justifies the approach taken here to determine their diameter, while also increasing 
confidence in the other sizing techniques described below, which rely on equations that 
assume a spherical particle shape. 
3.2.2 Dynamic light scattering 
Nanosilver suspensions in water were measured using DLS to determine their primary 
particle size distributions. A stable suspension is essential for effective particle size 
analysis by DLS. If there is agglomeration present, or settling due to gravity, this can make 
any DLS measurements on that sample totally invalid due to the fundamental mechanics 
of the technique: scattered light from a small number of large agglomerates can 
completely swamp any signal from the primary particles; and the equations used to 
calculate the particle size distribution assume that the only movement within the system 
is due to Brownian motion, so settling under gravity invalidates these equations 
completely. As such, sample preparation for DLS analysis is absolutely crucial to producing 
reliable data [211].  
Sigma nanosilver did not disperse at all in water, forming large agglomerates and dropping 
out of suspension rapidly. As such, it was impossible to produce a reliable measurement 
of Sigma nanosilver using DLS. The three remaining nanosilvers, ABC Nanotech, NM-300K 
and Carey Lea’s, dispersed relatively well in water, compared to Sigma. 
Particle size distributions from DLS analysis, derived Z-average hydrodynamic diameters 
and polydispersity indices are shown in Figure 3.4. The polydispersity index and Z-average 
hydrodynamic diameter are calculated from the raw autocorrelation data for each sample 
according to ISO 13321 by the instrument software analysis package, as mentioned in 
section 2.2.2. The Z-average hydrodynamic diameter is the intensity weighted mean 
particle size and is very sensitive to the presence of agglomerates in the sample. 
Polydispersity index is a measure of how mono- or polydisperse a given sample appears: 
samples between 0.05 – 0.1 are highly monodisperse; between 0.1 – 0.7 moderately 
polydisperse; and above 0.7 are highly polydisperse, and generally not suitable for DLS 
analysis [275]. Figure 3.4 shows that the three smaller nanosilvers are moderately 
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polydisperse, but Sigma is highly polydisperse. This is also reflected in the wide error 
margins in the size distribution data for Sigma: each of the three separate measurements 
conducted varied greatly from the others, and as such this data does not reflect the actual 
particle size of Sigma nanosilver. 
In this case, it seems that even the smaller nanosilvers have been affected by a level of 
agglomeration during DLS analysis. All of the intensity weighted size distribution curves 
show multiple peaks and the autocorrelation fit quality determined by the instrument 
software was low, despite the results being reproducible. When comparing the Z-average 
hydrodynamic diameter determined from DLS to the mean particle size determined from 
TEM, it is clear that the DLS results have been skewed upwards by a small amount of 
agglomerated material in the samples. Therefore, these DLS results are unreliable as a 
Figure 3.4: Nanosilver particle size distributions as determined by DLS analysis. Data is the 
average of three measurements: shaded areas and parentheses show standard error of 
the mean. 
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measure of the primary particle size, and give an example of the difficulty of using this 
technique to reliably estimate the size distribution of a sample of NPs. 
In addition to particle size, the Zetasizer Nano ZS instrument was used to measure the 
zeta potential of the nanosilver in water. Zeta potential describes the surface charge of 
the NPs and is important in predicting how the particles will interact with the test system: 
it has been shown that particles with a high positive surface charge in acidic conditions 
are cytotoxic due to their ability to disrupt phagolysosomes [276]. These results are 
shown in Table 3.2. The lower charge density of NM-300K compared to the other 
nanosilver is most likely due to the PVP coating, as a similar result was seen by Foldbjerg 
et al. for PVP coated nanosilver [169].  
Table 3.2: Zeta potential of nanosilver in water. Average of three measurements, standard 
error of the mean in parentheses. ND = not determined. 
Nanosilver Zeta potential (mV) 
ABC Nanotech -46.3 (0.6) 
NM-300K -15 (2) 
Carey Lea's ND 
Sigma -51 (4) 
 
3.2.3 Differential centrifugation sedimentation 
The DCS technique is useful for analysing agglomerated NP samples in suspension as it 
can more effectively discriminate between mixtures containing differently sized particles, 
and the detection of smaller particles is not hampered by the presence of larger particles 
or agglomerates, as is the case for DLS. As such, this technique is well suited to analysing 
the agglomeration state of NPs in suspension in a biological medium, such as the 
nanosilver samples suspended in TCM used in this project. 
After incubating the nanosilver in TCM for 24 hours or longer, aliquots were injected 
directly onto the spinning disc of the DCS instrument to analyse the agglomerate sizes 
that had formed under these conditions. The size distribution data obtained by DCS are 
shown in Figure 3.5, as well as D10, D50 and D90 values, i.e. the diameter that is larger 
than 10, 50 and 90% of measured particles respectively. 
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Figure 3.5: Size distributions of nanosilver incubated in TCM, using DCS. Shaded areas 
indicate standard error of the mean for two measurements. 
One difficulty in using DCS to measure a highly polydisperse sample of NPs is the time 
taken to resolve the whole size distribution. In order to resolve larger particle sizes, such 
as agglomerates above 500 nm, the rotation speed of the disc must be relatively low so 
that the particles don’t elute too quickly. If the instrument is not set up to ramp the disc 
rotation speed, this low starting speed means that it can take a significant period of time 
for the smaller particles, around 10 nm, to elute completely. Unfortunately, the 
instrument used to examine these samples was not equipped to ramp the disc rotation 
speed, and the time available for analysis was also restricted, resulting in the limited 
particle size dynamic range of this data. 
It is also important to consider the effects of this technique on the stability of 
agglomerates in these kinds of samples. If agglomerates are only loosely associated, as 
appears to be the case for NM-300K by the independent method of cryo-TEM (see section 
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3.2.4), the high shear forces experienced when the samples are injected onto the rapidly 
spinning disc, at 20 000 RPM, may disrupt the agglomerates entirely. This could have the 
effect of producing a size distribution in which large agglomerates are no longer present. 
3.2.4 Cryo-TEM 
Each type of nanosilver was examined using cryogenic transmission electron microscopy 
after being suspended in TCM for 24 hours at a concentration of 200 µg/mL. These 
suspensions were plunge frozen in liquid ethane on copper TEM grids coated with lacy 
formvar to trap nanosilver agglomerates as they would appear in the in vitro test system. 
Selected cryo-TEM micrographs for each type of nanosilver are shown in Figure 3.6.  
Cryo-TEM is very useful for qualitative information about the kind of agglomeration that is 
occurring in the in vitro system. The density and size of nanosilver agglomerates will affect 
the amount of surface area that the cells ‘see’ when they are exposed, and this property 
is difficult to observe using any other technique. Comparing the agglomerates of Sigma 
and NM-300K nanosilver in Figure 3.6, images D and B respectively, the difference in 
density is clearly apparent. Sigma forms much more dense agglomerates of closely 
associated particles, whereas NM-300K forms loose agglomerates of weakly associated 
particles. This different agglomeration behaviour will affect the rate and the amount of 
nanosilver uptake by cells in the in vitro test system, as well as the rate of settling in vitro, 
and therefore the amount of nanosilver that the cells ultimately are exposed to. 
Cryo-TEM micrographs generally have relatively poor contrast between particles and 
background, even for heavy elements like silver, compared to conventional TEM. This is 
due to the vitreous ice absorbing a portion of the incident electrons; and the ice will 
always be thicker around any large NP agglomerates due to surface tension effects (this 
can be seen as a diffuse darker area around the particle agglomerates in Figure 3.6, D). It 
is also necessary to use a lower electron flux than in conventional TEM, so as not to 
damage the samples or cause the ice to de-vitrify, which can reduce contrast as well. This 
low contrast issue, as well as the complexity of the images, dramatically increases the 
difficulty of automating the analysis of cryo-TEM micrographs. 
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A B 
C D 
Figure 3.6: Cryo-TEM micrographs of nanosilver in TCM: A: ABC Nanotech. B: NM-300K. C: 
Carey Lea’s. D: Sigma. Scale bar 500 nm. Lighter areas consist of vitreous ice in which the 
nanosilver agglomerates are embedded. Darker grey areas are the lacy formvar film on 
which the ice is frozen. 
While cryo-TEM is a very useful technique for gaining an insight into the different 
agglomeration behaviour of NPs in liquid suspension, it is difficult to produce statistically 
robust quantitative data. The nature of TEM is such that only a very small volume of any 
sample can be examined at a useful resolution within a reasonable time. Cryo-TEM also 
suffers from some systematic biases: the plunge freezing process, as described in section 
2.2.1.2, can remove larger agglomerates from the sample during the blotting step; the 
thickness of very large agglomerates makes them too opaque to electrons for effective 
TEM imaging; and it is difficult to effectively image highly polydisperse samples using TEM 
due to the wide range of required magnification. All these factors prevent cryo-TEM from 
being a straight-forward technique to quantitatively analyse the agglomeration of NPs in a 
biological suspension. Instead it is most effective when used to aid in the interpretation of 
data from other techniques such as DCS, as described in section 3.2.3. 
In addition to investigating nanosilver suspensions in TCM using cryo-TEM, a solution of 
TCM containing silver nitrate at a concentration of 40 µg/mL of Ag+ (used as an exposure 
78 
 
control) was examined. Micrographs at two different magnifications are shown in Figure 
3.7. It appears from this investigation that the silver nitrate forms NPs of an unknown 
composition, most likely containing silver chloride, when combined with TCM.  This is a 
somewhat shocking conclusion, given that silver nitrate was supposed to serve as an 
‘ionic’ control for the nanosilver samples that were tested in this project. Further 
investigation of the interactions between silver nitrate, or any other ionic control, used for 
the purposes of nanotoxicology testing is required to determine the implications of this 
discovery in interpreting the results of such testing.  
3.2.5 Specific surface area 
Specific surface area is an important property of NPs to characterise for use in 
toxicological investigations: high surface area is a defining characteristic of engineered 
nanomaterials and one of the reasons their novel properties. The primary method for 
assessing surface area of NPs is the Brunauer-Emmet-Teller (BET) technique [18]. This 
technique works by measuring the amount of inert gas, usually nitrogen, adsorbed onto 
the surface of solid particles at cryogenic temperature [277]. As such, this technique 
cannot be used for particles in suspension. Since three out of four of the nanosilver 
investigated in this project were prepared in suspension, the BET technique was not 
practical to assess their surface area. 
It is possible to estimate the specific surface area of a sample of NPs using their particle 
size distribution, assuming the particles are spherical. The TEM-derived particle size 
distributions of ABC Nanotech, NM-300K and Carey Lea’s nanosilver, as well as the DCS-
A B 
Figure 3.7: Cryo-TEM micrographs of a solution of TCM containing silver nitrate. Scale 
bars: A, 2 µm; B, 200 nm. 
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derived particle size distribution for Sigma nanosilver, were used to determine each 
nanosilver’s specific surface area and particle number density, as described in section 
2.2.4. These results are shown in Table 3.3. 
These calculated results will allow the concentration of nanosilver used in cell exposures 
for this project to be expressed in mass, surface area and particle number concentrations, 
an important aspect of interpreting the results of nanotoxicological investigations as 
described by the MINChar initiative [274] in section 3.1. 
Table 3.3: Calculated specific surface area and particle number density of nanosilver. 
Nanosilver Specific surface area (m2/g) Particle number mass density (particles/g) 
ABC Nanotech 53.3 2.9E+16 
NM-300K 32.1 1.2E+16 
Carey Lea's 46.5 4.3E+16 
Sigma 4.9 2.6E+13 
 
 
3.3 Discussion 
Some of the results described in this chapter illustrate the difficulties involved in 
thoroughly and accurately measuring the physicochemical characteristics of NPs for the 
purposes of nanotoxicology testing. Good quality size distribution data for NP samples is 
essential to the interpretation of toxicology endpoints, and the most common method of 
obtaining size distribution data appears to be dynamic light scattering. This is likely due to 
the relatively widespread availability of DLS instruments and the apparent ease of use of 
this technique. 
As shown in section 3.2.2, however, it is not a trivial exercise to obtain a reliable measure 
of the size distribution of a sample of NPs using DLS. Only a small amount of aggregation 
in a sample can overwhelm the signal from the primary particles, and any settling due to 
gravity in the sample will invalidate the results. Despite the popularity and availability of 
DLS, it is not an easy technique to use effectively for this purpose. This is especially true 
for NPs manufactured as a dry powder, which can be very difficult to disperse effectively 
to form a stable suspension. 
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In contrast, the TEM analysis undertaken in this project was effective in producing size 
distribution data for three out of four nanosilver as shown in section 3.2.1, although 
difficulties in dispersing Sigma nanosilver thwarted this approach as well, while enabling 
visual inspection of each sample to assess their shape. This is an important point because 
other particle sizing techniques rely on certain assumptions about the shape of the 
particles being measured, so it is valuable to have this information when interpreting 
these results. 
The two other techniques utilised here, namely differential centrifugal sedimentation and 
cryo-TEM, seem to be useful when used in conjunction as they produce complementary 
data. DCS was most useful for analysing the agglomeration state of nanosilver after being 
incubated in TCM due to its ability to effectively distinguish between a wide range of 
particle sizes. However, the interpretation of DCS results needs to take into account the 
shape and density of agglomerates, as these factors will influence the calculated size 
distribution. All particles measured by DCS are assumed to be spherical and of a constant 
density in order to calculate their diameter from the time taken for them to elute from 
the disc; so if agglomerates are an odd shape or less dense than the solid material, this 
can skew the results.  
Cryo-TEM can be very useful in supporting DCS data. It is clear from the micrographs 
shown in Figure 3.6 that the agglomerates of the different types of nanosilver have 
varying sizes, shapes and densities. While this information aids in the interpretation of the 
DCS data, cryo-TEM could also be used more effectively to produce a size distribution for 
agglomerated NP samples in suspension following more systematic research into how to 
effectively automate an image analysis process that could interpret these kinds of 
micrographs. Cryo-TEM was a very useful technique to interrogate the kind of 
agglomeration behaviour present in nanosilver suspensions in TCM, as this technique 
produced the closest snapshot of conditions that would be present in the in vitro test 
system, out of all the characterisation techniques that were investigated for this project. 
The physicochemical characteristics of the four nanosilver test materials investigated are 
summarised in Table 3.4. 
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Table 3.4: Summary table of physicochemical characteristics of nanosilver test materials. 
ND = not detected. 
Measured physicochemical 
characteristic 
Technique  
ABC 
Nanotech 
NM-300K 
Carey 
Lea's 
Sigma 
Mean primary particle 
diameter (nm ± SD)  
TEM 
(room temp.) 
8.6 ± 2.7 12.9 ± 5.4 9.2 ± 3.5 ND 
Z-average hydrodynamic 
diameter (nm ± SEM)  
DLS (water) 69.8 ± 0.7 36.1 ± 1.2 20.7 ± 0.4 746 ± 145 
Zeta potential (mV ± SEM)  DLS (water) -46.3 ± 0.6 -15 ± 2 ND -51 ± 4 
Median agglomerate 
diameter D50 (nm)  
DCS (TCM) 500 13.0 25.7 97.6 
Calculated specific surface 
area (m2/g)  
TEM & DCS  53.3 32.1 46.5 4.9 
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4 In vitro cytotoxicity of nanosilver to 
primary and THP-1 human 
monocytes and macrophages, and 
HaCaT human keratinocytes 
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4.1 Introduction 
In vitro testing is an important part of any comprehensive toxicology investigation [23], 
including nanotoxicology. Its uses include defining an appropriate exposure range for in 
vivo testing, investigating mechanistic interactions of the test material at the cellular and 
sub-cellular level, and characterisation of how the test material behaves in biological 
systems [241]. These are all important aspects of understanding nanotoxicology for 
regulatory purposes. 
Cytotoxicity is an important first step in any in vitro toxicological investigation as it 
provides the basic understanding of how the test system interacts with the materials to 
be tested, in this case nanosilver. By exposing the cell lines to a range of concentrations of 
the test materials, we can compare the relative potency of each material in that system 
and determine the most relevant concentration range for further toxicological testing 
with a wide range of biological endpoints. It is also important to characterise the 
timescale of any responses of the cells following in vitro exposure to the test materials. By 
establishing the delay between the time courses of the exposure and cytotoxicity 
endpoints, further toxicological testing can be directed at the appropriate time-points to 
avoid missing relevant signals of toxicity. This is particularly important for 
nanotoxicological investigations as the time taken for NP transport and uptake may vary 
between materials and cell lines [278]. 
There are a number of ways of assessing the cytotoxicity of different materials in vitro, 
which usually rely on either the membrane integrity or metabolic function of the cells 
being tested. A widely used method which assesses cell-membrane integrity is the trypan 
blue exclusion (TBE) assay: trypan blue is a vital dye that is excluded by viable cells with 
intact membranes, but it stains the RNA and DNA of cells with compromised membranes. 
This assay involves staining a cell suspension with trypan blue and inspecting the cells 
visually using haemocytometer with an optical microscope to count the number of 
stained (non-viable) and unstained (viable) cells. As such it is quite a tedious and 
laborious process that can be subject to biases if not undertaken with sufficient care. In 
contrast, a cell viability assay known as MTS, sold by Promega under the name “CellTiter 
96® Aqueous Non-Radioactive Cell Proliferation Assay”, uses a soluble tetrazolium dye 
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which is reduced by viable cells to a formazan product that absorbs light strongly at the 
490 nm wavelength. This assay simply requires adding the reagent to the cell culture 
system in a microplate at the desired time-point, incubating the sample for a short period 
of time and measuring the absorbance of the samples in the microplate wells at 490 nm 
using a spectrophotometric plate reader. 
This project utilised the MTS viability assay to assess the cytotoxicity of the four types of 
nanosilver described in section 2.2, and Ag+ from AgNO3 as a dissolved metal ion control. 
Cells that were tested include: primary human monocytes isolated from peripheral blood 
and their PMA-stimulated macrophage-like counterparts, THP-1 human acute monocytic 
leukemia cells and their PMA-stimulated macrophage-like counterparts, and HaCaT 
immortalised human skin keratinocytes, as a non-immune related cell for comparison. 
Cell viability was assessed at 4, 8, 12 and 24 hours following exposure to the nanosilver 
using the MTS viability assay. 
 
4.2 Results 
4.2.1 MTS viability assay optimisation  
In order to effectively utilise the MTS assay to its full potential, it was necessary to first 
optimise crucial conditions for the particular in vitro system being investigated: namely, 
the number of cells per well in a 96-well microplate and the incubation time following 
addition of the MTS reagent to the cell culture. Both of these conditions are dependent 
upon the mitochondrial activity of the specific cell type being investigated. 
4.2.1.1 THP-1 monocytes and macrophages 
THP-1 monocytes were seeded into a 96-well microplate at quantities covering three 
orders of magnitude: from 1000 to 2 x 106 cells per well. The cells were incubated with 
MTS according to the manufacturer’s instructions, and the absorbance of each well was 
measured after 1, 2, 3 and 4 hours incubation. The results for THP-1 monocytes are 
shown in Figure 4.1.  
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Below 104 cells per well the assay did not produce significant absorbance above 
background. An incubation time of 4 hours gave the most reliable results and showed a 
linear response between 104 and 4 x 105 cells per well. The mid-point of this range, 105 
THP-1 monocytes per well, was chosen as the standard cell density for cytotoxicity 
experiments to give adequate scope to observe either increases or decreases in MTS 
development, which is proportional to the number of viable cells in each microplate well. 
4.2.1.2 HaCaT keratinocytes 
When culturing HaCaT cells for nanosilver exposure experiments, cells were incubated for 
24 hours after seeding before being exposed to nanosilver and incubated for a further 24 
hours before assessing relevant endpoints. Therefore it was important to choose a 
seeding density for HaCaT cells that gave an appropriate confluency at both the 24 and 48 
hour time points after being seeded. HaCaT human keratinocytes were seeded in a 96-
well microplate at a range of cell densities and incubated for 24 and 48 hours before 
Figure 4.1: MTS assay optimisation for THP-1 monocytes. Cells were incubated with MTS 
for 1, 2, 3 and 4 hours. Data expressed as the mean blank-corrected absorbance of four 
replicates; error bars indicate SEM. 
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assessing confluency by optical microscopy. Two seeding densities, 3000 and 4000 cells 
per well, produced the most even coverage of the microplate well’s surface while giving a 
confluency of around 70% by 24 hours, with the cells in log-phase growth ready for 
exposure experiments. To determine the optimum conditions for HaCaT cytotoxicity 
assays using MTS, cell numbers between 3000 and 4000 were seeded in a 96-well 
microplate and incubated for 48 hours. MTS was then added to the cells and absorbance 
was measured after being incubated for periods of 30 minutes, up to a total of 4 hours. As 
shown in Figure 4.2, MTS absorbance plateaued by the 4 hour incubation time point. A 
cell seeding density of 4000 cells per well, which gave the strongest absorption signal 
while achieving the desired culture surface coverage, and 4 hours incubation with MTS, 
being the same used for THP-1 cytotoxicity experiments, were selected as the optimal 
conditions for the MTS viability assay in HaCaT keratinocytes. 
Figure 4.2: MTS assay optimisation for HaCaT keratinocytes. The decrease in apparent 
absorbance at two hours incubation is due to inconsistent development of blanks, 
consisting of MTS in media without cells. Mean of three replicates, blank-corrected, error 
bars indicate SEM. 
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4.2.1.3  Peripheral blood monocytes and macrophages 
Following isolation of monocytes from human peripheral blood buffy-coat fractions, as in 
section 2.3.2, the procedure to optimise the MTS viability assay was undertaken as 
described in section 4.2.1.1 for both primary human monocytes and PMA-stimulated 
macrophages. A range of cell densities from 104 to 2 x 105 cells per well were seeded in a 
96-well microplate and incubated with MTS for 1, 2, 3 and 4 hours before measuring 
absorbance, as shown in Figure 4.3. Compared to the results from THP-1 monocytes, 
shown in Figure 4.1, the increase in MTS absorption for primary human monocytes 
between 104 and 2 x 105 cells per well is lower, reaching a maximum of 0.9 compared to 
1.4 absorbance units for 105 cells per well. This is likely due to higher metabolic activity of 
the immortalised THP-1 cells compared to the primary cells. This poses a problem for MTS 
viability assays, as lower absorbance readings for controls ultimately make the 
experimental data more uncertain, especially when there is interference from test 
compounds, such as in the case of nanosilver. A cell seeding density for primary 
monocytes of 105 cells per well, coupled with a 4 hour MTS incubation period, was 
chosen as a reasonable compromise between sufficient control absorbance readings and 
the limited number of cells available following isolation of monocytes from peripheral 
blood buffy-coat fractions. This is also the same seeding density used for THP-1 
monocytes, ensuring a level of consistency across cell types. 
Figure 4.3: MTS assay optimisation for primary human monocytes (A) and PMA-
stimulated macrophages (B). Mean of three replicates, blank-corrected, error bars 
indicate SEM. 
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4.2.1.4 Comparison of MTS viability assay with trypan blue exclusion assay 
In order to assess the reliability of using the MTS assay to measure cytotoxicity of 
nanosilver to human cells in vitro, THP-1 monocytes and PMA-stimulated macrophages 
were exposed to a range of concentrations of Carey Lea’s nanosilver. Following exposure 
for 24 hours, cell viability was assessed using both the trypan blue exclusion assay and the 
MTS viability assay, as described in sections 2.5.1 and 2.5.2 respectively. The results of 
this experiment are shown in Figure 4.4. No significant difference was detected between 
the assays at any concentration for the monocytes, whereas a highly significant difference 
was detected at the three lowest concentrations for PMA-stimulated macrophages. 
Overall, two-way ANOVA statistical testing detected a small but significant (p = 0.044) 
effect for the monocytes, and a slightly larger but highly significant (p < 0.0001) effect for 
the PMA-stimulated macrophages from the type of assay used.  
The differences seen here between the MTS viability assay and the trypan blue exclusion 
assay are due to the fact that MTS measures the metabolic activity of the cells being 
tested, whereas trypan blue measures membrane integrity. The change in metabolic 
activity of the cells exposed to nanosilver is unlikely to correlate exactly with their 
decrease in membrane integrity. There is a well known effect in toxicology called 
‘hormesis’, which describes a modest (less than 130% of the control) stimulatory 
Figure 4.4: Comparison of MTS viability assay with trypan blue exclusion assay for THP-1 
monocytes (A) and PMA-stimulated macrophages (B) exposed to Carey Lea’s nanosilver 
for 24 hours. Mean of four replicates; error bars indicate SEM. Statistically significant 
differences between assays at each concentration is denoted by * where p < 0.05 as 
determined by two-way ANOVA with Bonferroni post-hoc test. 
A * 
* 
* 
B 
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behaviour, for certain cellular parameters, at low levels of exposure to cytotoxic agents, 
including metals. This may be due to one, or a combination, of the stimulation of adaptive 
pro-survival responses, such as cellular repair mechanisms, brought about by a 
disturbance to cellular homeostasis, or increased cellular proliferation [279], both of 
which would result in apparently increased cellular metabolism as measured by MTS. 
Such an effect can be seen in Figure 4.4, image ‘A’, where the lowest nanosilver 
concentrations produced a viability level of around 110% of the control for THP-1 
monocytes as measured by MTS, whereas viability as measured by TBE is around 100% of 
control. It seems that this hormetic effect is enough to explain the observed difference 
between the two assays. Overall, these two methods for determining the cytotoxicity of 
nanosilver are in relatively close agreement when the effects of hormesis are taken into 
account. 
4.2.2 Reduction in viability of cell cultures exposed to nanosilver over 24 hours 
The cytotoxicity of the four types of nanosilver described in section 2.2, as well as Ag+ 
from silver nitrate, was assessed over 24 hours using the MTS viability assay in HaCaT 
human keratinocytes, THP-1 monocytes and PMA-stimulated macrophages, and primary 
human monocytes isolated from peripheral blood and their PMA-stimulated 
macrophages. This was undertaken to assess the relative potency of different kinds of 
nanosilver to human immune and skin cells and to define a dose-range at which to test 
further toxicological end-points, as well as the timeline of cytotoxic effects in this system. 
4.2.2.1 HaCaT human keratinocytes 
One of the major uses of nanosilver is in wound infection control through the application 
of nanosilver-impregnated bandages [95]. As such, human keratinocytes are a major 
target of nanosilver-induced cytotoxicity and are an interesting parallel system to 
compare with human immune cells. HaCaT cells were cultured in 96-well microplates and 
exposed to nanosilver as described in section 2.3.4. Cell viability was assessed at 4, 8, 12 
and 24 hours after exposure using the MTS viability assay. This data was used to produce 
the cell viability contour plots shown in Figure 4.5.  
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The general shape of these contour plots, with the exception of Ag+, shows a dose-
dependent response across a broad concentration range at 4 hours of exposure, with cell 
recovery at low concentrations by 8 and 12 hours and increased cytotoxicity at 24 hours. 
This suggests that, initially, cellular activity is suppressed even at low concentrations after 
the initial insult, but by 8 hours the HaCaT cells have been stimulated to a higher level of 
cellular metabolism, possibly through activation of repair mechanisms. This effect then 
Figure 4.5: Viability over 24 hours of HaCaT human keratinocytes exposed to nanosilver. 
A: ABC Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Contour colour scale is cell 
viability compared to control. Concatenate logistic dose-response fit of two independent 
experiments; viability was measured at 4, 8, 12 and 24 hours exposure. Contour maps 
created by Renka Cline method XYZ interpolation of fitted dose-response curves. 
A B 
C D 
E 
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tails off by 24 hours as more cells succumb to the cytotoxic effects of the nanosilver. The 
broad dose-response at 4 hours, which narrows by 24 hours, is not apparent in cells 
exposed to Ag+ where there is a relatively uniform  narrow cytotoxic concentration range 
over time, although stimulation at low concentrations is still evident (shown by areas of 
grey on the contour plots). The cells show a rapid response to the nanosilver in a time-
period of less than 4 hours after exposure, a period that was not investigated here as 4 
hours was the required incubation time for the MTS reagent in this assay. 
In order to compare the effects of the nanosilver over time, the effective concentration of 
each type of nanosilver causing 20, 50 and 80% cytotoxicity compared to the control 
(EC20, EC50, and EC80 respectively, corresponding to 80, 50 and 20% viability) were derived 
from logistic dose-response curve-fits of each independent experiment, as described in 
section 2.5.2.1. However, if the data for a specific time-point has a limited range of cell 
viability for the assessed particle concentrations, as can be seen at 4 hours exposure for 
some of the types of nanosilver in Figure 4.5, it was not possible to calculate values for all 
of the desired ECs. Plots of EC20, EC50 and EC80 values derived in this way for HaCaT cells 
exposed to nanosilver are shown in Figure 4.6. One-way ANOVA with Tukey-Kramer post-
hoc statistical testing found no significant differences between EC values over time for any 
of the test materials in HaCaT cells, except for a slight but significant increase in the EC20 
concentration of Ag+ by 12 and 24 hours. This may be due to a stimulation of the cells at 
low concentrations which is only apparent 12 hours after exposure, an effect that can be 
seen in the contour plot for HaCaT cells exposed to Ag+ in Figure 4.5, E. 
One reason for the apparent lack of significance in this data is that the quick response of 
the HaCaT cells, as measured by the MTS viability assay within 4 hours after exposure, 
made it difficult to determine a full EC dose-response range for this time point. As such, 
the data that has been analysed is mostly missing values for the first measured time point 
after exposure. It appears that by 8 hours post-exposure the HaCaT cellular response to 
the nanosilver has reached equilibrium and does not change further up to 24 hours after 
exposure. The most that can be said from this data is that the cytotoxicity of these test 
materials in HaCaT human keratinocytes occurs very rapidly following exposure, within 
the first 4 to 8 hours. As such, the MTS viability assay was not sensitive enough to study 
the rapid nature of the events leading to cytotoxicity in this exposure model. There is also 
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the matter of reproducibility for this assay. As can be seen in Figure 4.6, much of the EC 
data points have large error bars and in only 4 cases was a significant difference between 
either EC20, EC50 or EC80 values determined. Conducting experiments of this nature with 
sufficient dose-range and resolution at 4 different time-points over 24 hours requires 
significant resources, and there are a number of factors which can contribute to variability 
between these experiments, such as the cell passage number. In order to produce data to 
B 
C D 
E 
A 
Figure 4.6: Timeline of cytotoxicity for HaCaT keratinocytes exposed to nanosilver. A: ABC 
Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Effective concentration causing 
20, 50, and 80% cytotoxicity compared to control, derived from logistic fits of two 
independent experiments ± SEM. Significant differences were determined by one-way 
ANOVA with Tukey-Kramer post-hoc test (p < 0.05): for each EC series § = different to 4 
hours; at each time-point ¥ = EC20 vs EC50, * = EC20 vs EC80. 
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make reliable conclusions, considering the narrow concentration range observed between 
EC20 and EC80 values 24 hours post-exposure, it would be necessary to undertake more 
than three independent experiments of this nature covering at least 6 different doses for 
each test material in the space of about 6 weeks, which was beyond the scope of this 
project. 
4.2.2.2 THP-1 human monocytes 
As people are exposed to nanosilver through consumer products or in the workplace, a 
certain percentage of particles will penetrate to their circulatory system, whether it is 
through translocation across lung barriers after inhalation, absorption through the gastro-
intestinal tract or directly, through application to wounds [21, 142]. In these 
environments, the nanosilver particles will encounter immune cells, such as monocytes 
and macrophages, which will try to engulf the particles to clear them from the system. 
THP-1 monocytes offer a useful in vitro test system in this context to investigate the 
immuno-cytotoxicity of nanosilver, as they are flexible and easy to culture and can provide 
important insights into the interactions between nanosilver and human immune cells to 
be investigated further. THP-1 monocytes were cultured in 96-well microplates and 
exposed to nanosilver as described in section 2.3.4. Their viability compared to 
unexposed controls was measured at 4, 8, 12 and 24 hours with the MTS viability assay 
and this data was used to create the cell viability over time contour plots shown in Figure 
4.7.  
Similar to the response seen in HaCaT cells, the THP-1 monocytes exhibit a relatively 
broad dose-dependent response at 4 hours post-exposure which narrows over the next 
18 hours, although this effect is less pronounced. In every test material except Sigma 
nanosilver, again, most of the cytotoxic effects occur within the first 4 hours following 
exposure. In addition, the stimulatory effect at low concentrations is even more 
pronounced in THP-1 monocytes than HaCaT keratinocytes. In all nanosilver test 
materials, except NM-300K where this effect may have occurred below the lowest tested 
concentration, there was a pronounced increase in cellular metabolism after 12 hours at 
low concentrations. 
94 
 
The cellular viability timeline data for THP-1 monocytes was analysed to determine EC20, 
EC50 and EC80 values for each time-point, as described previously for HaCaT cells. 
Statistically significant differences were determined using one-way ANOVA with Tukey-
Kramer post-hoc tests. This data is shown in Figure 4.8, and the results of one-way ANOVA 
testing for changes over time are shown in Table 4.1; P values of less than 0.05 were 
considered significant. 
 
A B 
C D 
E 
Figure 4.7: Viability over 24 hours of THP-1 human monocytes exposed to nanosilver. A: 
ABC Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Contour colour scale is cell 
viability compared to control. Concatenate logistic dose-response fit of three 
independent experiments; viability was measured at 4, 8, 12 and 24 hours exposure. 
Contour maps created by Renka Cline method XYZ interpolation of fitted dose-response 
curves. 
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There was no significant effect due to exposure time for Carey Lea’s and NM-300K 
nanosilver. Sigma nanosilver showed significant changes over time at all cytotoxicity 
levels, while ABC Nanotech showed an effect at EC50 and EC80, and Ag
+ at EC80 only. Where 
a significant effect due to time was observed, this accounted for more than 80% of the 
variation in the respective data sets. 
 
Figure 4.8: Timeline of cytotoxicity for THP-1 monocytes exposed to nanosilver. A: ABC 
Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Effective concentration causing 
20, 50, and 80% cytotoxicity compared to control, derived from logistic fits of three 
independent experiments ± SEM. Significant differences were determined by one-way 
ANOVA with Tukey-Kramer post-hoc test (p < 0.05): for each EC series § = different to 4 
hours; at each time-point ¥ = EC20 vs EC50, * = EC20 vs EC80, $ = EC50 vs EC80. 
 
B 
C D 
E 
A 
§
§ 
 
 
 
§
§ 
 
 
§
§ 
 
 
 
§
§ 
 
 
 
§ 
§ 
§ 
 
 
 
§ 
¥
*
$ 
 
* 
 ¥
* 
 
¥
*
$ 
 
* 
 
* 
 
* 
 
96 
 
Table 4.1: One-way ANOVA results of THP-1 monocyte cytotoxicity timeline data: change 
over time. 
Nanosilver ABC Nanotech NM-300K Carey Lea's 
ANOVA results P value R2 P value R2 P value R2 
EC20 0.25 0.60 0.89 0.13 0.51 0.35 
EC50 0.01 0.92 0.37 0.51 0.76 0.13 
EC80 0.01 0.92 0.20 0.65 0.72 0.15 
Nanosilver Sigma Ag+ 
  
ANOVA results P value R2 P value R2 
  
EC20 0.03 0.81 0.39 0.49   
EC50 0.002 0.94 0.13 0.72   
EC80 0.005 0.91 0.02 0.90   
 
In conjunction with the ANOVA results shown in Table 4.1, it can be seen in Figure 4.8 that 
both NM-300K and Carey Lea’s nanosilver show no significant changes in cytotoxicity over 
time, implying that the cytotoxic effects of these test materials occur completely within 4 
hours of exposure. Significant increases in cytotoxicity occurred between 4 and 8 hours in 
Sigma nanosilver and between 4 and 12 hours in ABC Nanotech. The cytotoxicity trend for 
Sigma continued to increase until 24 hours, whereas it remained constant in ABC 
Nanotech after 12 hours.  For these two test materials, a large part of the observed 
cytotoxicity happens within the first 4 hours following exposure, but a significant 
proportion of the cytotoxic effect also takes longer to occur. The cytotoxicity of Ag+ 
increased slightly between 4 and 12 hours, but decreased again between 12 and 24 hours 
as the cells recovered slightly. 
The distinct behaviour shown here by THP-1 macrophages, where some nanosilver test 
materials continue to increase in cytotoxicity between 4 and 12 hours following exposure 
and some remain constant after 4 hours, may be due to the size of agglomerates formed 
in the TCM. The two materials that showed increasing cytotoxicity after 4 hours exposure, 
ABC Nanotech and Sigma nanosilver, had the largest agglomerate size when incubated in 
TCM, as measured using DCS and cryo-TEM. However, materials with larger agglomerates 
would settle to the bottom of the wells, where the cells are exposed, faster than materials 
that are well dispersed. This implies that the THP-1 monocytes would be exposed to more 
ABC Nanotech and Sigma nanosilver in a shorter period of time than the other nanosilver, 
but the cytotoxicity data described above shows these more agglomerated materials have 
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a slower rate of cytotoxicity than NM-300K and Carey Lea’s. It is therefore more probable 
that the determining factor here is the rate of internalisation by cells of the nanosilver, 
and the materials with larger agglomerates are internalised more slowly than the well 
dispersed materials. 
4.2.2.3 THP-1 human macrophages 
Macrophages are the primary phagocytic cells of the human immune system and they 
reside in most organs and tissues of the human body [57]. These cells are responsible for 
clearing any foreign particles that enter the body, and as such they are likely to be a major 
target of nanosilver particles in exposed humans. As macrophages are fully differentiated, 
tissue resident immune cells, it is exceedingly difficult to culture them in vitro. In order to 
compare macrophages and monocytes, it was therefore necessary to approximate 
macrophages by stimulating THP-1 monocytes with PMA to cause them to differentiate 
into macrophage-like cells. PMA-stimulated THP-1 macrophage-like cells were cultured in 
96-well microplates and exposed to nanosilver as described in section 2.3.4. Their viability 
compared to unexposed control cells was measured at 4, 8, 12 and 24 hours with the MTS 
viability assay and this data was used to create the cell viability over time contour plots 
shown in Figure 4.9. 
The general shape of the dose response data for THP-1 macrophages is similar to that of 
THP-1 monocytes shown in Figure 4.7, but the dose response ranges appear to be 
broader in macrophages. The narrowing of the dose response range after 4 hours 
exposure seen in HaCaT keratinocytes and THP-1 monocytes is also present in THP-1 
macrophages, but to a lesser degree. There is little evidence of the stimulatory effects at 
low concentrations seen in HaCaT keratinocytes and THP-1 monocytes, except for the 
period around 8 to 12 hours following exposure to Carey Lea’s nanosilver. This is likely due 
to two effects of the stimulation by PMA while culturing the THP-1 macrophage-like cells: 
the cells are unable to increase their metabolism further; and their differentiated state 
induced by the PMA prevents further cell proliferation.  
The cellular viability timeline data for THP-1 macrophage-like cells was analysed to 
determine EC20, EC50 and EC80 values for each time-point, as described previously for 
HaCaT keratinocytes and THP-1 monocytes. Statistically significant differences were 
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determined using one-way ANOVA with Tukey-Kramer post-hoc tests. This data is shown 
in Figure 4.10, and the results of one-way ANOVA testing for changes over time are shown 
in   
Table 4.2; P values of less than 0.05 were considered significant. 
Sigma nanosilver again showed a highly significant effect due to exposure time, with 
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Figure 4.9: Viability over 24 hours of THP-1 human macrophages exposed to nanosilver. A: 
ABC Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Contour colour scale is cell 
viability compared to control. Concatenate logistic dose-response fit of three 
independent experiments; viability was measured at 4, 8, 12 and 24 hours exposure. 
Contour maps created by Renka Cline method XYZ interpolation of fitted dose-response 
curves. 
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cytotoxicity increasing up to 24 hours after exposure. Although the cytotoxicity clearly 
appears to change over time for ABC Nanotech, in Figure 4.9 ‘A’, the variability in this data 
masked any significant effect. The dose response over time of macrophages exposed to 
NM-300K appeared to be very similar to the monocytes, with a narrow range between 
EC20 and EC80 which was constant between 4 and 24 hours of exposure. This is also the 
Figure 4.10: Timeline of cytotoxicity for THP-1 macrophages exposed to nanosilver. A: 
ABC Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Effective concentration 
causing 20, 50, and 80% cytotoxicity compared to control, derived from logistic fits of 
three independent experiments ± SEM. Significant differences determined by one-way 
ANOVA with Tukey-Kramer post-hoc test (p < 0.05): for each EC series § = different to 4 
hours, † = different to 8 hours; at each time-point ¥ = EC20 vs EC50, * = EC20 vs EC80, $ = 
EC50 vs EC80. 
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case for macrophages exposed to Carey Lea’s nanosilver, except for the 4 hour exposure 
time-point which shows a much wider dose-response range, in line with the contour plot 
in Figure 4.9 ‘C’. The dose response range for Carey Lea’s narrows between 4 and 8 hours, 
a pattern that also appears in ABC Nanotech and Ag+, although statistical significance is 
again masked by data variability. This effect was also seen in THP-1 monocytes, although 
it was less pronounced. This is likely due to the THP-1 cells being stimulated at low 
concentrations, as discussed previously for HaCaT cells, between 4 and 8 hours before 
being overwhelmed between 12 and 24 hours, as can be seen in the contour plots in 
Figure 4.9.  
Table 4.2: One-way ANOVA results of THP-1 macrophage cytotoxicity timeline data: 
change over time. 
Nanosilver ABC Nanotech NM-300K Carey Lea's 
ANOVA results P value R2 P value R2 P value R2 
EC20 0.80 0.10 0.33 0.54 0.01 0.88 
EC50 0.06 0.68 0.62 0.24 0.08 0.84 
EC80 0.10 0.62 0.20 0.51 0.05 0.90 
Nanosilver Sigma Ag+ 
  
ANOVA results P value R2 P value R2 
  
EC20 < 0.0001 0.89 0.94 0.06   
EC50 0.03 0.81 0.80 0.15   
EC80 0.03 0.84 0.20 0.58   
 
4.2.2.4 Primary human monocytes 
Although THP-1 monocytes are a flexible and convenient model to screen for the effects 
of nanosilver on human immune cells, there is always some uncertainty when comparing 
the behaviour of transformed or cancerous cell lines to primary cells. To evaluate the 
representativeness of the THP-1 in vitro model, it was therefore desirable to compare the 
results with isolated primary human monocytes. After being isolated from the buffy-coat 
fractions of blood donations, as described in section 2.3.2, primary human monocytes 
were cultured in 96-well microplates and exposed to the nanosilver test materials as 
described in section 2.3.4. Their viability compared to unexposed control cells was 
measured at 4, 8, and 24 hours and this data was used to create cell viability over time 
contour plots as shown in Figure 4.11. As this data is derived from only one experiment, 
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and due to the limited nature of the dose-responses observed, values for EC20, EC50 and 
EC80 at each time-point were derived from the relevant contours shown in Figure 4.11, 
and are shown in Table 4.3 .  
Despite undertaking range-finding experiments with 24 hours of exposure to determine 
the likely cytotoxicity threshold concentration for each test material in isolated primary 
human monocytes, the concentrations used for the comprehensive cell viability timeline 
experiment were too low to show a complete dose response, except in the case of Ag+. As 
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Figure 4.11: Viability over 24 hours of primary human monocytes exposed to nanosilver. 
A: ABC Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Contour colour scale is cell 
viability compared to control. Viability was measured at 4, 8 and 24 hours exposure. 
Contour maps created by Renka Cline method XYZ interpolation of raw dose-response 
data. 
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such, it was not possible to determine EC20, EC50 and EC80 values for all time-points and all 
test materials. Also, due to the fact that only one viability timeline experiment was 
undertaken, it was not possible to conduct the same statistical significance analysis as for 
other cell lines.  
Despite this, it appears that cytotoxicity of nanosilver to primary human monocytes 
increases between 4 and 24 hours following exposure, and that some stimulation is 
observed at low concentrations, in line with what was observed for THP-1 monocytes, 
while the concentrations required to show cytotoxicity (where cytotoxicity was observed) 
were much lower than for THP-1 monocytes. 
Table 4.3: Primary human monocytes exposed to nanosilver over 24 hours: effective 
concentrations causing 20, 50 and 80% cytotoxicity compared to control, derived from 
contour plots. ND = not determined. 
Nanosilver ABC Nanotech NM-300K Carey Lea's 
Exposure (hours) 4 8 12 24 4 8 12 24 4 8 12 24 
EC20 
ND 
23 
ND ND 
44 
EC50 39 ND 
EC80 ND ND 
Nanosilver Sigma Ag+ 
    
Exposure (hours) 4 8 12 24 4 8 12 24 
    EC20 23 22 21 20 4.0 5.0 4.8 1.4 
    EC50 
ND 
155 6.5 6.9 6.7 3.2 
    EC80 ND 8.7 8.8 8.5 6.6 
      
4.2.2.5 Primary human macrophages 
As mentioned above, it was important to test both circulating and tissue resident immune 
cells for their reaction to nanosilver exposure, as both of these cell types are likely to 
encounter nanosilver in exposed humans. Therefore, freshly isolated primary human 
monocytes were stimulated with PMA to differentiate them into macrophage-like cells, in 
the same way as for THP-1 cells.  
The PMA-stimulated primary human macrophage-like cells were cultured in 96-well 
microplates and exposed to the nanosilver test materials as described in section 2.3.4. 
Their viability compared to unexposed control cells was measured at 4, 8, and 24 hours 
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and this data was used to create cell viability over time contour plots as shown in Figure 
4.12. Again, this data is derived from only one experiment, and for consistency with 
primary human monocyte data, values for EC20, EC50 and EC80 at each time point were 
derived from the relevant contours shown in Figure 4.12, and are described in Table 4.4.  
The PMA-stimulated primary macrophages appear to be much more sensitive to 
nanosilver exposure than the primary monocytes from which they were derived. 
Compared to THP-1 macrophages, the primary macrophages were around 30 to 40-fold 
A B 
C D 
E 
Figure 4.12: Viability over 24 hours of primary human macrophages exposed to 
nanosilver. A: ABC Nanotech, B: NM-300K, C: Carey Lea’s, D: Sigma, E: Ag+. Contour colour 
scale is cell viability compared to control. Viability was measured at 4, 8 and 24 hours 
exposure. Contour maps created by Renka Cline method XYZ interpolation of raw dose-
response data. 
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more sensitive to ABC Nanotech, 3 to 4-fold more sensitive to NM-300K, 6-fold more 
sensitive to Carey Lea’s, 25-fold more sensitive to Sigma and 4 to 5-fold more sensitive to 
Ag+. Again, the tested concentration range did not produce complete dose-response 
curves for primary human macrophages: the only complete dose-response data for these 
cells was from those exposed to Ag+. 
Since full dose-response curves were measured for primary human monocytes and PMA-
stimulated macrophages exposed to Ag+, a comparison between EC20, EC50 and EC80 
values in primary cells and THP-1 cells is shown in Figure 4.13. 
There is no significant difference between THP-1 monocytes and macrophages at any of 
the EC values, but the primary cells are both substantially more sensitive to Ag+, with the 
macrophages appearing to be more sensitive than the monocytes. Both types of primary 
cells also appear to show a proportionally broader dose-response range than their THP-1 
cell counterparts. 
Table 4.4: Primary human macrophages exposed to nanosilver over 24 hours: effective 
concentrations causing 20, 50 and 80% cytotoxicity compared to control, derived from 
contour plots. ND = not determined. 
Nanosilver ABC Nanotech NM-300K Carey Lea's 
ABC Nanotech Exposure (hours) Exposure (hours) Exposure (hours) 
Cytotoxicity (% control) 4 8 12 24 4 8 12 24 4 8 12 24 
EC20 ND ND 2 ND ND ND ND ND ND ND ND ND 
EC50 ND 5 6 ND 34 40 39 30 28 25 25 36 
EC80 7 13 13 3 ND 50 49 44 43 42 44 45 
Nanosilver Sigma Ag+ 
    
  Exposure (hours) Exposure (hours) 
    Cytotoxicity (% control) 4 8 12 24 4 8 12 24 
    EC20 ND ND ND ND ND 0.6 1.1 0.5 
    EC50 13 27 34 10 0.6 2.2 2.3 1.8 
    EC80 51 86 84 23 3.6 3.7 3.4 3.4 
     
4.2.3 Comparison of nanosilver cytotoxicity across three cell types and the effect 
of concentration metrics 
A major aim of the investigation of the cytotoxicity of nanosilver described in section 
4.2.2 was to compare the relative potency of four different kinds of silver NPs in HaCaT 
keratinocytes and THP-1 monocytes and PMA-stimulated macrophage-like cells. To 
105 
 
adequately compare their potency, it was necessary to take into account different particle 
exposure concentration metrics: mass, surface area, and particle number concentration. 
The exposures described in section 4.2.2 were calculated in mass concentration, as this 
was the most practical way to ensure repeatable dosing using laboratory scales to weigh 
the amount of nanosilver in each exposure. The mass concentrations were converted into 
surface area and particle number concentrations as described in section 2.2.4. Effective 
concentrations causing 50% cytotoxicity compared to control in each concentration 
metric for each type of nanosilver were compared for the 24 hour exposure time-point in 
HaCaT keratinocytes, THP-1 monocytes and macrophages. Effects due to cell type and 
nanosilver were analysed using two-way ANOVA statistical testing. 
These results show a significant interaction effect between cell type and nanosilver across 
all concentration metrics. This is due to the large difference in sensitivity to nanosilver of 
Figure 4.13: Comparison of EC20, EC50 and EC80 values for THP-1 monocytes and PMA-
stimulated macrophages, and primary monocytes and PMA-stimulated macrophages 
exposed to Ag+ for 24 hours. Error bars indicate SEM. 
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the keratinocytes compared to the immune cells in this in vitro system, which can be seen 
in Figure 4.14: differences ranged between 0.6 and 1.3 orders of magnitude for the same 
nanosilver between keratinocytes and immune cells at EC50. Bonferroni post-hoc testing 
showed that HaCaT keratinocytes were significantly different to both THP-1 monocytes 
and macrophages for all nanosilver in all concentration metrics, whereas THP-1 
monocytes and macrophages were statistically equivalent.  
Given the strong, but trivial, nature of the interaction due to cell type in this analysis, the 
differences between respective nanosilver EC50 values within each cell type for the three 
concentration metrics were analysed in greater detail using one-way ANOVA with Tukey-
Kramer post-hoc testing, where P values of less than 0.05 were considered significant. 
Figure 4.14: Relative potency of nanosilver at effective concentration causing 50% 
cytotoxicity compared to control after 24 hours for HaCaT keratinocytes, THP-1 
monocytes and THP-1 macrophages, expressed in different particle concentration 
metrics. A: Mass, B: Number, C: Surface area. Data derived from logistic fits of 2 to 4 
independent experiments ± SEM. Significant differences determined by one-way ANOVA 
with Tukey-Kramer post-hoc test (p < 0.05): for nanosilver in each cell type § = different to 
ABC Nanotech, † = different to NM-300K, X = different to Carey Lea’s, * = different to 
Sigma. 
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These results are shown in Figure 4.14. 
For EC50s expressed in terms of particle mass concentration, ABC Nanotech, NM-300K and 
Carey Lea’s were not significantly different from each other in any cell type, while Sigma 
nanosilver EC50 values were significantly higher than all other nanosilver in all three cell 
types. For particle number concentration, this was reversed in HaCaT keratinocytes where 
Sigma nanosilver EC50 values were significantly lower than the other three types of 
nanosilver. In THP-1 monocytes and macrophages, particle number concentration EC50 
values for Sigma were again significantly lower than all other types of nanosilver, but NM-
300K was also significantly lower than ABC Nanotech and Carey Lea’s. 
In terms of particle surface area concentration, there was no significant difference 
between any of the four types of nanosilver in HaCaT keratinocytes. In THP-1 monocytes 
and macrophages, NM-300K and Sigma nanosilver EC50 values were statistically 
equivalent and significantly lower than ABC Nanotech and Carey Lea’s, which were also 
statistically equivalent. 
NP size seems to play a role in relative potency when dose concentrations are expressed 
in terms of mass or particle number. The three smaller nanosilver show equivalent 
cytotoxicity while the larger nanosilver is significantly less cytotoxic by mass, and the 
increased potency of NM-300K in number concentration terms compared to ABC 
Nanotech and Carey Lea’s is likely due to the presence of surfactants in the NM-300K 
formulation. When expressed in terms of particle number, Sigma nanosilver was up to 2.6 
orders of magnitude more potent than the other particles. 
However, when expressed in terms of particle surface area, particle size seems to have 
much less of an effect on cytotoxicity. In HaCaT keratinocytes, the four types of nanosilver 
tested here had statistically equivalent levels of cytotoxicity when expressed in terms of 
particle surface area. In THP-1 monocytes and macrophages, both NM-300K and Sigma 
nanosilver were slightly more potent than ABC Nanotech and Carey Lea’s. That two such 
different types of nanosilver as NM-300K and Sigma have equivalent potency in this 
system when expressed in terms of surface area suggests that this is likely to be the one 
of the determining factors of relative potency of nanosilver cytotoxicity.  
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The specific surface area of each type of nanosilver can be misleading when considering 
these issues on the cellular level. The specific surface areas of NM-300K and Sigma 
nanosilver are 32.1 and 4.9 m2/g respectively, but an average sized particle of Sigma has 
71 times the surface area of an average sized particle of NM-300K. So, a cell would have 
to take up 71 times as many particles of NM-300K to receive the same surface area dose 
as for Sigma nanosilver. The actual dose delivered will depend on how particle size, and 
agglomeration, affects the rate of cellular uptake, something which was beyond the scope 
of this study. 
To determine whether there was any difference in the relative cytotoxic potency of each 
type of nanosilver between the cell lines investigated here, the mean EC50s in terms of 
surface area concentration in each cell line were subtracted from the same EC50s in the 
other cell lines. These differences were adjusted to control for the concentrations 
required to produce the same cytotoxicity in each type of nanosilver. This data was 
analysed using two-way ANOVA with Bonferroni post-hoc testing and is shown in Figure 
4.15. None of the differences in mean EC50s for THP-1 monocytes compared with 
macrophages were significantly different from zero, so this data was excluded from the 
ANOVA analysis to focus on differences between keratinocytes and immune cells. 
In this analysis, a negative value means that the first cell type was more sensitive to this 
nanosilver than the second cell type. The comparison of interest is the relative magnitude 
of these differences for each type of nanosilver; equal sensitivity to all nanosilver 
between cell types would show equivalent differences in this analysis.  
HaCaT cells were less sensitive to Sigma than the other types of nanosilver when 
compared to THP-1 monocytes and macrophages. Although this difference was only 
statistically significant for ABC Nanotech in both cell type comparisons, differences to the 
other types of nanosilver were very close to the 95% confidence limit. The relatively lower 
potency of the largest nanosilver in HaCaT keratinocytes when compared to the two 
immune cells may be due to the rate of cellular uptake. The THP-1 monocytes and 
macrophages are able to actively take up particles through phagocytosis [239], although 
the macrophages phagocytosis is much more active than the monocytes, while HaCaT 
keratinocytes take up particles through other processes, such as endocytosis, which are 
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likely to be more effective for smaller than larger particles. This could lead to the lower 
observed relative sensitivity of HaCaT cells to Sigma nanosilver compared to the other, 
smaller types of nanosilver. 
4.2.4 Discussion 
The MTS cell viability assay was a useful technique to examine the cytotoxicity of 
nanosilver to the cell lines investigated here. This assay was able to detect a hormetic 
response by HaCaT keratinocytes and THP-1 monocytes and PMA-stimulated 
macrophages exposed to low concentrations of nanosilver within 8 to 12 hours post-
exposure. This effect will require further investigation to determine its importance in 
regards to interpreting early responses to nanosilver exposure, such as intercellular 
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Figure 4.15: Difference in mean EC50 value for each type of nanosilver between three cell 
types, normalised for comparison. Data derived from logistic fits of 2 to 4 independent 
experiments ± SEM. Significant differences determined by two-way ANOVA with 
Bonferroni post-hoc test (p < 0.05): for nanosilver in each cell type comparison § = 
different to ABC Nanotech, † = different to NM-300K, * = different to Sigma. 
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signalling and cellular repair mechanisms, which may provide insights into the cytotoxic 
mechanisms of nanosilver. The MTS viability assay also allowed the cytotoxic 
concentration range for each of the types of nanosilver in HaCaT keratinocytes and THP-1 
monocytes and PMA-stimulated macrophages to be defined for the purposes of further 
toxicological investigation. Some of the types of nanosilver tested here did cause 
interference with the MTS viability assay due to their strong optical absorbance 
characteristics, but this was able to be overcome through centrifugation of the samples 
prior to absorbance measurements, as described in section 2.5.2. Interestingly, this 
procedure generally agrees with the independently developed protocol for this kind of 
assay in the Quality Handbook: Standard Procedures for Nanoparticle Testing published 
recently by Nanommune for the 7th Framework Programme [280]. 
Using the MTS cell viability assay to assess the timeline of cytotoxicity in cells exposed to 
nanosilver over 24 hours was effective in a broad sense, in that it was able to determine 
that, at cytotoxic concentrations, the majority of the observed cytotoxicity occurred 
within the first 4 to 8 hours in all cell lines. Sigma nanosilver, the test material with the 
largest particle size, was an exception to this, taking up to 24 hours to exhibit full 
cytotoxicity. However, other techniques will be required to investigate the cellular 
processes leading to cytotoxicity within the first 4 hours following exposure, as MTS was 
unsuitable for this very short exposure time period. 
The MTS viability assay was unable to detect any difference in sensitivity to nanosilver or 
Ag+ between THP-1 monocytes and PMA-stimulated macrophages at 24 hours post-
exposure for EC20, EC50 and EC80. This suggests that even after PMA-stimulated 
differentiation, THP-1 macrophages respond to the nanosilver in this system in the same 
manner as THP-1 monocytes. Difficulties in the isolation of primary human monocytes 
from peripheral blood, as well as time constraints, prevented a full comparison of the 
sensitivity of these cells compared to the immortalised THP-1 cell line. The limited data 
that was collected suggests that primary human monocytes and PMA-stimulated 
macrophages are more sensitive to the types of nanosilver investigated here than THP-1 
monocytes and THP-1 PMA-stimulated macrophages. 
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When comparing the relative cytotoxicity of the four kinds of nanosilver investigated for 
this project, the three different particle concentration metrics provided starkly different 
assessments. Mass concentration was the simplest way of expressing exposure, as this 
was the most practical method to prepare exposure experiments in the laboratory. 
However, mass concentration fails to take into account particle size, and so is of limited 
utility when comparing the cytotoxic potential of different kinds of nanosilver. Particle 
number concentration does take into account the size of the particles being investigated, 
but at an abstracted level that also limits its practicality in describing the system under 
investigation. Particle surface area appears to be the most useful concentration metric of 
the three, as it accounts for the size of the particles, which may affect their rate of uptake, 
and directly reflects the amount of interaction sites on the surface of the particles to 
which the cells are exposed. It may also be possible to use surface area concentration to 
account for particle agglomeration if surface area can be measured under conditions 
present in the in vitro system, such as suspended in cell culture media. Others have 
previously discussed the importance of surface area when assessing the cytotoxicity of 
nanomaterials [184, 281]. If the cytotoxicity of the material under investigation is 
primarily due to the intracellular release of toxic ions or oxidative stress, dubbed the 
Trojan-horse mechanism [125, 166], and which is particularly relevant for nanosilver, then 
surface area concentration and surface area per particle also reflect the likely intracellular 
dissolution rates and ROS generation. 
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5 Cell death pathways of HaCaT 
keratinocytes, and THP-1 human 
monocytes and macrophages 
exposed to nanosilver 
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5.1 Introduction 
Cell death has been characterised into two major mechanisms, with different causes and 
consequences. Necrosis is a process involving non-physiological, extrinsic stimulus, such 
as ischemia, the action of toxins, and physical trauma, e.g. heat. It results in the swelling 
of cells and bursting of cellular membranes, which releases the cytoplasmic contents into 
the surrounding environment. This results in an inflammatory response from the innate 
immune system in order to destroy any pathogens that may have entered through the 
injury, and to remove the necrosed cells [282]. 
In contrast, apoptosis is the process of ‘programmed cell death’ which is intrinsic to 
normal cellular turnover in tissues, and embryonic development, although it can also be 
initiated by external factors. Apoptosis is an energy-dependent process in which cells 
form a number of ‘apoptotic bodies’, membrane-bound capsules containing the 
cytoplasm and organelles, which are then usually phagocytosed by surrounding cells and 
digested. As the cellular contents are not released into their surroundings, apoptosis is 
not accompanied by inflammation [283, 284]. 
Examining the mode of cell death is important for in vitro toxicological investigations as it 
can provide a greater level of understanding than simply measuring cell viability. 
Determining whether cells die by necrosis or apoptosis after being exposed to a toxic 
agent can help to infer the rate and mechanisms of the toxic responses. 
A common method for investigating in vitro apoptosis and necrosis uses two fluorescent 
dyes and is measured by flow cytometry. The components of the lipid bilayer membrane 
surrounding a healthy cell are normally polarised, so that the phosphatidylserine (PS) 
component is only on the inside of the membrane. When a cell undergoes apoptosis, its 
membrane loses this polarisation, exposing PS to the surroundings. This is recognised by 
adjacent cells and causes the apoptotic bodies to be rapidly phagocytosed. A protein 
known as Annexin V preferentially binds to PS, and when conjugated with the green 
fluorescent probe fluorescein isothiocyanate (FITC), it provides a convenient way to 
fluorescently stain apoptotic cells [268]. By combining the Annexin V-FITC stain with 
propidium iodide (PI), a red fluorescent vital dye that is excluded by cells with intact 
membranes, individual cells can be measured by flow cytometry to distinguish their 
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viability and what cell death pathway they are following, i.e.: viable cells will be negative 
for both stains; early apoptotic cells will be positive for FITC but negative for PI, as their 
membranes remain intact; and necrotic cells will be positive for both FITC and PI [268]. 
This assay was used to investigate the cell death behaviour of human THP-1 monocytes 
and macrophages exposed to the four types of nanosilver described in section 2.2, and 
Ag+ from silver nitrate as a dissolved silver control. The investigation was conducted as a 
timeline at 4 hour incubation intervals up to 24 hours, in order to determine the ratio of 
apoptotic and necrotic cells for each type of nanosilver, and how this parameter evolved 
over time. Human HaCaT keratinocytes were also investigated for apoptosis and necrosis 
after 24 hours exposure. Nanosilver exposure concentrations used for this investigation 
are shown in Table 5.1. 
Table 5.1: Nanosilver exposure concentrations for cell death pathways experiments, silver 
concentrations in µg/mL. 
Cell type Monocytes Macrophages HaCaTs 
Dose Low Medium High Low Medium High Medium High 
Cytotoxicity Subtoxic EC20 EC50 Subtoxic EC20 EC50 EC50 EC80 
ABC Nanotech 100 130 180 15 60 150 13 20 
NM-300K 80 100 120 15 80 130 20 30 
Carey Lea's 50 120 170 25 100 140 15 23 
Sigma 600 700 800 100 400 600 200 270 
Ag+ 2 5 7 2 4 6 2.75 4 
 
5.2 Results 
Cell death pathways of apoptosis or necrosis were determined after exposure and staining 
as described in sections 2.3.4 and 2.6.1 respectively. The HaCaT keratinocytes, and THP-1 
monocytes and macrophages were analysed using flow cytometry following nanosilver 
exposure. A side-scatter versus forward-scatter plot was produced for each sample to 
identify the cell population for analysis – examples for an unexposed THP-1 monocyte 
control specimen and a THP-1 monocyte specimen exposed to NM-300K are shown in 
Figure 5.1 and Figure 5.2. Material showing low forward-scatter was excluded in order to 
avoid interference from nanosilver agglomerates: the events shown in red in Figure 5.1 
were analysed for fluorescence. As shown in Figure 5.2, the fluorescence intensity of  
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Figure 5.1: Scatter plots from flow cytometry of THP-1 monocytes showing cell 
population gated for fluorescence analysis, 24 hours after exposure: A, unexposed 
control; B, NM-300K 120 µg/mL. 
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Figure 5.2: Scatter plots from flow cytometry of THP-1 monocytes showing fluorescence 
intensity for FITC and PI in stained cells, 24 hours after exposure: A, unexposed control; B, 
NM-300K 120 µg/mL. 
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the two probes, FITC and PI were plotted against each other, and the scatter plots were 
split into four quadrants. The bottom left quadrant contained viable cells that were 
negative for both FITC and PI, the bottom right quadrant contained apoptotic cells that 
were positive for FITC but negative for PI, and the top right quadrant contained necrotic 
cells that were positive for both FITC and PI. The top left quadrant contained cellular 
debris that was only stained with PI, and was excluded from the analysis. The number of 
events falling in each of the three quadrants was used to determine the ratios of viable, 
apoptotic and necrotic cells. 
5.2.1 Apoptosis and necrosis over 24 hours in THP-1 monocytes and 
macrophages exposed to nanosilver and Ag+ 
THP-1 monocytes and macrophages were exposed to nanosilver or Ag+, and their levels of 
apoptosis and necrosis were measured at 4, 8, 12 and 24 hours following exposure. The 
cells were exposed to different concentrations of each test material such that they would 
give a cytotoxic response roughly equal to EC20 and EC50 as previously determined by the 
MTS assay in section 4 as well as a sub-toxic dose. Subtoxic, EC20 and EC50 data for THP-1 
monocytes are shown in Figure 5.3, Figure 5.4, and Figure 5.5 respectively.  Subtoxic, EC20 
and EC50 data for PMA-stimulated macrophages are shown in Figure 5.6, Figure 5.7, and 
Figure 5.8 respectively. 
Each category of stained cells is expressed as the percentage of total events recorded in 
that sample, excluding any events in quadrant 1 as described above. This is unlike the 
MTS viability assay data shown in section 4, which is expressed as a percentage of the 
control values. As the control samples generally had very low levels of apoptosis and 
necrosis, values expressed in percent control terms were less intuitive in comparing 
between cell types and test materials. 
Whilst there was a dose-dependent decrease in viable cells, coupled with increases in 
necrotic and apoptotic cells, the observed variation over time in these figures does not 
appear to follow a clear pattern, although there is a slight trend towards an increased 
proportion of apoptotic cells and decreased necrotic cells over time. For monocytes, the 
proportion of viable cells at 8 hours appears higher than the average for all test materials, 
especially at the two higher concentrations, but this does not follow for macrophages. 
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Figure 5.3: Timeline of cell death pathways with linear regressions. THP-1 monocytes 
exposed to nanosilver and Ag+ for 24 hours at subtoxic concentrations for each test 
material. Mean of three replicates, error bars indicate SEM. Dose concentrations shown in 
Table 5.1. 
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Figure 5.4: Timeline of cell death pathways with linear regressions. THP-1 monocytes 
exposed to nanosilver and Ag+ for 24 hours at EC20 concentrations for each test material. 
Mean of three replicates, error bars indicate SEM. Dose concentrations shown in Table 
5.1. 
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Figure 5.5: Timeline of cell death pathways with linear regressions. THP-1 monocytes 
exposed to nanosilver and Ag+ for 24 hours at EC50 concentrations for each test material. 
Mean of three replicates, error bars indicate SEM. Dose concentrations shown in Table 
5.1. 
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Figure 5.6: Timeline of cell death pathways with linear regressions. THP-1 PMA-
stimulated macrophages exposed to nanosilver and Ag+ for 24 hours at subtoxic 
concentrations for each test material. Mean of three replicates, error bars indicate SEM. 
Dose concentrations shown in Table 5.1. 
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Figure 5.7: Timeline of cell death pathways with linear regressions. THP-1 PMA-
stimulated macrophages exposed to nanosilver and Ag+ for 24 hours at EC20 
concentrations for each test material. Mean of three replicates, error bars indicate SEM. 
Dose concentrations shown in Table 5.1. 
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Figure 5.8: Timeline of cell death pathways with linear regressions. THP-1 PMA-
stimulated macrophages exposed to nanosilver and Ag+ for 24 hours at EC50 
concentrations for each test material. Mean of three replicates, error bars indicate SEM. 
Dose concentrations shown in Table 5.1. 
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The reason for this variation is likely due to the practicalities of the assay. Analysing one 
sample by flow cytometry for this assay can take 3 minutes or more, simply in terms of 
data collection. Each treatment here was performed in triplicate, so for each time-point 
48 individual samples required analysis. At 3 minutes each, the data collection alone 
would have taken 2 hours and 24 minutes. This assay can also be sensitive to a delay 
between cell staining and analysis, and given the number of samples being processed, 
and the time required for data collection, this delay is unlikely to be constant across 
different time-points. Despite the variation between time-points, it is still possible to 
analyse the proportion of cells undergoing apoptosis and necrosis independently of 
exposure time, for comparison between the responses of different cell types. 
5.2.2 Effect of cell type on apoptosis and necrosis in HaCaT keratinocytes, and 
THP-1 monocytes and macrophages exposed to nanosilver and Ag+ 
In addition to the data described in section 5.2.1, the same assay was carried out for 
HaCaT human keratinocytes 24 hours following exposure to a limited range of nanosilver 
concentrations. The increase in the proportion of apoptotic and necrotic cells as viable 
cells decreased is shown for each test material in Figure 5.9, and a summary of the 
associated linear regressions is shown in Table 5.2.  
The proportion of apoptotic cells increased the most in exposed THP-1 macrophages, 
followed by THP-1 monocytes and then HaCaT keratinocytes, which showed almost no 
apoptosis at all. Conversely, necrosis increased the most in HaCaT keratinocytes, followed 
by THP-1 monocytes and, finally, THP-1 macrophages. This relationship held across all test 
materials. This implies that cell type has a significant influence on the cell death pathway 
followed upon exposure to cytotoxic levels of nanosilver, and Ag+, even between THP-1 
monocytes and PMA-stimulated macrophages. 
The role of macrophages in general is to attack pathogens and foreign particulates in 
tissues and to recruit neutrophils, which also help to destroy invading pathogens [57]. The 
mechanisms that macrophages and neutrophils use to destroy pathogens include a kind 
of ‘chemical warfare’, utilising highly reactive chemicals such as hypochlorous acid and 
ROS generation, and even ejecting the contents of their own lysosomes into the 
surrounding environment [285]. It is therefore important for macrophages to be able to 
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withstand this adverse environment in order to carry out another of their important roles, 
as antigen presenting cells (APCs). By phagocytosing pathogens and entering the 
lymphatic system, macrophages can prime the T-cells located in the lymph nodes with 
antigens derived from the pathogens, in order to stimulate an acquired immune response 
[286]. Neither monocytes nor keratinocytes fill these roles, and will be more sensitive to 
oxidative stress than macrophages. One of the major mechanisms for silver cytotoxicity, 
Figure 5.9: Proportion of apoptotic and necrotic cells as viability decreases compared by 
cell type for HaCaT keratinocytes, and THP-1 monocytes and macrophages exposed to 
nanosilver over 24 hours. A: ABC Nanotech; B: NM-300K; C: Carey Lea’s; D: Sigma; E: Ag+. 
Data from one experiment in triplicate, with linear regressions. Dose concentrations 
shown in Table 5.1. 
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Table 5.2: Summary of linear regressions shown in Figure 5.9, rate of change of the proportion of apoptotic and necrotic cells as viable cells 
decrease, for THP-1 monocytes, PMA-stimulated macrophages, and HaCaT keratinocytes. SE = standard error. * = significantly different from 
other test materials within a cell type and a cell death pathway. 
 
Apoptosis Necrosis 
 
 
Monocytes SE Macrophages SE HaCaTs SE Monocytes SE Macrophages SE HaCaTs SE 
 
ABC Nanotech 
-0.09 0.03 -0.63 0.03 -0.025 0.056 -0.91 0.03 -0.37 0.03 -0.98 0.06 Slope 
14.4 2.0 64.4 1.5 7.0 4.3 85.6 2.0 35.6 1.5 93.0 4.3 Y intercept 
NM-300K 
-0.08 0.01 -0.61 0.02 -0.009 0.006 -0.92 0.01 -0.39 0.02 -0.99 0.01 Slope 
13.8 1.1 63.4 0.8 4.1 0.4 86.2 1.1 36.6 0.8 95.9 0.4 Y intercept 
Carey Lea's 
-0.08 0.02 -0.61 0.02 -0.008 0.017 -0.92 0.02 -0.39 0.02 -0.99 0.02 Slope 
13.4 1.6 63.9 0.8 5.1 1.3 86.6 1.6 36.1 0.8 94.9 1.3 Y intercept 
Sigma 
-0.10 0.02 -0.47 * 0.02 -0.024 0.007 -0.90 0.02 -0.53 * 0.02 -0.98 0.01 Slope 
15.4 1.2 54.0 * 1.2 5.5 0.4 84.6 1.2 46.0 * 1.2 94.5 0.4 Y intercept 
Ag+ 
-0.10 0.01 -0.68 0.01 0.003 0.008 -0.90 0.01 -0.32 0.01 -1.00 0.01 Slope 
15.0 0.8 67.6 0.8 3.0 0.4 85.0 0.8 32.4 0.8 97.0 0.4 Y intercept 
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whether from ionic or nanosilver, is attributed to ROS production [74]. The lower 
observed rates of necrosis in THP-1 macrophages compared to THP-1 monocytes and 
HaCaT keratinocytes may therefore be due to the macrophages having a greater ability to 
withstand increased oxidative stress. 
Additionally, it has been shown that dendritic cells can act effectively as APCs after 
internalising apoptotic bodies from other cells which contain antigens [287]. It is 
therefore likely that if the macrophages defences against oxidative stress are 
overwhelmed, it will undergo apoptosis in order to facilitate an effective acquired 
immune response by the uptake of its apoptotic bodies by other APCs. This may explain 
the higher observed rates of apoptosis in THP-1 macrophages compared to THP-1 
monocytes and HaCaT keratinocytes. 
The only significant difference in the rates of change in apoptosis and necrosis between 
the different test materials for each cell type was in THP-1 macrophages, as determined 
by comparison of linear regressions. The apoptosis and necrosis data for THP-1 
macrophages has been consolidated in Figure 5.10 for easier comparison. The increase in 
apoptotic cells in THP-1 macrophages exposed to Sigma nanosilver is significantly lower 
than all other test materials, and the opposite is true for necrosis, where it has a higher 
increase in necrotic cells. This can be seen in Figure 5.10 where the orange coloured line 
and ‘X’ symbols clearly diverge from the other series below approximately 50% cell 
viability. Compared to the other three types of nanosilver tested in THP-1 macrophages, 
Sigma caused (on average) a 24% lower increase in apoptotic cells, and a 38% greater 
increase in necrotic cells, for the same loss of viable cells. 
The data for Ag+ in THP-1 macrophages also shows a slight divergence from the other test 
materials in terms of the rate of increase of apoptotic and necrotic cells, but in the 
opposite direction of Sigma nanosilver. Compared to the three smaller nanosilver 
materials, Ag+ caused (on average) a 10% greater increase in apoptotic cells, and a 17% 
lower increase in necrotic cells, for the same loss of viable cells. Compared with Sigma 
nanosilver, Ag+ caused a 31% greater increase in apoptotic cells and a 65% lower increase 
in necrotic cells. 
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Figure 5.10: Proportional increase in apoptotic (A) and necrotic (B) cells as viability 
decreases in THP-1 PMA-stimulated macrophages exposed to nanosilver and Ag+ over 24 
hours. Data from one experiment in triplicate, with linear regressions. Dose 
concentrations shown in Table 5.1. 
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Sigma nanosilver is the largest and most agglomerated of the test materials, making it a 
good candidate for phagocytosis by the THP-1 macrophages. By phagocytosing large 
agglomerates of Sigma nanosilver (larger than 500 nm), which would then dissolve in 
phagolysosomes [84, 288], macrophages could be exposed to a large bolus dose of silver 
ions at once. Such a localised high concentration of silver ions would do serious damage 
to cellular homeostasis. It is possible that this is the reason for the increased occurrence 
of necrosis in THP-1 macrophages exposed to Sigma nanosilver compared to the other 
types of nanosilver, which formed smaller agglomerates as can be seen in the cryo-TEM 
section 3.2.4. 
5.3 Discussion 
The Annexin V-FITC and propidium iodide dual-stain assay to assess apoptosis and 
necrosis proved to be useful for measuring the relative proportions of HaCaT 
keratinocytes, and THP-1 monocytes and macrophages undergoing each cell death 
pathway, following exposure to nanosilver or Ag+. However, in this case it was 
unsuccessful in monitoring the changes in these proportions for THP-1 monocytes and 
macrophages over time at 4 hour intervals. This was due to variation between time-points 
which exceeded any variation due to changes in cell death. 
Foldbjerg et al. (2009) were able to show progressive changes in the proportions of 
apoptotic and necrotic cells in THP-1 monocytes exposed to nanosilver or Ag+ using this 
assay over periods of 60 minutes up to 6 hours following exposure [169]. In their 
experiment, Ag+ caused a rapid spike in apoptosis and necrosis which had concluded 
entirely by 6 hours following exposure to match the 24 hour result, while nanosilver 
caused significant necrosis and apoptosis by 6 hours, but at a slower rate than Ag+. It is 
possible, therefore, that the 4 hour time-points used in the experiment described above 
did not have sufficient resolution to detect the rapid changes in apoptosis and necrosis, 
although the results in section 4.2.2 show that, for some of the nanosilver tested here, 
cytotoxic effects had a longer time-scale than that shown by Foldbjerg and co-workers, 
especially for the larger Sigma nanosilver. 
The results for THP-1 monocytes agree broadly with those of Foldbjerg and colleagues: at 
cytotoxic concentrations in this study, apoptotic cells accounted for a fairly consistant 10 
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to 15% of the total events, while Foldbjerg et al. showed constant apoptosis between 20 
to 25% after 24 hours [169]. A very low rate of apoptosis was observed in HaCaT 
keratinocytes exposed to nanosilver. This is most likely due to the p53 gene mutation 
present in HaCaT keratinocytes which inactivates some apoptotic pathways in these cells 
[289]. There were no comparable cell death pathway studies published for HaCaT 
keratinocytes exposed to nanosilver. 
Nanosilver has been shown to induce apoptosis in NIH3T3 mouse fibroblast cells, BHK21 
hamster kidney cells, HT29 human colon adenocarcinoma cells, and A549 human alveolar 
adenocarcinoma cells, as well as THP-1 human monocytes  [156, 169, 290, 291]. These 
studies have observed a common role of ROS production by nanosilver in inducing 
apoptosis, and have also implicated JNK activation, and protein kinase C signalling, but it 
is clear that there still remains a significant gap in the understanding of nanosilver 
induced apoptosis and necrosis.  
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6 ROS generation and oxidative stress 
in THP-1 monocytes and 
macrophages exposed to nanosilver 
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6.1 Introduction 
It has been observed that a major mechanism of toxicity due to exposure to ultrafine 
particles and nanoparticles is the generation of reactive oxygen species (ROS) resulting in 
oxidative stress [72, 292, 293]. Some of the most common ROS include radical species 
with an excess electron, such as the superoxide anion, O2
●–, and hydroxyl radical, ●OH, 
and non-radical species such as hydrogen peroxide, H2O2 [294]. ROS causes oxidative 
damage to DNA, proteins, and the lipids that make up cellular membranes, and is 
implicated in many disease states, including cancer, and the aging process [295, 296]. 
The ROS are naturally produced by cells both intracellularly, as a consequence of normal 
mitochondrial respiration [297], and extracellularly, in the case of immune cells such as 
macrophages and neutrophils, to destroy pathogens [298]. To counteract this, cells have 
innate defences against the damage caused by ROS: enzymes to passivate ROS, such as 
superoxide dismutase (SOD) and catalase; as well as sacrificial molecules such as reduced 
glutathione (GSH) [299, 300]. However, these defences can be overwhelmed by excess 
ROS generation from exogenous sources, such as NPs, leading to oxidative stress, 
inflammation and cell death [294, 301]. 
A common method of measuring intracellular ROS production involves the use of a probe 
molecule H2DCF-DA. This non-polar molecule can freely penetrate cellular membranes, 
where the diacetate groups are cleaved by intracellular esterases, leaving a polar 
molecule that cannot escape the cytosol [302]. This 2’,7’-dichlorodihydrofluorescein 
molecule is transformed to the fluorescent 2’,7’-dichlorofluorescein (DCF) when oxidised 
by interacting with ROS, predominantly peroxides [302]. By measuring the level of 
fluorescence, using flow cytometry, fluorescence microscopy, or a spectrofluorometric 
plate reader, the level of intracellular ROS production can be quantified. In addition to 
H2DCF-DA, another probe called MitoSOX™ Red (MSR) can be used to measure 
superoxide production in cell mitochondria by flow cytometry in a similar fashion [249, 
303]. 
Oxidative stress, due to excess ROS production, can be assessed by measuring its effects 
on target molecules and structures within cells. A commonly assessed indicator of cellular 
oxidative stress is intracellular reduced glutathione levels, a primary defence against ROS 
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[304]. GSH is transformed into the disulfide GSSG when it reacts with ROS, and there are a 
number of analytical techniques which can be used to monitor the rate at which GSH is 
depleted in cells [304].  
As well as monitoring the depletion of GSH, oxidative stress can be assessed by measuring 
the level of lipid peroxidation. As ROS generation increases in cells, the lipids that make 
up the cellular membranes can become oxidised, forming peroxides [305]. A number of 
methods have been used to assess lipid peroxidation, and one of the more recent 
biomarkers to be discovered is a group of chemicals known as isoprostanes [306].  
ROS can react with unsaturated fatty acids present in the phospholipid cellular 
membrane, such as arachadonic acid, to remove a hydrogen atom causing a chain 
reaction resulting in the formation of a number of different types of prostaglandin-like 
chemicals known as isoprostanes [307]. This process is independent of cyclooxygenase 
and isoprostanes can be formed directly on phospholipid molecules within cellular 
membranes [306]. Since the discovery of isoprostanes, they have become a widely used 
biomarker of oxidative stress in vivo, as they can be measured in urine or blood, providing 
a non-invasive measure of oxidative stress, and they are more specific for lipid 
peroxidation than other traditional methods such as malondialdehyde and lipid 
hydroperoxides [308]. Levels of isoprostanes can be measured using gas chromatography-
mass spectrometry or enzyme immunoassays, providing a convenient method to measure 
lipid peroxidation in samples from either in vivo or in vitro testing [309, 310]. 
ROS production and oxidative stress in THP-1 monocytes and PMA-stimulated 
macrophages exposed to nanosilver or Ag+ for 24 hours were assessed using the 
techniques described above and in sections 2.6.3 and 2.7. The concentrations of test 
materials used for these experiments are shown in Table 6.1 and Table 6.2. 
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Table 6.1: Nanosilver exposure concentrations for H2DCF-DA and DCF-DA experiments in 
THP-1 human monocytes and PMA-stimulated macrophages, silver concentrations in 
µg/mL, H2O2 concentrations in % v/v. 
Experiment Microplate reader Flow cytometry 
Dose Low High Low High 
ABC Nanotech 150 250 - 240 
NM-300K 100 150 - 140 
Carey Lea's 150 200 - - 
Sigma 600 800 - - 
Ag+ 5 8 - 8 
H2O2 0.01% - 0.001% 0.01% 
 
Table 6.2: Nanosilver exposure concentrations for MSR superoxide production, GSH 
depletion and lipid peroxidation experiments in THP-1 human monocytes and PMA-
stimulated macrophages, silver concentrations in µg/mL, H2O2 concentrations in % v/v. 
Cell type Monocytes Macrophages 
Dose Low Medium High Low Medium High 
Cytotoxicity Subtoxic EC20 EC50 Subtoxic EC20 EC50 
ABC Nanotech 100 130 180 15 60 150 
NM-300K 80 100 120 15 80 130 
Carey Lea's 50 120 170 25 100 140 
Sigma 600 700 800 100 400 600 
Ag+ 2 5 7 2 4 6 
H2O2 0.01% 0.1% 1% 0.01% 0.1% 1% 
 
6.2 Results 
6.2.1 Detection of ROS production in THP-1 monocytes and macrophages 
exposed to nanosilver and Ag+ using H2DCF-DA 
The THP-1 monocytes and PMA-stimulated macrophages were exposed to two 
concentrations of nanosilver, Ag+ or H2O2 (as a positive control agent) after being loaded 
with either non-fluorescent probe H2DCF-DA or fluorescent product DCF-DA as described 
in section 2.6.3.1. Fluorescence was measured through the bottom of the microplate 
wells using a spectrofluorometric plate reader every 60 minutes after exposure up to 4 
hours, and then from 21 hours to 24 hours as described in section 2.7.1. The results from 
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the THP-1 monocytes are shown in Figure 6.1 and PMA-stimulated macrophages in Figure 
6.2. 
The H2DCF-DA loaded cells treated with 0.01% H2O2 showed a large increase in 
intracellular ROS from 60 minutes after exposure onwards. Monocytes exposed to Ag+ 
also showed a small increase in ROS, although it was not dose dependent and it 
decreased below the control values after 21 hours. Cells loaded with DCF-DA showed no 
increase in fluorescence, which was to be expected as this molecule is already fluorescent 
and is not affected by ROS. 
Cells exposed to all 4 types of nanosilver showed time dependent decreases in 
fluorescence. This was the case for cells loaded with either H2DCF-DA or DCF-DA. Higher 
concentrations of each type of nanosilver resulted in a greater decrease in fluorescence in 
all cases. The most likely explanation for these results is interference from the nanosilver 
in the fluorescence measurements. All types of nanosilver showed significant absorbance 
at the excitation and emission wavelengths used for the H2DCF-DA fluorescence assay, 
with the same relative magnitude of the decrease in fluorescence shown in Figure 6.1 and 
Figure 6.2 after 24 hours, i.e. the optical absorption of Ag+ < Sigma < NM-300K < Carey 
Lea’s ≈ ABC Nanotech at the concentrations investigated here. The decrease in 
fluorescence between 1 and 4 hours appears to be due to the settling of the nanosilver in 
the wells, as the rate of change decreases exponentially over time. 
The interference due to nanosilver in the H2DCF-DA fluorescence assay measured using a 
spectrofluorometric plate reader overwhelmed any signal due to an increase in ROS 
generation caused by exposure to the nanosilver, as indicated by the addition of the 
positive control agent H2O2 alone to cells showing a large increase in fluorescence. To try 
to overcome this interference, a limited set of samples exposed to ABC Nanotech, NM-
300K and Ag+ were prepared in the same way but analysed using flow cytometry instead 
of a spectrofluorometric plate reader, 24 hours after exposure, as described in section 
2.6.3.1. These flow cytometric results are shown in Figure 6.3. 
Cells treated with H2O2 showed a dose dependent increase in intracellular ROS after 24 
hours. The only silver treatment to show an increase in fluorescence was with the THP-1 
monocytes exposed to NM-300K, with nearly 20% greater intracellular ROS generation  
136 
 
Figure 6.1: ROS levels in THP-1 monocytes exposed to nanosilver and Ag+. H2DCF-DA 
loaded (A), and DCF-DA loaded (B). Mean of three replicates, error bars indicate SEM. 
Control fluorescence at 24 hours: A = 152 ± 3; B = 2.91 ± 0.03 x 104 RFU. Dose 
concentrations shown in Table 6.1. 
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Figure 6.2: ROS levels in THP-1 PMA-stimulated macrophages exposed to nanosilver and 
Ag+. H2DCF-DA loaded (A), and DCF-DA loaded (B). Mean of three replicates, error bars 
indicate SEM. Control fluorescence at 24 hours: A = 209 ± 23; B = 2.0 ± 0.2 x 104 RFU. 
Dose concentrations shown in Table 6.1. 
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than the untreated cells. Monocytes exposed to Ag+ showed no significant difference to 
untreated cells, but all silver treatments in macrophages showed a reduced level of 
fluorescence compared to the untreated control cells. 
This observed decrease in fluorescence was unlikely to be due to any interference from 
the nanosilver, as was observed in the microplate reader experiment, because the cells 
were washed in PBS and diluted in flow cytometer sheath fluid during analysis. It is 
possible that the cytotoxic effects of the nanosilver caused the treated cells to lose 
membrane integrity, such as through necrosis as shown in section 5.2.1, resulting in the 
fluorescent probe leaking out of the cells during washing steps and analysis. 
Consequently, it was concluded that this assay procedure was unsuccessful in monitoring 
ROS production in THP-1 monocytes and PMA-stimulated macrophages exposed to 
nanosilver. 
 
Figure 6.3: ROS detection in THP-1 monocytes and PMA-stimulated macrophages loaded 
with H2DCF-DA and exposed to nanosilver and Ag
+ by flow cytometry. Mean of three 
replicates, error bars indicate SEM. Control fluorescence: monocytes = 199 ± 4; 
macrophages = 349 ± 35 RFU. Dose concentrations shown in Table 6.1. 
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6.2.2 Mitochondrial superoxide production in THP-1 monocytes and 
macrophages exposed to nanosilver and Ag+ 
The THP-1 monocytes and PMA-stimulated macrophages were exposed to three 
concentrations of nanosilver or Ag+ after being loaded with MitoSOX™ Red and their 
fluorescence was measured using flow cytometry, 24 hours after exposure. The results 
from these cells are shown in Figure 6.4. 
In THP-1 monocytes, all treatments showed a dose dependent increase in mitochondrial 
superoxide generation. In THP-1 PMA-stimulated macrophages, only ABC Nanotech 
showed a significant, dose dependent increase compared to control, and while Sigma 
showed a significant increase between low and high concentrations they were not 
significantly different to the control. 
The MSR assay measures mitochondrial superoxide production, by localising specifically in 
mitochondria [303]. Mitochondria naturally produce superoxide at varying rates 
depending on their metabolic activity [311]. It is possible that the observed changes in 
mitochondrial superoxide production seen in Figure 6.4 may be due to changes in 
mitochondrial function brought about by the cytotoxic effects of the nanosilver, and not 
superoxide production by the nanoparticles themselves. 
Figure 6.4: Detection of mitochondrial superoxide generation by flow cytometry in THP-1 
monocytes (A) and macrophages (B) loaded with MitoSOX™ Red, exposed to nanosilver 
and Ag+ for 24 hours. Mean of three replicates, error bars indicate SEM. Significant 
differences were determined by one-way ANOVA with Bonferroni post-hoc test (p < 0.05), 
* = different to control. Control fluorescence: monocytes = 1787 ± 5; macrophages = 800 
± 40 RFU. Dose concentrations shown in Table 6.2. 
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6.2.3 Depletion of intracellular reduced glutathione in THP-1 monocytes and 
macrophages exposed to nanosilver and Ag+ 
The THP-1 monocytes and PMA-stimulated macrophages were exposed to three 
concentrations of nanosilver, Ag+ or H2O2 (as a positive control agent) for 24 hours before 
the levels of intracellular reduced glutathione were assessed, as described in section 
2.7.2. The results from these cells are shown in Figure 6.5. 
All treatments in both THP-1 monocytes and PMA-stimulated macrophages showed a 
significant dose dependent decrease in levels of intracellular GSH, except at the lowest 
concentration of Ag+. It is clear that exposure to nanosilver and Ag+ depletes the levels of 
GSH in cells, although whether this is through increased ROS production or inactivation 
through direct interactions between the thiol groups in GSH and silver ions is unknown. 
The cell viability of THP-1 monocytes and PMA-stimulated macrophages under the same 
conditions as described in Figure 6.5 was also assessed. Correlations between viability 
and GSH depletion are shown in Figure 6.6, and the results of the linear regressions are 
shown in Table 6.3. 
There is a strong correlation between cell viability and the depletion of intracellular GSH 
in PMA-stimulated macrophages exposed to nanosilver or Ag+. The decrease in viability as 
Figure 6.5: Intracellular reduced glutathione levels in THP-1 monocytes (A) and 
macrophages (B) exposed to nanosilver and Ag+. Mean of two independent experiments 
of three replicates each, error bars indicate SEM. Significant differences were determined 
by one-way ANOVA with Tukey-Kramer post-hoc test (p < 0.05), all conditions except Ag+ 
low concentration treatment, in both cell types, were different to control values. Control 
GSH: monocytes = 3.6 ± 0.1; macrophages = 3.2 ± 0.2 µM. Dose concentrations shown in 
Table 6.2. 
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Figure 6.6: Correlation between reduced glutathione levels and cell viability in THP-1 
monocytes (A) and macrophages (B) exposed to nanosilver and Ag+. Mean of two 
independent experiments of three replicates each, error bars indicate SEM.  
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the level of intracellular GSH decreases in THP-1 PMA-stimulated macrophages exposed 
to ABC Nanotech, Carey Lea’s, Sigma, Ag+ and H2O2 is very similar, ranging between 0.73 
and 1.01 % decrease in GSH levels for every 1 % decrease in viability compared to the 
control. 
In contrast, the correlation in THP-1 monocytes between viability and GSH levels is weak. 
While all the nanosilver treatments decreased the levels of intracellular GSH in THP-1 
monocytes, the slopes of the linear regressions of GSH levels against viability were not 
significantly greater than zero. However, the slopes of the regressions for Ag+ and H2O2 
were similar in monocytes and macrophages. The levels of GSH in untreated THP-1 
monocytes were 36 ± 1 µM/million cells, while GSH levels in untreated PMA-stimulated 
macrophages were 41 ± 2 µM/million cells. While the levels of GSH in macrophages are 
significantly greater than monocytes (p < 0.05), this difference is relatively small.  
Table 6.3: Slopes of linear regressions of glutathione levels against cell viability as 
percentages of control values in THP-1 monocytes and PMA-stimulated macrophages 
exposed to nanosilver or Ag+ under conditions described in Figure 6.5. SE = standard error. 
 
Monocytes SE Macrophages SE 
ABC Nanotech 0.40 0.20 1.01 0.01 
NM-300K 0.40 0.54 0.35 0.03 
Carey Lea's 0.22 0.12 0.74 0.15 
Sigma 0.15 0.04 0.96 0.15 
Ag+ 0.62 0.60 0.73 0.49 
H2O2 0.60 0.04 0.86 0.10 
 
6.2.4 Levels of lipid peroxidation biomarker 8-isoprostane in THP-1 monocytes 
and macrophages exposed to nanosilver and Ag+ 
The THP-1 monocytes and PMA-stimulated macrophages were exposed to three 
concentrations of nanosilver, Ag+ or H2O2 (as a positive control agent) for 24 hours, using 
the same conditions that were described in section 6.2.3, and the levels of lipid 
peroxidation biomarker 8-isoprostane were measured, as described in section 2.7.3. The 
results from these cells are shown in Figure 6.7. 
In THP-1 monocytes, only the Sigma treatments and the highest H2O2 concentration were 
significantly different from the control. In PMA-stimulated macrophages, Sigma showed a 
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dose dependent increase in lipid peroxidation, but the rest of the treatments showed less 
than a 50 % increase in lipid peroxidation compared to the control, and did not appear to 
be dose dependent.  
 As in section 6.2.3, the cell viability of THP-1 monocytes and PMA-stimulated 
macrophages was also assessed under the same conditions as described in Figure 6.7. The 
comparison of cell viability and lipid peroxidation is shown in Figure 6.8. 
No correlation was observed in either THP-1 monocytes or PMA-stimulated macrophages 
between the level of cell viability and the observed levels of lipid peroxidation biomarker 
8-isoprostane. These results show increased levels of oxidative stress through lipid 
peroxidation in THP-1 monocytes and PMA-stimulated macrophages exposed to Sigma 
nanosilver, but it does not appear to be related to cell viability in a predictable fashion. 
 
6.3 Discussion 
The H2DCF-DA assay measured by a spectrofluorometric plate reader and by flow 
cytometry showed an increase in intracellular ROS in THP-1 monocytes and PMA-
stimulated macrophages exposed to H2O2, but interference due to the strong optical 
Figure 6.7: Levels of lipid peroxidation biomarker 8-isoprostane in THP-1 monocytes (A) 
and macrophages (B) exposed to nanosilver and Ag+. Mean of two independent 
experiments of three replicates each, error bars indicate SEM. Significant differences were 
determined by one-way ANOVA with Tukey-Kramer post-hoc test (p < 0.05), * = different 
to control. Control 8-isoprostane: monocytes = 11.9 ± 1.6; macrophages = 11.5 ± 2.0 
pg/mL. Dose concentrations shown in Table 6.2. 
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Figure 6.8: Correlation between levels of lipid peroxidation biomarker 8-isoprostane and 
viability in THP-1 monocytes (A) and macrophages (B) exposed to nanosilver and Ag+. 
Mean of two independent experiments of three replicates each, error bars indicate SEM. 
B 
A 
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absorption properties of the nanosilver overwhelmed any signal due to increased ROS 
generation when measured using a plate reader. When measured using flow cytometry, 
this assay did not show an increase in intracellular ROS in THP-1 monocytes and PMA-
stimulated macrophages treated with ABC Nanotech, NM-300K or Ag+, and even showed 
a decrease in fluorescence compared to the untreated control. 
This result contradicts that shown by Foldbjerg et al. (2009) who showed an 
approximately 17-fold increase in fluorescence of THP-1 monocytes exposed to PVP-
capped nanosilver and Ag+ for 24 hours compared to the untreated control, using the 
same flow cytometry H2DCF-DA assay described here [169]. This concentration of 
nanosilver was observed to cause approximately 75 % of cells to die through necrosis in 
the treated THP-1 monocytes, which might have been expected to cause a loss of 
fluorescence signal from the fluorescent probe molecule escaping through holes in the 
cellular membrane, as was seen here in Figure 6.3. It is unclear why this contradictory 
result occurred and will require further investigation, but it is important to be aware of 
possible interferences from nanoparticle test materials, such as those observed here, 
when using this kind of in vitro fluorescence assay. 
The MitoSOX™ Red assay was able to detect a dose dependent increase in mitochondrial 
superoxide production in THP-1 monocytes exposed to nanosilver and Ag+, and in PMA-
stimulated macrophages exposed to ABC Nanotech nanosilver over 24 hours. A study 
exposing luminescent bacteria, sensitive to specific ROS species, to nanosilver showed 
that addition of SOD to the culture media was able to ameliorate the toxic effects of 
nanosilver on superoxide sensitive bacteria to some degree [92], but a similar study found 
that superoxide production by Ag+ was likely due to disruption of the respiratory chain 
[93]. Therefore, it is possible that the observed increase in superoxide production in THP-
1 human monocytes and PMA-stimulated macrophages is due to the interaction of 
nanosilver with thiol-containing enzymes in the respiratory chain leading to mitochondrial 
dysfunction, rather than superoxide production by the nanosilver itself [93], but the 
causality of this requires further investigation.  
A dose dependent decrease in intracellular GSH was observed for THP-1 monocytes and 
PMA-stimulated macrophages exposed to nanosilver and Ag+ over 24 hours. This agrees 
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with other studies examining the effects of nanosilver on cell cultures [171, 185, 250], and 
Piao et al. have shown that treatment with the synthetic antioxidant N-acetylcysteine 
(NAC) can partially ameliorate the depletion of GSH by nanosilver [185]. It is likely that 
this depletion of intracellular GSH is due to a combination of increased ROS production by 
nanosilver, increased ROS production by the cell due to the cytotoxic effects of nanosilver, 
and the inactivation of GSH by binding directly to silver through its high affinity for thiol-
containing molecules. Therefore the protective effect of NAC could also be due to its ROS 
scavenging ability or its thiol group binding to silver ions, or a combination of both. More 
research is required to tease apart the complicated interactions in this area. 
An increase in lipid peroxidation biomarker 8-isoprostane was observed in THP-1 
monocytes and PMA-stimulated macrophages treated with Sigma nanosilver for 24 hours, 
but not for other types of nanosilver or Ag+. It is unclear why the largest nanosilver should 
cause more lipid peroxidation than the other types of nanosilver, but it may have 
something to do with the rate of cytotoxicity. As observed in section 4.2.2, cytotoxicity 
due to Sigma nanosilver took place over a longer period of time than for the other types 
of nanosilver. It is possible that this slower rate of cell death allowed a longer period of 
time for oxidative damage to build up in the cellular membrane. Other studies have also 
shown modest increases in lipid peroxidation caused by exposure to nanosilver in cell 
cultures, using the same 8-isoprostane assay as well as a fluorescent probe-based assay 
(diphenyl-1-pyrenylphosphine), and the thiobarbituric acid assay (TBARS) [185, 250]. 
ROS generation and oxidative stress play an important role in the cytotoxic effects of 
nanosilver, with many studies using a range of techniques to show increased intracellular 
ROS generation, GSH depletion, lipid peroxidation, DNA damage, ROS induced apoptosis 
and mitochondrial dysfunction [74, 92, 93, 153, 155, 158, 169-171, 173, 183, 185, 250, 
290, 312]. However, it is still ambiguous as to the role of nanosilver and silver ions in 
direct generation of ROS, compared to causing increased intracellular ROS through 
disruption to the mitochondrial respiratory chain, and impairing cellular defences against 
oxidative stress by directly binding molecules such as GSH through silver’s high affinity for 
thiols, and it may be a combination of all of these effects, possibly working synergistically. 
This is a very complex area of research and further efforts are required to better 
understand the causality of ROS generation and oxidative stress in nanosilver cytotoxicity. 
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7 Cytokine expression by primary 
human and THP-1 monocytes and 
macrophages exposed to nanosilver 
  
148 
 
7.1 Introduction 
Cytokines are intracellular signalling molecules produced by many different types of cells. 
They are used by immune cells to coordinate immune responses to infection and injury 
[313]. Different cytokines can act synergistically or antagonistically [314], and there is 
much redundancy in this system with some cytokines performing similar functions [315]. 
Cytokines are grouped into families based broadly around their biological function: 
interleukins (ILs), named for their ability to alter the behaviour of leukocytes; interferons 
(FNs), which interfere directly with viral replication, among other things; and the tumor 
necrosis factor (TNF) family which helps the immune system to combat cancers [57, 316, 
317]. 
The understanding of the importance of cytokines in the immune system has been 
growing over the last two decades, with the ability to synthesise cytokines using 
recombinant DNA technology [318]. The adaptive immune response to a range of 
pathogens has been shown to be modulated by innate immune cells depending on the 
nature of the pathogen and its portal of entry [57]. The specific cytokines released by 
dendritic cells, macrophages, monocytes and other innate immune cells in response to 
stimuli, which may be due to injury or infection, determines the path which the overall 
immune response will take [319]. These pathways have historically been divided into two 
distinct responses, called T-helper 1 and T-helper 2 (Th1 and Th2), characterised by the 
different kinds of T cells involved in each pathway, and the characteristic set of cytokines 
produced by each [320]. As greater understanding of these processes developed, other 
response pathways and cell types were identified, such as T-helper 17 (Th17). Also, the 
Th1/Th2 paradigm was recognised as being two ends of a spectrum which is influenced 
not just by which types of cytokines the T cells are exposed to, but the relative levels of 
critical cytokines such as IL-4 and IL-12 [321, 322]. The Th1, Th2 and Th17 responses have 
also been shown to be antagonistic towards each other, so that a specific response is the 
result of suppressing other response pathways, as well as stimulating the relevant 
response, as described below. 
The Th1 response is directed at intracellular pathogens, such as viral and bacterial 
infections, and is stimulated by the release of IL-12 by phagocytes that have been infected 
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by such pathogens, including dendritic cells, macrophages and monocytes [323]. This 
results in the proliferation of Th1 cells, that release more cytokines, such as IL-2, which 
stimulates cytotoxic T lymphocytes (Tc) to kill virus infected cells, and IFN-γ. This 
interferes directly with viral replication, as well as directly stimulating macrophages to 
phagocytose and kill intracellular bacteria, and to release IL-12, reinforcing the Th1 
response [57]. IL-12 and IFN-γ also antagonise IL-4 receptors, suppressing Th2 responses 
[314]. 
The Th2 response is directed at extracellular pathogens, such as parasitic worms, and is 
stimulated by IL-4 release, which antagonises IL-12 receptors to suppress Th1 
polarisation. Th2 cells express cytokines which recruit eosinophils, cells that are able to 
kill pathogens which are too large to be phagocytosed by macrophages. 
Following exposure to nanoparticles, whether incidental, workplace-related, or from 
nanoparticle-containing consumer products, the immune system will be exposed to 
significant levels of these materials in the lungs, circulation, liver or lymphatic system 
[186-188, 205]. It is therefore an important part of nanotoxicological investigations to 
determine whether nanoparticles may have immunomodulatory effects, such as whether 
they can stimulate production of Th1 or Th2 specific cytokines by cells of the innate 
immune system [190]. 
Any immunomodulatory effects of exposure to nanoparticles can be observed by 
monitoring the cytokine expression profile of innate immune cells, as this will determine 
the nature of any immune response in vivo. Multiplexing fluorescent bead-based assays 
now exist, which can detect levels of many different cytokines in a single 50 µL sample of 
cell culture supernatant, such as the 13-plex Th1/Th2/Th17 kit from eBiosciences used in 
this investigation. Different sized fluorescent beads are covered with antibodies specific to 
each cytokine to be measured. By incubating a mixture of these beads with cell culture 
supernatants, any cytokine molecules present will be captured by the relevant antibodies 
[270]. The captured cytokines are then recognised by detection antibodies conjugated to 
biotin, which then binds Streptavidin-Phycoerythrin to give a fluorescent signal 
proportional to the concentration of the relevant cytokine in the sample. When analysed 
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using flow cytometry, this technique allows the simultaneous quantification of 
concentrations of 13 different cytokines in a high throughput format. 
A more traditional technique for analysing cytokine expression is the enzyme-linked 
immunosorbent assay (ELISA), which relies on the same basic principle as the fluorescent 
bead assay described above, but the cytokine detection antibodies are adsorbed to the 
plastic surface of microplate wells and only one cytokine can be measured for each assay 
[324]. This technique can be used to investigate in detail the expression of any particular 
cytokine of interest identified by the screening assay. 
The cytokine expression profile of THP-1 monocytes and PMA-stimulated macrophages 
exposed to nanosilver or Ag+ for 24 hours was examined using the human Th1/Th2 11-
plex flow cytometric bead assay from eBiosciences. The cytokine expression profile of 
primary human monocytes and PMA-stimulated macrophages from three healthy donors 
exposed to nanosilver or Ag+ for 24 hours in vitro was examined using the human Th1/Th2 
/Th17 13-plex flow cytometric bead assay from eBiosciences. The endotoxin 
lipopolysaccharide (LPS), a component of bacterial cell walls, was used as a positive 
control for both THP-1 and primary cell experiments due to its ability to stimulate 
proinflammatory cytokine production in immune cells [325-327]. 
In addition, the change in expression of TNF and IL-8 by THP-1 and primary human 
monocytes and PMA-stimulated macrophages exposed to nanosilver or Ag+ relative to cell 
viability were examined, as well as the expression timeline of IL-8 by THP-1 monocytes 
and PMA-stimulated macrophages exposed to nanosilver or Ag+. The concentrations of 
test materials used for these experiments are shown in Table 7.1, Table 7.2, Table 7.3, and 
Table 7.4. 
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Table 7.1: Test material exposure concentrations for cytokine profile screening 
experiments in THP-1 human monocytes and PMA-stimulated macrophages. Silver 
concentrations in µg/mL. 
  THP-1 cytokine profile 
Carey Lea's 25 50 100 150 
Sigma 100 200 300 400 
Ag+ 2.5 3.5 4.5 5.5 
LPS - 10 100 - 
 
Table 7.2: Test material exposure concentrations for cytokine profile screening 
experiments, and IL-8 and TNF compared to cell viability, in primary human monocytes 
and PMA-stimulated macrophages. Donor 1: first number, Donors 2 and 3: second 
number. Silver concentrations in µg/mL. 
Cell type Monocytes (1, 2 and 3) Macrophages (1, 2 and 3) 
Dose Low Medium High Low Medium High 
ABC Nanotech 10, 10 - 20, 60 1, 1 - 10, 20 
NM-300K 10, 10 20, 30 50, 60 1, 1 5, 15 20, 60 
Carey Lea's 10, 10 20, 30 50, 60 1, 1 5, 10 20, 30 
Sigma 50, 10 - 100, 300 10, 10 - 30, 300 
Ag+ 0.5, 0.5 - 1, 5 0.5 1, 5 - 
LPS - 10 100 1 10 - 
 
Table 7.3: Test material exposure concentrations for IL-8 and TNF expression ELISA 
experiments compared to cell viability in THP-1 monocytes and PMA-stimulated 
macrophages. Experiment 1: first number, Experiments 2 and 3: second number. Silver 
concentrations in µg/mL. 
Cell type Monocytes (1, 2 and 3) Macrophages (1, 2 and 3) 
Dose Low Medium High Low Medium High 
Cytotoxicity Subtoxic EC20 EC50 Subtoxic EC20 EC50 
ABC Nanotech 50, 100 130, 130 150, 180 15, 15 60, 60 150, 150 
NM-300K 25, 80 80, 100 100, 120 15, 15 80, 80 130, 130 
Carey Lea's 50, 50 130, 120 150, 170 25, 25 100, 100 160, 140 
Sigma 300, 600 600, 700 800, 800 100, 100 250, 400 500, 600 
Ag+ 2, 2 6, 5 7, 7 2, 2 7, 4 8, 6 
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Table 7.4: Test material exposure concentrations for IL-8 expression timeline experiments 
in THP-1 monocytes and PMA-stimulated macrophages. Silver concentrations in µg/mL. 
Cell type Monocytes Macrophages 
Dose Low Medium High Low Medium High 
Cytotoxicity Subtoxic EC20 EC50 Subtoxic EC20 EC50 
ABC Nanotech 100 130 180 15 60 150 
NM-300K 80 100 120 15 80 130 
Carey Lea's 50 120 170 25 100 140 
Sigma 600 700 800 100 400 600 
Ag+ 2 5 7 2 4 6 
 
7.2 Results 
7.2.1 Cytokine expression profile in THP-1 and primary human monocytes and 
PMA-stimulated macrophages exposed to nanosilver or Ag+ for 24 hours 
The cytokine expression profile of THP-1 monocytes and PMA-stimulated macrophages 
exposed to nanosilver, Ag+, and LPS (as a positive control agent) for 24 hours was 
investigated using the Th1/Th2 11-plex flow cytometric bead assay from eBiosciences, as 
described in section 2.3.4. The cytokines measured included: Th1 characteristic cytokines, 
IL-12 p70, IFN-γ, IL-2 and lymphotoxin (LT); Th2 characteristic cytokines, IL-4, IL-10 and IL-
5; Th17-related pro inflammatory cytokine, IL-6; and proinflammatory cytokines IL-1β, IL-
8 and TNF. Cells were exposed to nanosilver or Ag+ at 4 concentrations, and LPS at 2 
concentrations, as described in section 2.3.4 and shown in Table 7.1. These results are 
shown in Figure 7.1. Statistically significant differences from untreated control cells were 
determined using one-way ANOVA with Dunnet’s post-hoc test; p < 0.05 was considered 
significant. 
The THP-1 monocytes showed no significant cytokine expression above assay detection 
limits (see section 2.6.2) by either untreated cells or cells exposed to nanosilver or Ag+. 
After LPS exposure in an independent experiment, the corresponding untreated 
monocytes showed low-level expression of Th1 cytokines IL-12, IFN-γ, IL-2 and LT, and Th2 
cytokine IL-5, but LPS exposure caused no change in expression compared to the 
untreated cells. In contrast, proinflammatory cytokines IL-1β, IL-8 and TNF showed 
dramatic increases in THP-1 monocytes exposed to LPS, as expected, from negligible 
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Figure 7.1: Multiplex cytokine screen of THP-1 monocytes (A) and PMA-stimulated 
macrophages (B) exposed to nanosilver, Ag+ and LPS. Mean of three replicates, error bars 
indicate SEM. LPS exposure was conducted independently from nanosilver exposure. 
Dose concentrations shown in Table 7.1. 
 
Th1 cytokines Th2 cytokines Pro inflammatory 
cytokines 
 
B 
A 
Detection limit 
= 
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levels in the control to 4.5, 2.7, and 3.6 ng/mL respectively. 
Untreated THP-1 PMA-stimulated macrophages showed no significant expression of 
cytokines except for proinflammatory cytokines IL-1β, IL-6, IL-8 and TNF, with 
concentrations of 2, 173, 3622, and 5 pg/mL respectively. After LPS exposure in an 
independent experiment, the corresponding untreated THP-1 PMA-stimulated 
macrophages showed a very similar cytokine profile for the Th1 and Th2 cytokines 
compared to THP-1 monocytes, and similar values for IL-1β, IL-8 and TNF compared to the 
untreated macrophages in the nanosilver exposure experiment, with concentrations of 
146, 5742, and 44 pg/mL respectively. LPS exposure caused no change in cytokine 
expression of Th1 or Th2 cytokines in THP-1 PMA-stimulated macrophages, but 
significantly increased levels of IL-1 β and TNF, while decreasing levels of IL-8. 
IL-6 expression was slightly increased in THP-1 PMA-stimulated macrophages exposed to 
nanosilver or Ag+, although only the highest concentration of Sigma nanosilver was 
considered significantly different to the untreated cells. All but the highest concentration 
of Ag+ stimulated a small increase in IL-1β expression, while the highest concentration of 
Carey Lea’s and the second highest concentration of Sigma nanosilver stimulated small 
increases in IL-8 expression. No statistically significant increase in TNF was observed for 
treated THP-1 macrophages, due to the variability of these results. 
The lack of Th1 and Th2 cytokine expression suggests that the THP-1 monocytes and 
PMA-stimulated macrophages are not reacting to the nanosilver as they would to 
pathogenic infections. LPS is known to induce IL-1β, TNF, IL-8 and IL-6, so this response is 
as expected.  
As THP-1 cells are derived from a cancerous cell line, it was important to compare their 
cytokine expression profile with that of primary monocytes isolated from peripheral 
human blood. 
The cytokine expression profile of primary human monocytes and PMA-stimulated 
macrophages exposed to nanosilver, Ag+, and LPS (as a positive control agent), for 24 
hours was investigated using the Th1/Th2/Th17 13-plex flow cytometric bead assay from 
eBiosciences, as described in section 2.3.4. The cytokines measured included: Th1 
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characteristic cytokines, IL-12 p70, IFN-γ, and IL-2; Th2 characteristic cytokines, IL-4, IL-10, 
IL-5, IL-9 and IL-13; Th17 cytokines IL-17A and IL-22; and proinflammatory cytokines IL-1β, 
IL-6, and TNF. The proinflammatory cytokine IL-8 was also measured for the same 
samples, but using the ELISA technique, as the very high levels of IL-8 expression would 
have interfered with the bead assay sensitivity for the other cytokines. Cells were exposed 
to nanosilver or Ag+ at 2 or 3 concentrations, and LPS at 2 concentrations, as described in 
section 2.3.4 and shown in Table 7.2. The results for primary human monocytes are 
shown in Figure 7.2, and for PMA-stimulated macrophages in Figure 7.3. Statistically 
significant differences from untreated controls were determined using one-way ANOVA 
with Dunnet’s post-hoc test, and differences in basal cytokine expression between donors 
were determined using one-way ANOVA with Bonferroni post-hoc test; p < 0.05 was 
considered significant.  
Basal cytokine expression of the primary human monocytes varied in some cases 
between the three donors investigated. IL-12 p70 expression was not detected at all for 
any of the donors. Of the other Th1 cytokines, donor 1 showed negligible  basal 
expression of IFN-γ, while donors 2 and 3 showed levels of 80 and 110 pg/mL respectively, 
and only donor 2 showed significant expression of IL-2 at 872 pg/mL. 
Basal expression of Th2 cytokines was negligible in donors 1 and 3 for IL-4 and IL-10, but 
donor 2 expressed 135 pg/mL and 85 pg/mL respectively. IL-5 and IL-13 showed negligible 
basal expression in all three donors, while IL-9 expression was 147 and 110 pg/mL in 
donors 2 and 3 respectively, but negligible in donor 1.  
Basal expression of Th17-related cytokine IL-6 was negligible in donor 3, but 21 and 58 
pg/mL in donors 1 and 2 respectively. Basal expression of Th17 cytokines IL-17A and -22 
were negligible in donor 1, but donors 2 and 3 showed levels of 69 and 57 pg/mL, and 842 
and 737 pg/mL respectively. 
Proinflammatory cytokines all showed significant basal expression in donors 1, 2 and 3, 
but with different relative levels: IL-1β, 12, 156, and 104 pg/mL respectively; IL-8, 9227, 
9302, and 274 pg/mL respectively; and TNF, 7, 818, and 42 pg/mL respectively.  
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Figure 7.2: Multiplex cytokine screen of primary human monocytes, from three healthy donors, 
exposed to nanosilver, Ag+  and LPS. Mean of three replicates, error bars indicate SEM. A = donor 
1, B = donor 2, C = donor 3. Dose concentrations shown in Table 7.2. 
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LPS stimulation caused a significant increase by donor 2 and 3 in the expression of IFN-γ, 
IL-10, IL-6, IL-1β and TNF, while causing a decrease in IL-8 expression for donor 2 but no 
change for donor 3. A summary of statistically significant changes in the expression of 
cytokines by primary human monocytes exposed to nanosilver or Ag+ is shown in Table 
7.5. 
The stimulation or suppression of cytokine expression in primary human monocytes 
exposed to nanosilver appears to depend on the basal expression levels of those 
cytokines. In cases where basal expression was at low levels, such as TNF for donor 1 and 
3, and IL-8 for donor 3, nanosilver exposure was able to stimulate expression. But where 
basal expression was high, such as IL-8 in donor 1 and 2, nanosilver suppressed its 
expression.  
Table 7.5: Stimulation and suppression of cytokine expression in primary human 
monocytes exposed to nanosilver or Ag+. 
 
Stimulated Suppressed 
 
Cytokines Treatment Cytokines Treatment 
Donor 1 TNF ABC Nanotech high 
IL-1β 
All except ABC Nanotech and 
Sigma low, and both Ag+ 
IL-8 NM-300K all 
Donor 2 
IFN-γ NM-300K high IL-10 
ABC Nanotech low, Carey Lea's 
high, Sigma high 
IL-5 - IL-8 - 
Donor 3 
IL-8 All nanosilver high 
- - 
TNF 
ABC Nanotech and 
Ag+ high 
 
Basal cytokine expression by PMA-stimulated macrophages derived from primary human 
monocytes also varied significantly in some cases. For Th1 cytokines, IL-12 p70 expression 
was not detected for the same reasons discussed above. IFN-γ expression was negligible 
in donors 1 and 2, and donor 3 showed a level of 160 pg/mL. IL-2 expression was 
negligible in donors 1 and 3, and donor 2 expressed 1070 pg/mL. These levels of Th1 
expression were very similar to those shown by primary monocytes. 
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Th17 cytokines 
Figure 7.3: Multiplex cytokine screen of PMA-stimulated primary human macrophages, from 
three healthy donors, exposed to nanosilver, Ag+ and LPS. Mean of three replicates, error bars 
indicate SEM. A = donor 1, B = donor 2, C = donor 3. Dose concentrations shown in Table 7.2. 
Th1 cytokines Th2 cytokines Pro inflammatory 
cytokines 
 
Detection limit 
= 
A 
B 
C 
159 
 
Th2 cytokine expression by PMA-stimulated macrophages was negligible in donor 1, while 
donor 2 showed levels of 78 and 130 pg/mL for IL-4 and IL-9 respectively, and donor 3 
showed levels of 56, 209, and 90 pg/mL for IL-10, IL-5, and IL-9 respectively. IL-13 
expression was negligible in all cases. 
Th17-related cytokines all had a significant basal expression in donor 2, with IL-6, IL-17A, 
and IL-22 levels of 59, 61, and 1181 pg/mL respectively, while donor 1 only showed 
significant basal expression of IL-6 at 115 pg/mL and donor 3 only showed expression of 
IL-17A at 64 pg/mL. 
Proinflammatory cytokines IL-1β, IL-8 and TNF showed significant basal expression in all 
three donors: IL-1β was expressed at 37, 341, and 214 pg/mL; IL-8 was expressed at 10, 
17, and 61 ng/mL; and TNF was expressed at 199, 4714, and 7123 pg/mL in donor 1, 2 
and 3 respectively. 
Exposure of PMA-stimulated macrophages to LPS increased the expression of IL-10, IL-6, 
IL-1β, and TNF in donors 2 and 3, while suppressing expression of IL-8 in donor 3, but 
stimulating it in donor 2. Expression of IFN-γ was also stimulated by LPS in donor 3. 
A summary of statistically significant changes in the expression of cytokines by PMA-
stimulated macrophages, derived from primary human monocytes, exposed to nanosilver 
or Ag+ is shown in Table 7.6. 
The changes in cytokine expression by PMA-stimulated macrophages caused by exposure 
to nanosilver varied between the 3 donors. Donor 1 showed no significant stimulation of 
any cytokines, but proinflammatory cytokines were suppressed in a dose dependent 
manner. Donor 2 showed little significant change: IL-8 was both marginally stimulated and 
suppressed, although no treatment alone was considered significantly different to the 
control; also, TNF was suppressed and IL-10 was stimulated. For donor 3, IL-17A showed 
marginal stimulation and suppression, while TNF was also suppressed. Donor 3 showed 
stimulation of more cytokines than the other two donors, with IL-9, IL-13, IL-1β, and IL-8 
all being significantly stimulated by nanosilver exposure. 
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IL-8 expression appeared to vary depending more on the donor than other variables. In 
both monocytes and PMA-stimulated macrophages from donor 3, IL-8 was significantly 
stimulated by exposure to nanosilver, despite these macrophages showing the highest 
basal expression levels.  
These results have shown that exposure to nanosilver did not elicit a typical Th1 or Th2 
specific response from primary human monocytes or PMA-stimulated macrophages. 
While responses varied between cells sourced from different donors, exposure to 
nanosilver seemed to have the most effect on proinflammatory cytokines such as IL-8 and 
TNF, stimulating their expression in some cases and suppressing it in others. These 
somewhat contradictory responses reflect what has also been reported in the scientific 
literature, where different studies have shown stimulation and suppression of 
proinflammatory cytokines in vivo and in vitro [168, 232, 233, 328, 329]. 
Table 7.6: Stimulation and suppression of cytokine expression in primary human PMA-
stimulated macrophages exposed to nanosilver or Ag+. 
 
Stimulated Suppressed 
 
Cytokines Treatment Cytokines Treatment 
Donor 1 - - 
IL-6 
ABC Nanotech high, NM-300K medium 
and high, Carey Lea's high 
IL-8 
ABC Nanotech, Carey Lea's and Sigma 
high 
TNF 
ABC Nanotech and Sigma high, NM-
300K and Carey Lea's medium and high 
Donor 2 
IL-10 Sigma low IL-8 - 
IL-8 - TNF Sigma high 
Donor 3 
IL-9 NM-300K high IL-17A - 
IL-13 
Carey Lea's 
high 
TNF 
ABC Nanotech, NM-300K and Sigma 
high 
IL-17A - 
- - 
IL-1β 
Carey Lea's and 
Sigma high 
IL-8 
NM-300K low 
and high 
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7.2.2 Change in IL-8 and TNF expression compared to viability in THP-1 and 
primary human monocytes and PMA-stimulated macrophages exposed to 
nanosilver and Ag+. 
To examine whether changes in expression of pro inflammatory cytokines by THP-1 and 
primary human monocytes, and the PMA-stimulated macrophages derived from these 
cells, were related to cellular viability, cell culture supernatants were collected from 
experiments, that also assessed cell viability, to be analysed for IL-8 and TNF expression 
using the ELISA technique. These results for THP-1 monocytes and PMA-stimulated 
macrophages are shown in Figure 7.4, and the exposure concentrations used are shown in 
Table 7.3. Linear regression and correlation analysis was performed to determine any 
relationships between cytokine expression and cell viability. Expression of cytokines by 
untreated THP-1 cells is shown in Table 7.7. 
IL-8 expression in THP-1 monocytes exposed to nanosilver showed a dose dependent 
increase that was inversely proportional to cell viability with a 20 percentage point (pp) 
increase in IL-8 levels compared to control for every 1 pp decrease in viability, and was 
not suppressed under any investigated conditions. In THP-1 PMA-stimulated macrophages 
exposed to nanosilver, IL-8 showed some stimulation, particularly in experiment 3, but 
overall there was no significant correlation between viability and IL-8 expression. 
TNF expression in THP-1 monocytes exposed to Sigma nanosilver increased substantially 
more than for cells exposed to the other types of nanosilver. Due to this large difference, 
no significant overall correlation between cell viability and TNF expression was found. 
However, if the two data points showing large increases for THP-1 monocytes exposed to 
Sigma nanosilver are excluded from the analysis, a significant correlation is observed such 
that TNF expression increases by 1.8 pp compared to control for every 1 pp decrease in 
cell viability (this regression is shown by the red dashed line in Figure 7.4 ‘C’). TNF 
expression in THP-1 PMA-stimulated macrophages showed a weak but significant 
correlation with cell viability, such that for every 1 pp decrease in viability, TNF expression 
increased by 1.5 pp compared to untreated control levels.  
The results described above show that the expression of proinflammatory cytokines IL-8 
and TNF are increased in THP-1 monocytes and PMA-stimulated macrophages exposed to 
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Table 7.7: Pro inflammatory cytokine expression by untreated THP-1 monocytes and 
macrophages corresponding with the data shown in Figure 7.4. Cytokine concentrations 
in pg/mL. 
Cytokine IL-8 TNF 
Cell type Monocytes Macrophages Monocytes Macrophages 
Experiment 1 21 ± 1 6100 ± 200 1.5 ± 0.5 2.2 ± 0.3 
Experiment 2 33 ± 2 18000 ± 1000 - - 
Experiment 3 60 ± 3 2440 ± 80 - 0.9 ± 0.3 
Figure 7.4: Change in expression of IL-8 (A and B) and TNF (C and D) with viability as a 
percentage of untreated cell levels in THP-1 monocytes (A and C) and PMA-stimulated 
macrophages (B and D) exposed to nanosilver and Ag+ for 24 hours. Mean of three 
replicates for each experiment, error bars indicate SEM. Solid line is the linear regression 
of the combined data in each case. Cytokine expression levels by untreated cells are 
shown in Table 7.7. Dose concentrations shown in Table 7.3. 
C 
A 
D 
B 
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nanosilver, and that the increase is inversely proportional to cell viability. Even where 
nanosilver exposure caused almost total cytotoxicity, IL-8 and TNF expression was not 
suppressed below untreated control levels indicating that these cytokines were expressed 
and released before cell death occurred. 
IL-8 and TNF expression compared to cell viability for primary human monocytes and 
PMA-stimulated macrophages are shown in Figure 7.5, and the exposure concentrations 
used are shown in Table 7.2. Expression of cytokines by untreated primary immune cells is 
shown in Table 7.8. As observed in section 7.2.1, IL-8 expression in primary monocytes 
from donor 3 increased substantially compared to the control when the cells were 
exposed to nanosilver, but was mildly suppressed in donors 1 and 2. Due to these 
divergent responses, it was not appropriate to assess the correlation of all three donors 
combined. No significant correlation between cell viability and IL-8 expression was 
observed for primary monocytes from donor 1, while donor 2 showed a strong, but 
shallow, positive correlation and donor 3 showed a strong negative correlation, where IL-8 
expression was stimulated by 50 pp compared to the control values for every 1 pp decline 
in cell viability. In comparison, IL-8 expression by PMA-stimulated macrophages from all 3 
donors showed very similar behaviour compared to cell viability, with a strong positive 
correlation where for every 1 pp decrease in cell viability, IL-8 expression compared to the 
control values decreased by 0.9 pp. At high viability, IL-8 was weakly stimulated, and at 
low viability it was weakly suppressed. 
No significant correlation between TNF expression and cell viability was observed in 
primary human monocytes exposed to nanosilver, despite a slightly negative trend. In 
PMA-stimulated macrophages there was a significant correlation, but TNF levels 
compared to the untreated control only declined by 0.3 pp for every 1 pp decline in cell 
viability. TNF expression was not stimulated at any level of cell viability for PMA-
stimulated macrophages.  
These results have shown that expression of inflammatory cytokines IL-8 and TNF in 
primary human monocytes and PMA-stimulated macrophages are generally unrelated to 
the level of cell viability, and in the cases where expression decreased proportionally to 
viability, only a very small effect was observed. 
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Table 7.8: Pro inflammatory cytokine expression by untreated primary human monocytes 
and macrophages corresponding with the data shown in Figure 7.5. Cytokine 
concentrations in pg/mL. 
Cytokine IL-8 TNF 
Cell type Monocytes Macrophages Monocytes Macrophages 
Donor 1 9000 ± 1000 10100 ± 700 7 ± 2 199 ± 4 
Donor 2 9300 ± 900 17000 ± 2500 800 ± 200 4700 ± 200 
Donor 3 270 ± 80 61000 ± 4000 42 ± 13 7000 ± 1000 
Figure 7.5: Change in expression of IL-8 (A and B) and TNF (C and D) with viability as a 
percent of untreated cell levels in primary human monocytes (A and C) and PMA-
stimulated macrophages (B and D) exposed to nanosilver and Ag+ after 24 hours. Mean of 
three replicates for each experiment, error bars indicate SEM. Solid line is the linear 
regression of the combined data in each case. Cytokine expression levels by untreated 
cells are shown in Table 7.8. Dose concentrations shown in Table 7.2. 
C 
A 
D 
B 
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7.2.3 Expression of IL-8 over time by THP-1 monocytes and PMA-stimulated 
macrophages exposed to nanosilver and Ag+ 
Supernatants from the cell death timeline experiment described in section 5.2.1 were 
collected and analysed for IL-8 levels using the ELISA technique, in order to examine the 
timeline of cytokine release following exposure to nanosilver or Ag+, and the exposure 
concentrations used are shown in Table 7.4. Statistically significant differences over time 
were determined using two-way ANOVA with Bonferroni post-hoc testing, where p < 0.05 
was considered significant. Results for IL-8 expression in THP-1 monocytes exposed to 
nanosilver over 24 hours are shown in Figure 7.6.  
The untreated THP-1 monocyte control showed a constant low level of IL-8 expression of 
between 60 and 80 pg/mL over 24 hours. By 4 hours after exposure to nanosilver, IL-8 
expression had already increased significantly compared to the control in all cases, except 
the low concentration of Carey Lea’s and Ag+, which did not differ from the control at any 
time-point. In THP-1 monocytes exposed to Carey Lea’s nanosilver, IL-8 expression 
continued to rise until 8 hours after exposure, and until 12 hours after exposure in 
monocytes exposed to Sigma nanosilver, before plateauing. The trend for IL-8 expression 
in THP-1 monocytes exposed to the other test materials was not as obvious, but in most 
cases there was a significant increase between 4 and 8 hours. Overall, it appears that the 
majority of IL-8 expression occurred by 8 hours after exposure. 
Results for IL-8 expression in THP-1 PMA-stimulated macrophages exposed to nanosilver 
over 24 hours are shown in Figure 7.7. The untreated PMA-stimulated macrophage 
control expression of IL-8 increased gradually over time, from 760 pg/mL at 4 hours, to 
1457, 1830 and 2436 pg/mL at 8, 12 and 24 hours respectively. All test materials caused a 
dose-dependent increase in IL-8 expression by THP-1 PMA-stimulated macrophages 
which continued to increase up to 24 hours after exposure. Under all conditions, except 
the low Ag+ concentration, IL-8 levels at 24 hours exposure were significantly greater than 
all previous time-points. 
Compared to THP-1 monocytes exposed to nanosilver, in which IL-8 expression plateaued 
after 8 to 12 hours following exposure, PMA-stimulated macrophages produced large 
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quantities of IL-8 continuously. It is expected that IL-8 production would have continued 
to increase after 24 hours.  
 
Figure 7.6: Change in IL-8 expression over 24 hours in THP-1 monocytes exposed to three 
concentrations of nanosilver and Ag+: A, ABC Nanotech; B, NM-300K; C, Carey Lea’s; D, 
Sigma; E, Ag+. Mean of three replicates, error bars indicate SEM. For each concentration, 
§ = different to 4 hours, † = different to 8 hours, * = different to 12 hours. Dose 
concentrations shown in Table 7.4. 
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Figure 7.7: Change in IL-8 expression over 24 hours in PMA-stimulated THP-1 
macrophages exposed to three concentrations of nanosilver and Ag+: A, ABC Nanotech; B, 
NM-300K; C, Carey Lea’s; D, Sigma; E, Ag+. Mean of three replicates, error bars indicate 
SEM. For each concentration, § = different to 4 hours, † = different to 8 hours, * = 
different to 12 hours. Dose concentrations shown in Table 7.4. 
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7.3 Discussion 
The multiplex fluorescent bead assay used in this project to screen cytokine expression 
profiles in THP-1 and primary human monocytes and PMA-stimulated macrophages 
proved to be a useful tool for screening the immune response caused by exposure to 
nanosilver in vitro. This assay has also proven useful in our research group [192] for 
screening the cytokine release profiles of human immune and skin cells following 
exposure to zinc oxide nanoparticles. However, this assay had relatively poor sensitivity at 
low cytokine concentrations. Secondary investigations using the ELISA technique would 
be necessary to more precisely measure changes in cytokine expression due to nanosilver 
exposure.  
From the results of the cytokine screening assays, it is clear that exposure to nanosilver 
does not elicit any kind of Th1 or Th2 specific response from either THP-1 or primary 
human monocytes or PMA-stimulated macrophages. The critical cytokines to stimulate a 
Th1 or Th2 immune response, IL-12 and IL-4 respectively, showed no significant changes 
for the THP-1 or primary immune cells tested under any conditions. 
The expression of cytokines that were most effected by exposure to nanosilver were the 
pro inflammatory cytokines IL-8 and TNF, and to a lesser degree IL-6 and IL-1β. In THP-1 
monocytes and macrophages, a significant stimulation of IL-8 was observed following 
exposure to nanosilver or Ag+. This stimulation was inversely proportional to decreases in 
cell viability caused by the nanosilver. In contrast, changes in IL-8 expression in primary 
monocytes and PMA-stimulated macrophages were less predictable. One of the donors 
showed a strong stimulatory response in monocytes exposed to nanosilver, and the 
others showed a decrease in IL-8 expression proportional to the decrease in cell viability, 
while macrophages from all three donors showed a mild stimulation at low 
concentrations and a mild suppression at high concentrations. 
IL-8 behaves as a chemoattractant to neutrophils in vivo, causing them to migrate out of 
the circulatory system to sites of injury or infection in order to kill invading pathogens 
[330, 331]. This is a pro inflammatory process, due to the harsh chemicals released by the 
neutrophils which can cause damage to surrounding tissues [332]. If some individuals are 
more sensitive than others to proinflammatory stimuli, of which the strong stimulation of 
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IL-8 expression in monocytes from donor 3 may have been evidence, exposure to 
nanosilver may lead to a severe acute inflammatory reaction that would likely be dose 
dependent in nature. This finding may have implications for inhalational exposure to 
nanosilver, which may be dangerous for individuals prone to pulmonary inflammation, 
such as asthma sufferers. The likelihood of such a scenario would need to be tested in 
vivo in appropriate animal models with the possible later stage of confirmation in a 
carefully controlled small-scale human trial. 
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8 Intracellular localisation of 
nanosilver in THP-1 monocytes and 
macrophages 
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8.1 Introduction 
The cellular uptake of NPs has received significant attention from researchers over the 
past decade, from the perspectives of nanomedicine, nanotoxicology, and live cell 
imaging [82, 83, 256, 333]. Cellular internalisation mechanisms have been studied for a 
wide range of NPs in a number of different cell lines, but this still remains a relatively 
poorly understood area [239, 334-337]. 
The intracellular localisation of NPs is important in nanotoxicology as this may have a role 
in determining the level of cytotoxicity and the mechanisms by which cells suffer damage. 
If NPs are taken up in endosomes or phagosomes and remain inside the vesicles while 
being chemically stable at low pH, they may not cause any major adverse effects on the 
cell unless they build up inside the cell and disrupt cellular processes physically. But if the 
NPs are able to escape into the cytosol, disrupt the vesicles, or dissolve at the low pH 
typical of digestive vacuoles they have the potential to disrupt important organelles and 
processes causing cytotoxicity. Specifically, if NPs are able to localise within mitochondria 
or penetrate the nucleus there is significant potential for disrupting cellular metabolism 
or DNA damage [251]. 
A number of different techniques have been employed to assess cellular uptake and 
intracellular localisation of NPs [338]. One major technique is ultra-thin section TEM, 
which involves fixing cells, after being exposed to NPs in vitro, and embedding them in 
resin before cutting using an ultramictrotome to produce sections less than 100 nm thick. 
By mounting these sections on TEM grids and using a routine staining protocol to increase 
contrast of cellular components, this technique can be used to precisely locate NPs within 
different cellular organelles and compartments, especially for NPs composed of electron 
dense material such as silver or gold [252, 339].  
Suzuki et al. (2001) proposed a comparatively simple technique for measuring NP uptake 
by cells using flow cytometry [271]. Briefly, they measured the side-scatter intensity of 
cells exposed to TiO2 NPs and saw a dose-dependent increase over time due to the 
internalised NPs scattering more light. This technique was useful for the qualitative 
assessment of NP uptake by cells in vitro, and requires very little preparation of samples, 
unlike the TEM technique described above. Side-scatter intensity data can also be 
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collected from experiments which use flow cytometry to measure other endpoints, such 
as cell death pathways. 
Another technique that can be useful for examining uptake and intracellular localisation 
of nanoparticles is X-ray fluorescence microscopy (XFM), a technique that commonly 
utilises a synchrotron-radiation microbeam [340]. Irradiating thin samples, such as fixed 
cells mounted on SiN windows, with a microbeam of intense synchrotron X-rays (typically 
with a spot-size between 0.3 and 0.1 µm) produces characteristic X-ray emissions from 
atoms of different elements within the sample. Mapping a cell exposed to NPs in this way 
can reveal the relative abundance and location of different elements within the cell at 
sub-micron resolution, including any NPs that have been internalised [341, 342]. This is 
particularly useful for investigating NPs composed of elements that are not usually found 
within normal cells, such as silver. 
Another technique useful for silver and gold NPs specifically is surface enhanced Raman 
scattering (SERS), which has received some attention recently for research areas other 
than nanotoxicology [253-255],. The SERS operates on the same basic principle as 
ordinary Raman infrared spectroscopy, in which monochromatic laser photons are 
characteristically shifted in frequency by interacting with organic molecules depending on 
their various molecular vibrational modes, but it involves the use of gold or silver NPs or 
nanostructured surfaces to greatly enhance the intensity of the Raman scattered signal 
[343]. The interaction between the surface plasmons of the NPs and the organic 
molecules of interest can enhance the Raman signal sometimes by as much as a factor of 
1012 compared to the molecule alone [344]. There has been some interest in using silver 
and gold NPs, with and without specific label molecules, as probes for cellular imaging 
using SERS [256], but it is also possible to take advantage of this technique to investigate 
cellular uptake and intracellular localisation of nanosilver from a nanotoxicological 
perspective. Areas of the cell that contain silver NPs will show a strong Raman signal due 
to their SERS activity, while areas of the cell which do not contain nanosilver would show 
much lower Raman intensity. 
The internalisation and intracellular localisation of nanosilver in THP-1 monocytes and 
PMA-stimulated macrophages after 24 hours exposure was investigated in this study 
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using flow cytometry, synchrotron XFM, ultra-thin section TEM and SERS intensity 
mapping of live cells. The exposure concentrations of test materials used in these 
experiments are shown in Table 8.1. 
Table 8.1: Test material exposure concentrations for internalisation and intracellular 
localisation experiments in THP-1 monocytes and PMA-stimulated macrophages. Silver 
concentrations in µg/mL. 
Cell type Monocytes Macrophages 
Experiment XFM TEM SERS XFM TEM SERS 
ABC Nanotech - 130 - 25 60 30 
NM-300K - 100 - 25 80 30 
Carey Lea's - 120 - 25 100 50 
Sigma - 700 - 25 400 200 
Ag+ - 5 - 5 4 - 
 
8.2 Results 
8.2.1 Flow cytometry: side-scatter intensity of THP-1 monocytes and PMA-
stimulated macrophages exposed to nanosilver 
Flow cytometry side-scatter intensity data was collected from the cell-death pathway 
experiments described in section 5.2.1 for THP-1 monocytes and PMA-stimulated 
macrophages exposed to nanosilver or Ag+ over 4, 8, 12 and 24 hours. The test material 
exposure concentrations for this experiment are shown in Table 5.1, in section 5.1. The 
mean side-scatter intensity was plotted against nanosilver concentration for all time-
points and is shown in Figure 8.1. Linear regression and correlation analysis was 
performed for the combined data for each test material. 
In monocytes, all test materials except NM-300K showed significant positive correlations 
between side-scatter intensity and silver concentration. The lack of observed correlation 
for NM-300K may have been due to the limited concentration range investigated. In PMA-
stimulated macrophages, Carey Lea’s nanosilver and Ag+ showed no significant 
correlation, while the other test materials showed significant positive correlations. 
While the side-scatter from monocytes exposed to Ag+ increased rapidly with 
concentration, the highest value was only 150% of the unexposed cells, compared to 
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highest values of around 225% for ABC Nanotech and Carey Lea’s nanosilver. Side-scatter 
from PMA-macrophages exposed to Ag+ did not increase significantly compared to the 
unexposed control. The tested concentrations of Ag+ caused significant cytotoxicity, 
comparable to the nanosilver, so changes in side-scatter observed here for cells exposed 
to nanosilver are unlikely to be solely due to changes in cellular granularity caused by 
cytotoxicity. Rather, the large observed increase in side-scatter intensity for THP-1 
monocytes and macrophages exposed to nanosilver must be due to increased optical 
density of the cells caused by uptake of silver NPs. 
The change in side-scatter intensity for THP-1 monocytes and PMA-stimulated 
macrophages was also assessed over time, after 4, 8, 12 and 24 hours of exposure to 
nanosilver or Ag+. This data is shown in Figure 8.2 for monocytes and Figure 8.3 for 
macrophages. Statistical analysis was performed using two-way ANOVA with Bonferroni 
post-hoc testing to determine changes over time and between concentrations for each 
test material. 
Side-scatter intensity in THP-1 monocytes showed a dose dependent increase for ABC 
Nanotech, Carey Lea’s and Ag+ at all time-points, while NM-300K and Sigma nanosilver 
only showed a significant difference between concentrations at 24 hours exposure. A 
significant effect due to exposure time was observed for all test materials in THP-1 
Figure 8.1: Flow cytometry side-scatter intensity compared to unexposed cells of THP-1 
monocytes (A) and PMA-stimulated macrophages (B) exposed to nanosilver and Ag+, and 
linear regressions. Mean of three replicates, error bars indicate SEM. Dose concentrations 
shown in Table 5.1, in section 5.1, corresponding to subtoxic, EC20 and EC50 doses. 
B A 
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Figure 8.2: Change in flow cytometry side-scatter intensity compared to unexposed cells 
of THP-1 monocytes exposed to nanosilver for 4, 8, 12 and 24 hours. A: ABC Nanotech; B: 
NM-300K; C: Carey Lea’s; D: Sigma; E: Ag+. Mean of three replicates, error bars indicate 
SEM. At each concentration, § = different to 4 hours, † = different to 8 hours, * = different 
to 12 hours. Dose concentrations shown in Table 5.1, in section 5.1, corresponding to 
subtoxic, EC20 and EC50 doses. 
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Figure 8.3: Change in flow cytometry side-scatter intensity compared to unexposed cells 
of THP-1 PMA-stimulated macrophages exposed to nanosilver for 4, 8, 12 and 24 hours. 
A: ABC Nanotech; B: NM-300K; C: Carey Lea’s; D: Sigma; E: Ag+. Mean of three replicates, 
error bars indicate SEM. At each concentration, § = different to 4 hours, † = different to 8 
hours, * = different to 12 hours. Dose concentrations shown in Table 5.1, in section 5.1, 
corresponding to subtoxic, EC20 and EC50 doses. 
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monocytes, but it generally accounted for a small amount of variation compared to 
concentration. The NM-300K nanosilver showed a small but significant increase at 24  
hours compared to the previous time-points, while none of the other test materials 
showed increases after 12 hours.  
Side-scatter intensity increased in a dose dependent manner in PMA-stimulated 
macrophages exposed to nanosilver, except for Carey Lea’s where the highest 
concentration showed a lower intensity than the middle concentration. There was a 
significant effect on side-scatter intensity due to time for all materials but, like monocytes, 
the magnitude of this effect was generally small. There were very few obvious trends in 
side-scatter intensity over time, such as the slight increase between 4 and 12 hours in 
macrophages exposed to ABC Nanotech, but otherwise there was no significant change. 
These results have shown that flow cytometry side-scatter intensity increases in a dose 
dependent manner for THP-1 monocytes and macrophages due to the uptake of 
nanosilver, and that this effect reaches a maximum by 12 hours following exposure. 
8.2.2 Synchrotron X-ray fluorescence microscopy of fixed THP-1 PMA-stimulated 
macrophages exposed to nanosilver 
The THP-1 PMA-stimulated macrophages grown on SiN windows were exposed to 
nanosilver or Ag+ for 24 hours to concentrations of test materials shown in Table 8.1, 
before being fixed as described in section 2.9.2. The fixed macrophages were analysed at 
the Australian Synchrotron by XFM to assess the intracellular localisation of nanosilver by 
elemental mapping. Due to the time consuming nature of XFM mapping, only one cell for 
each exposure material was able to be mapped at high resolution. Elemental distribution 
maps for these cells are shown in Figure 8.4. 
The abundance of important cellular elements such as calcium (Ca), chlorine (Cl), 
phosphorus (P), sulfur (S) and zinc (Zn) are shown, as well as silver (Ag). Negligible levels 
of silver were detected in the unexposed control and the Ag+ exposed cells, whereas very 
high levels of silver were detected in the cells exposed to nanosilver. The Ca and P maps 
are useful for defining the area limits of the cell being mapped, and they show a 
consistent abundance and distribution across the cells examined.  
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Levels of Cl in the cells increased in line with levels of Ag: in the unexposed control and 
the Ag+ exposed cell, maximum Cl concentrations reached between 2 to 3 µg/cm2, but in 
nanosilver exposed cells Cl concentrations reached maximum levels of between 50 to 100 
µg/cm2, and in the Sigma exposed cell up to 614 µg/cm2. Silver reacts with chloride ions 
to form AgCl, which is practically insoluble in these conditions. Considering the very high 
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Figure 8.4: Elemental distribution maps of fixed THP-1 PMA-stimulated macrophages 
exposed to nanosilver and Ag+ obtained by synchrotron XFM. Elemental abundance is 
given by minimum and maximum numbers above each image corresponding to the colour 
scale from left to right in µg/cm2. The scale bar is consistent for all images, equal to 10 
µm. ‘ABC Nano’ denotes the ABC Nanotech test material. Dose concentrations shown in 
Table 8.1. 
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concentration of Cl- in TCM (181 mM), it would be expected that the nanosilver would 
react, at least to some degree, with the Cl- to form AgCl which may then end up forming a 
coating of sorts on the outside of the silver NPs. 
Increases in S and Zn maximum concentrations were also seen in nanosilver exposed cells: 
from 6.5 µg/cm2 for S in the unexposed control to 21 µg/cm2 in NM-300K and Sigma 
exposed cells; and from 0.1 µg/cm2 for Zn in the unexposed control to 0.96 µg/cm2 in 
NM-300K exposed cells. Like Cl, the higher concentrations of Zn appeared to be 
colocalised with the Ag signals, but for S, only the NM-300K exposed cell clearly showed 
colocalisation with Ag. Silver has a high affinity for sulfur bonds, so it may be expected to 
find a significant concentration of S associated with the nanosilver in an in vitro 
environment, since TCM is relatively high in S containing molecules. 
In Figure 8.5, some of the elemental distribution maps from Figure 8.4 have been 
combined to give composite colocalisation maps for the different elements in the cells 
examined. The first column shows the colocalisation of Ag, Ca, and P. The map of Ca and P 
together serves very well to outline the extent of the cell and to visualise where in the cell 
the nanosilver is located. In the unexposed control and the Ag+ exposed cell, silver levels 
are negligible. In the ABC Nanotech exposed cell, large agglomerates of silver, around 2 
µm in size, can be seen in the centre of the cell, as well as towards the periphery, and an 
agglomerate is also visible on the SiN support. In comparison, the cells exposed to NM-
300K and Carey Lea’s show agglomerates of nanosilver mostly just inside the periphery of 
the cell with very little silver in the centre, with a size range of between 1 and 3 µm for 
NM-300K and around 0.5 to 3 µm for Carey Lea’s. The cell exposed to Sigma showed a 
very large nanosilver agglomerate associated with a cell that appeared quite small 
compared to the untreated cell and the other exposed cells. It is possible that this is a 
remaining fragment of a cell that died by apoptosis. The largest Sigma agglomerate is 
about 8 µm in diameter while the smaller agglomerates are between 2 and 3 µm.  
Although this technique could not distinguish between nanosilver agglomerates taken up 
by cells or merely attached to the outer surface of the cell membrane as seen by the X-ray 
detector, there was a clear association observed for all 4 types of nanosilver with the 
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PMA-stimulated macrophages, and it is likely that at least some of this nanosilver had 
been taken up by these actively phagocytosing cells. 
The colocalisation maps of Ag, Cl, and S, show that for ABC Nanotech, Carey Lea’s and 
Sigma, the signals for Ag and Cl were highly colocalised, but S appeared to be mostly 
spread evenly throughout the cell, similar to the controls. For NM-300K, there was a more 
pronounced colocalisation of S with Ag, but for some agglomerates there appeared to be 
distinct areas of Cl and Ag signal that contained little of the other element. The 
Figure 8.5: Elemental colocalisation composite maps for THP-1 PMA stimulated 
macrophages exposed to nanosilver and Ag+, obtained by synchrotron XFM. Column 1: Ag 
= green, Ca = red, P = blue. Column 2: Ag = green, Cl = blue, S = red. Column 3: Ag = green, 
Cl = blue, Zn = red. Elemental abundance concentrations are as described in Figure 8.4. 
Scale bar is consistent for all images, equal to 10 µm. ‘ABC Nano’ denotes the ABC 
Nanotech test material. Dose concentrations shown in Table 8.1. 
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colocalisation maps of Ag, Cl and Zn showed some interesting behaviour by zinc in the 
exposed cells. In the controls, levels of Zn were distributed evenly throughout the cell 
with the Cl signal, but in the nanosilver exposed cells there was a distinct colocalisation of 
Zn, Ag and Cl. While this colocalisation could be a real effect as described above, it is also 
possible that this could be the result of overlap between the energies of the characteristic 
X-rays emitted by Ag and those used to detect Zn and Cl. The high local concentrations of 
Ag in the nanosilver agglomerates would emit very intense X-rays which could easily 
‘bleed’ through into other channels during analysis of the XFM data. Therefore, the 
colocalisation of Ag, Cl and Zn requires further clarification. 
8.2.3 Ultra-thin section transmission electron microscopy of THP-1 monocytes 
and PMA-stimulated macrophages exposed to nanosilver 
The THP-1 monocytes and PMA-stimulated macrophages were exposed to the 4 types of 
nanosilver described in section 2.2, or Ag+, with exposure concentrations shown in Table 
8.1. The exposed cells were then fixed, embedded and sectioned for analysis of NP uptake 
by TEM, as described in section 2.9.3. Figure 8.6 shows micrographs of an unexposed 
THP-1 monocyte control and a THP-1 monocyte exposed to ABC Nanotech nanosilver. 
Visible in the unexposed cell are the cell membrane, intracellular vesicles, the nucleus, 
nuclear membrane, and mitochondria. The same features are visible in the ABC Nanotech 
exposed cell, as well as a nanosilver agglomerate approximately 250 nm across contained 
within an intracellular vesicle denoted by the large, open arrow (in Figure 8.6 D). The 
intracellular ABC Nanotech agglomerate looks very similar to agglomerates seen by cryo-
TEM as described in section 3.2.4. The nanosilver clearly appears to be within the cell, but 
confined to the vesicle, and in close proximity to a number of mitochondria and the 
nuclear membrane. 
Figure 8.7 shows TEM micrographs of THP-1 monocytes exposed to NM-300K and Carey 
Lea’s nanosilver. Despite some lead carbonate precipitate contamination from the staining 
process, a common problem in ultra-thin section TEM using triple lead staining [345], and 
distortion of the Carey Lea’s exposed cell from the fixing process, similar features are 
visible as in Figure 8.6, as well as microvilli visible around the edge of the monocyte in 
Figure 8.7 ‘A’.  
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Figure 8.6: Ultra-thin section TEM micrographs of fixed THP-1 monocytes, unexposed or 
exposed to nanosilver for 24 hours. A and B: unexposed control. C, D and E: exposed to 
ABC Nanotech. N, nucleus; CM, cell membrane; NM, nuclear membrane; V, vesicle; *, 
mitochondria; large arrow = internalised silver nanoparticles. Note: the thick black line at 
the bottom of ‘C’ is an artefact due to an overlapped region from a crease in the ultra-
thin section. 
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Figure 8.7: Ultra-thin section TEM micrographs of fixed THP-1 monocytes exposed to 
nanosilver for 24 hours. A, B and C: exposed to NM-300K. D, E and F: exposed to Carey 
Lea’s. N, nucleus; CM, cell membrane; NM, nuclear membrane; large arrow = internalised 
silver nanoparticles. Note: large black objects visible in ‘A’ and ‘D’ are lead carbonate 
precipitate contamination due to the staining process. 
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Small agglomerates of nanosilver are visible inside the cells exposed to either NM-300K or 
Carey Lea’s nanosilver. In the NM-300K exposed cell, the nanosilver agglomerates do not 
appear to be associated with vesicles, and may be in the cytosol itself. In the Carey Lea’s 
exposed cell, the larger agglomerate does appear to be contained inside a vesicle, but the 
smaller agglomerates seem to be in the cytosol. 
Figure 8.8 shows micrographs of THP-1 monocytes exposed to Sigma nanosilver and Ag+. 
In the Sigma exposed monocyte, two agglomerates of nanosilver can be seen within a 
slightly less electron-dense region of the cell, which is likely to be an intracellular vesicle 
in close proximity to the nuclear membrane. In the Ag+ exposed monocytes, there were 
no visible agglomerates or particles that appeared like those visualised by cryo-TEM 
shown in Figure 3.7. These cells appeared practically indistinguishable from the 
unexposed control monocytes.  
Figure 8.9 shows TEM micrographs of an unexposed control THP-1 PMA-stimulated 
macrophage and a macrophage exposed to ABC Nanotech nanosilver. The unexposed 
control macrophage shows many similar features to the control THP-1 monocytes, but is 
significantly larger and contains more vesicles. In the ABC Nanotech exposed macrophage, 
two nanosilver agglomerates are visible inside the cell, and both appear to be associated 
with less electron-dense regions that are likely to be vesicles in close proximity to the 
nuclear membrane.  
Figure 8.10 shows TEM micrographs of THP-1 PMA-stimulated macrophages exposed to 
NM-300K or Carey Lea’s nanosilver. The NM-300K exposed macrophage shows a number 
of nanosilver agglomerates with a range of sizes inside the cell, with some being close to 
the nuclear membrane and some close to the outer cellular membrane. Most appear to 
be associated with cellular vesicles. The Carey Lea’s exposed cell has been captured while 
actively phagocytosing a large agglomerate of nanosilver, having previously taken up 
other agglomerates which are localised within large vesicles. Projections from the cellular 
membrane can be seen engulfing the nanosilver agglomerate in order to internalise it into 
a phagosome. 
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Figure 8.8: Ultra-thin section TEM micrographs of fixed THP-1 monocytes exposed to 
nanosilver for 24 hours. A, B and C: exposed to Sigma. D and E: exposed to Ag+. N, 
nucleus; CM, cell membrane; NM, nuclear membrane; V, vesicle; *, mitochondria; large 
arrow = internalised silver nanoparticles. Note: the thick black line in ‘A’ is an artefact due 
to an overlapped region from a crease in the ultra-thin section. 
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Figure 8.9: Ultra-thin section TEM micrographs of fixed THP-1 PMA stimulated 
macrophages unexposed or exposed to nanosilver for 24 hours. A and B: unexposed 
control. C, D and E: exposed to ABC Nanotech. N, nucleus; CM, cell membrane; NM, 
nuclear membrane; V, vesicle; *, mitochondria; large arrow = internalised silver 
nanoparticles. 
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Figure 8.10: Ultra-thin section TEM micrographs of fixed THP-1 PMA stimulated 
macrophages exposed to nanosilver for 24 hours. A, B and C: exposed to NM-300K. D, E 
and F: exposed to Carey Lea’s. N, nucleus; CM, cell membrane; NM, nuclear membrane; P, 
phagosome; large arrow = internalised silver nanoparticles. Note: large black object 
visible in ‘D’ at the upper-left of the nucleus is lead carbonate precipitate contamination 
due to the staining process. 
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 Samples of THP-1 PMA-stimulated macrophages exposed to Sigma nanosilver and Ag+ 
were unable to be micrographed successfully due to poor resin embedding making 
sectioning unsuccessful. Due to time limitations and equipment access difficulties, these 
specimens were unable to be repeated to produce representative micrographs. 
Overall, the TEM micrographs for THP-1 monocytes and PMA-stimulated macrophages 
show that when exposed to nanosilver, both cell types will internalise agglomerates of 
silver NPs of various sizes. In all cases, the observed nanosilver agglomerates inside the 
cells looked very similar to agglomerates of the same type of nanosilver observed in the 
media using cryo-TEM. In no cases were nanosilver agglomerates observed inside the cell 
nucleus or associated with the nuclear membrane, but primarily appeared to be 
contained inside cellular vesicles or the cytosol. The nanosilver agglomerates also did not 
appear to be colocalised with any mitochondria, although a more focussed investigation 
would be required to confirm this. Figure 8.10 has also shown that PMA-stimulated 
macrophages are able to actively phagocytose micron-sized agglomerates of nanosilver. 
8.2.4 Surface enhanced Raman spectroscopy of THP-1 PMA-stimulated 
macrophages exposed to nanosilver 
Live THP-1 PMA-stimulated macrophages exposed to nanosilver, at test material exposure 
concentrations shown in Table 8.1, were examined using an infra-red microscope to 
determine if a SERS signal from the nanosilver could be useful in tracking internalisation 
of silver NPs by live cells. The four types of nanosilver described in section 2.2 were 
incubated in TCM for 48 hours and their Raman spectra were collected, as shown in 
Figure 8.11. 
All four types of nanosilver showed SERS activity to some degree, and a strong peak was 
detected at 230 cm-1 in each spectrum. This peak is likely due to the C-N torsion vibration 
mode absorption band of primary alkylamines [346], which are present in TCM in large 
amounts in the forms of amino acids such as lysine. There are also a number of lysine 
residues in BSA, which is a major component of TCM through the addition of FBS. 
By mapping the Raman intensity at 230 cm-1 of nanosilver exposed THP-1 PMA-stimulated 
macrophages grown on an aluminium support (which is not SERS active) it was possible to  
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Figure 8.12: Unexposed control THP-1 PMA-stimulated macrophage on aluminium 
support. A: optical micrograph. B: Raman intensity map at 230 cm-1 overlayed on optical 
micrograph. The cell is indicated by the white circle in A. 
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Figure 8.11: Raman spectra of four types of nanosilver incubated in TCM for 48 hours. 
The strong peak at 230 cm-1 denoted by the vertical dashed line present in all four spectra 
is likely due to the absorption band of primary amines.  
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examine the uptake of nanosilver by these cells. Figure 8.12 shows an unexposed control 
THP-1 PMA-stimulated macrophage and the corresponding Raman intensity map at 230 
cm-1. There is no observed difference in Raman signal intensity between the cell and the 
aluminium support for the unexposed control cell. The Raman intensity range was 
between -20 to 30 counts per second (cps), effectively indistinguishable from background 
noise.  
Figure 8.13 shows two THP-1 PMA-stimulated macrophages exposed to ABC Nanotech 
and the corresponding Raman signal intensity maps. Areas of high signal are colocalised 
with the mapped cells in both cases, indicating cellular uptake of nanosilver. The Raman 
intensity range for these maps is between 80 and 4000 cps, a clear indication of SERS 
enhancement. Nanosilver agglomerates on the aluminium support also produced areas of 
high signal, as can be seen in the upper-right corner of the Raman signal intensity map for 
Figure 8.13 ‘D’. 
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Figure 8.13: THP-1 PMA-stimulated macrophages on aluminium support exposed to ABC 
Nanotech. A and C: optical micrographs. B and D: Raman intensity maps at 230 cm-1 
overlayed on optical micrographs. The cells are indicated by the white circles in A and C. 
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Figure 8.14 shows two THP-1 PMA-stimulated macrophages exposed to NM-300K and the 
corresponding Raman signal intensity maps. The cell shown in image ‘A’ seems to contain 
a large amount of nanosilver with no discrete agglomerates, resulting in the dark 
appearance in the optical micrograph and the relatively uniform Raman signal as seen in 
image ‘B’. The observed Raman signal range for this map was -10 to 800 cps. The cell in 
image ‘C’ contains a number of nanosilver agglomerates similar to the ABC Nanotech 
exposed cells above. The Raman signal range for the map in image ‘D’ is -5 to 400 cps. 
Figure 8.15 shows two THP-1 PMA-stimulated macrophages exposed to Carey Lea’s 
nanosilver and the corresponding Raman signal intensity maps. Strong Raman signals 
have again been produced by nanosilver agglomerates colocalised with the cells, as well 
as on the aluminium support. The Raman signal intensity range is between 10 and 600 cps 
for the map in image ‘B’ and 50 to 2000 cps for the map in image ‘D’. 
Optical only 
A 
Figure 8.14: THP-1 PMA-stimulated macrophages on aluminium support exposed to NM-
300K. A and C: optical micrographs. B and D: Raman intensity maps at 230 cm-1 overlayed 
on optical micrographs. The cells are indicated by the white circles in A and C. Separate 
intensity scales for each specimen are labelled B and D correspondingly. 
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Figure 8.16 shows two THP-1 PMA-stimulated macrophages exposed to Sigma nanosilver 
and the corresponding Raman signal intensity maps. The first cell shown in image ‘A’ 
contains one large nanosilver agglomerate which produced a strong SERS signal, similar to 
the other types of nanosilver, while the second cell shown in image ‘B’ contains several 
agglomerates which also produced strong SERS signals. The Raman signal intensity range 
for the map in image ‘B’ was between -10 and 2400 cps, while for the map in image ‘D’ it 
is between 0 and 1800 cps. 
The data described here shows that it is possible to use the SERS activity of nanosilver to 
track its uptake by cells in vitro for the purposes of nanotoxicology. One limiting factor in 
the usefulness of this technique, which can be seen in some of this data, is the currently 
available spot size of the infra-red laser used to illuminate the samples. This problem is 
illustrated by the Raman signal intensity map shown in Figure 8.16 ‘B’, where the strong 
A 
Figure 8.15: THP-1 PMA-stimulated macrophages on aluminium support exposed to 
Carey Lea’s nanosilver. A and C: optical micrographs. B and D: Raman intensity maps at 
230 cm-1 overlayed on optical micrographs. The cells are indicated by the white circles in 
A and C. Separate intensity scales for each specimen are labelled B and D 
correspondingly. 
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SERS signal due to the single large agglomerate, visible in the optical micrograph, is 
spread across a larger area of the cell than the agglomerate itself. This is due to residual 
illumination from the laser spot, and could be reduced if a more finely focussed beam was 
able to be produced, thereby providing a smaller spot-size. This depends ultimately upon 
the optical hardware set-up of the infrared microscope being used for the Raman 
spectroscopy. 
Despite the physical limitations encountered, it has been demonstrated that SERS can be 
used as a technique for examining the uptake of nanosilver agglomerates by cells in vitro. 
By culturing cells on an aluminium-foil support, it was possible to expose the cells to 
nanosilver by the same protocol used for the other exposure experiments described in 
previous chapters, while still being able to retrieve the cells, wash them gently in 
physiological buffer and examine them in a clean buffer solution without interference 
A 
Figure 8.16: THP-1 PMA-stimulated macrophages on aluminium support exposed to 
Sigma nanosilver. A and C: optical micrographs B and D: Raman intensity maps at 230 cm-1 
overlayed on optical micrographs. The cells are indicated by the white circles in A and C. 
Separate intensity scales for each specimen are labelled B and D correspondingly. 
SERS signal intensity map 
C 
Optical only 
B 
D 
SERS signal 
intensity 
-10 
 
2400 
 0 
 
1800
 
 
B: 
D: 
194 
 
from suspended nanosilver agglomerates and particles, and also exclude any Raman 
signal interference from the cultureware plastic. Since this can be done at room 
temperature under hydrated conditions, it may be possible to use a similar technique to 
monitor the uptake of nanosilver agglomerates by cells in close to real-time, as producing 
the Raman signal intensity maps described here can be achieved within a matter of 
minutes. 
 
8.3 Discussion 
Multiple techniques, including flow cytometry side-scatter intensity analysis, synchrotron 
XFM, ultra-thin section TEM, and SERS intensity mapping of live cells, have shown that 
upon in vitro exposure THP-1 monocytes and PMA-stimulated macrophages take up 
nanosilver particles and agglomerates, including micron sized agglomerates. Analysis of 
flow cytometry side-scatter intensity of cells exposed over a time course to nanosilver 
was able to show that the uptake of nanosilver reached a maximum by 12 hours following 
exposure.  
Synchrotron XFM showed an increase in the presence of chlorine and zinc atoms in cells 
exposed to nanosilver, with both elements being colocalised with the NP agglomerates. 
This may have been due to the nanosilver reacting with components of the TCM, which 
contained a significant concentration of free Cl- ions. But this signal may also have been 
due to the intense x-ray emissions of the Ag atoms in the nanosilver agglomerates causing 
a spurious result.  
It was also possible to identify internalised silver NPs in THP-1 monocytes and PMA-
stimulated macrophages by their morphology and electron density using ultra-thin 
section TEM. Although it is difficult to draw many conclusions from TEM studies due to 
the relatively small number of cells sampled, this was an important investigation as it 
showed definitively that the nanosilver particles were being taken up by the immune 
cells. A range of sizes of nanosilver agglomerates, from just a few particles up to micron-
sized, were observed in cellular vesicles and in the cytoplasm, as well as being actively 
phagocytosed, but in no cases were NPs observed within the cell nucleus. It is possible 
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that these four types of nanosilver are able to exert their observed cytotoxic effects from 
within cellular vesicles, by releasing toxic silver ions due to the low pH present in these 
microenvironments. 
Although inapplicable for many types of NPs, SERS has been shown to be a useful 
technique for probing the interactions of live cells with silver nanoparticles. Through 
some refinement of the techniques shown here, it may be possible to use SERS mapping 
to track the uptake of nanosilver over time by cells in vitro. As well as the applications of 
using nanosilver as an intracellular probe for better imaging and understanding of cellular 
processes, this technique has significant potential for nanotoxicological investigations of 
both silver and gold NPs. 
Despite the success of these techniques in examining the uptake of nanosilver, only 
limited information was gained about the intracellular localisation of nanosilver once it 
was taken up by the cells. Ultra-thin section TEM proved to be the most useful technique 
for this aspect, as the other techniques lacked the required resolution to visualise cellular 
organelles. In addition, none of these techniques were able to illuminate the processes 
responsible for the observed cytotoxicity of Ag+ in this system. Cells exposed to Ag+ 
appeared similar to the unexposed controls in both synchrotron XFM and ultra-thin 
section TEM, while the observed increase in flow cytometry side-scatter intensity for Ag+ 
exposed cells is expected as they become more granular upon losing viability. Despite 
observing particulates formed by the addition of Ag+ to TCM using cryo-TEM, the same 
was not seen in synchrotron XFM or ultra-thin section TEM. At this point, it is unclear 
what role the interactions between TCM and Ag+ play in the observed cytotoxicity, and 
more research is required to better understand the role of silver ions in nanosilver 
cytotoxicity. 
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9 General discussion and conclusions 
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9.1 General discussion 
9.1.1 Characterisation of nanosilver for in vitro nanotoxicology 
The aim of this project was to investigate the interactions between human immune cells 
and nanosilver in an in vitro exposure system. The four types of nanosilver investigated 
are described in Chapter 3, and comprise a range of commercially available and 
laboratory prepared samples including two test materials from the OECD WPMN 
Sponsorship Programme for the Testing of Manufactured Nanomaterials, with different 
coatings, stabilisation and sizes. A major area of technical concern amongst 
nanotoxicology researchers has been the adequate characterisation of NP test materials, 
in order to accurately interpret the results of nanotoxicological testing and develop a 
mechanistic understanding of the processes involved [22, 347]. Despite the increasing 
awareness of the importance of thorough physicochemical characterisation of test 
materials for nanotoxicological investigations, this still remains a complicated and difficult 
area for most researchers to consider adequately [210]. Part of the problem for many 
nanotoxicology researchers is that adequate characterisation of test materials requires 
access to a range of expensive equipment and capabilities. 
One of the least expensive and most widespread techniques for measuring particles in 
liquid is dynamic light scattering, and consequently this is one of the most common 
techniques utilised for characterisation in nanotoxicology investigations due to its easy 
availability and the potential to assess particle size distributions in the relevant exposure 
context, such as cell culture media [348]. However, in reality DLS is an unreliable 
technique for measuring agglomerated particle suspensions. A wide range of NPs have 
been shown to agglomerate significantly in water and under in vitro exposure conditions 
[349], and as such DLS results must be interpreted with care. The DLS results in section 
3.2.2 illustrated how difficult it can be to obtain reliable NP size distribution data for 
nanotoxicology testing, even for particles dispersed in water. Significant agglomeration of 
each type of nanosilver resulted in high polydispersity indices, between 0.3 and 0.5 for 
the smaller NPs and over 0.8 for the larger Sigma nanosilver. This meant that the 
nanosilver samples as prepared were unsuitable for primary particle size distribution 
analysis by DLS. It may have been possible to produce more effective dispersions of each 
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type of nanosilver for DLS analysis of primary particle size distribution, but this would 
defeat the purpose of trying to use DLS to measure particle or agglomerate size in the cell 
exposure media. As such, DLS was found to have limited utility in this project due to the 
interference of NP agglomerates. A recent investigation by Kato et al. (2009) showed how 
complicated it is to effectively measure NP size distribution in exposure media using DLS 
[350]. Particle size distribution results from DLS need to be treated with caution in 
nanotoxicology research; it is easy for DLS to produce misleading data without an easy 
way for researchers to assess the reliability of their results, especially if they have little 
experience in this technique.  
Characterisation of NP agglomeration in exposure media is likely to be crucial to 
understanding the results of nanotoxicology testing, as it will affect the total dose and 
rate of delivery (sedimentation compared to diffusion), cellular uptake rate, and effective 
surface area [77, 242]. However, NP agglomeration is also the most difficult of NP 
physicochemical properties to accurately measure due to its dynamic nature. This project 
investigated two complementary techniques for assessing nanosilver agglomeration in 
cell culture media for in vitro nanotoxicology testing: differential centrifugal 
sedimentation, or disc centrifugation; and cryogenic transmission electron microscopy. 
These techniques have not been as widely used as DLS in nanotoxicology research, but 
they were successful in this project and offered superior capability for understanding the 
agglomeration behaviour of NPs under biologically relevant conditions [22, 210, 351]. The 
visual agreement between the nanosilver agglomerates seen in cryo-TEM micrographs 
and in ultra-thin section TEM micrographs of THP-1 monocytes and PMA-stimulated 
macrophages illustrates this point well. 
Overall, the characterisation techniques undertaken for this project went part of the way 
towards gaining a full understanding of the behaviour of nanosilver in cell culture media 
for in vitro nanotoxicology testing. Nanotoxicology researchers are still attempting to 
determine the minimum amount of nanomaterial characterisation required, as well as the 
techniques that are most useful for in vitro and in vivo testing that are reproducible and 
comparable across laboratories, in addition to determining which NP characteristics have 
the greatest impact on observed adverse effects and why. The techniques investigated 
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here are likely to be included among the core techniques utilised by nanotoxicology 
researchers in the future. 
9.1.2 The toxicology of nanosilver to human immune and skin cells in vitro 
The cytotoxic potential of silver ions and silver nanoparticles to mammalian cells has been 
demonstrated in several previous studies [86, 169, 171, 182, 250, 259, 352]. The results 
shown here in Chapter 4 have illustrated this cytotoxicity in THP-1 monocytes and PMA-
stimulated macrophages, HaCaT human keratinocytes and isolated primary human 
monocytes and PMA-stimulated macrophages. The majority of cytotoxicity caused by 
nanosilver occurred within the first 4 to 8 hours of exposure, in agreement with results 
shown by Foldbjerg et al. [169], but in most cases there was also a significant recovery at 
low concentrations, and increased cytotoxicity at high concentrations over time from 8 to 
24 hours following exposure. Research findings in Chapter 8 shows that nanosilver is 
taken up to a significant degree by human immune cells following exposure, which has 
also been shown in other cell lines [153, 155, 166, 353]. This cellular uptake likely plays a 
significant role in the observed cytotoxicity. 
The mechanisms behind silver cytotoxicity are still not well understood, but previous 
research has shown that the presence of silver ions are necessary for both antibacterial 
activity and cytotoxicity [88, 159]. The importance of silver ions in the observed 
cytotoxicity of nanosilver is yet to be resolved by nanotoxicology researchers, but it is 
likely that the release of silver ions by silver nanoparticles plays some role in their 
cytotoxicity [159, 160]. It has also been shown that there is a significant increase in ROS 
generation coinciding with exposure of bacteria or animal cells to silver ions and 
nanosilver [93, 169, 185, 312, 354].  
In Chapter 6, nanosilver and Ag+ was observed to cause a dose dependent increase in 
mitochondrial superoxide production in THP-1 monocytes and PMA-stimulated 
macrophages, as well as a dose dependent decrease in intracellular reduced glutathione 
and an increase in levels of the lipid peroxidation biomarker 8-isoprostane. These results 
are consistent with other published studies which have shown oxidative damage to cells 
exposed to nanosilver and other signs of oxidative stress [170, 171, 185].  
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It is likely that oxidative stress caused by increased ROS production plays a significant role 
in the cytotoxicity of nanosilver, a conclusion that is also true of many other kinds of 
incidental and engineered NPs. The importance of oxidative stress in the observed toxicity 
of NPs, or ultrafine particles, with a range of compositions has been recognised for at 
least a decade [68, 355-357]. This common oxidative activity of NPs, which is thought to 
relate to specific surface area, may contribute to the observed cytotoxicity of nanosilver. 
However, it is also likely that the chemical properties of silver cause a series of synergistic 
processes to take place in nanosilver exposed cells, stimulating oxidative stress and 
resulting in cytotoxicity.  
The sulfur-containing amino acid cysteine is important for the synthesis of intracellular 
proteins and other important protective biomolecules, such as glutathione [358, 359]. 
Silver has a high affinity for sulfur bonds, and any nanosilver particles entering cells, or 
silver ions released from such particles, will strongly bind molecules containing thiol or 
sulfide groups [102, 360, 361]. Nanosilver has also been shown to disrupt mitochondrial 
function and inhibit enzyme activity within the electron transport chain [259, 362]. Taken 
together, it seems plausible that if nanosilver is taken up by a cell into a degradative 
vesicle, as was observed in Chapter 8, it can produce ROS and silver ions, destabilising the 
vesicle and releasing a high bolus dose of silver ions into the cytosol, known as a ‘Trojan-
horse’ effect [166]. From there, the interactions of silver ions, nanosilver and ROS can 
deplete stores of cellular reduced glutathione, leaving the cell vulnerable to oxidative 
stress by interfering with thiol homeostasis [363], and disrupt mitochondrial function, 
resulting in the production of more ROS as electrons leak from the electron transport 
chain [165]. This would then lead to cell death by apoptotic or necrotic pathways [290], 
depending on the extent of damage done to mitochondria, intracellular stores of 
glutathione and cellular membrane damage. Chapter 5 showed cell death occurring in 
THP-1 monocytes and PMA-stimulated macrophages by both apoptosis and necrosis, with 
higher levels of apoptosis in the more ROS-resistant macrophages. 
The responses of THP-1 monocytes and PMA-stimulated macrophages exposed to 
nanosilver as described in Chapters 4, 5 and 6, are consistent with the scenario described 
above. It is likely that a combination of some or all of these mechanisms is responsible for 
the observed cytotoxicity and oxidative stress caused by exposure to nanosilver or Ag+. 
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9.1.3 Immunomodulatory effects of nanosilver on THP-1 and primary human 
monocytes and PMA-stimulated macrophages 
Exposure to NPs has the potential to cause immunomodulation, by either stimulation, 
suppression, or a combination of both, due to the high likelihood of interaction between 
NPs in the body and components of the immune system, such as tissue resident and 
circulating immune cells [190]. There is good evidence that NPs are distributed widely 
through the circulation depending on particle size, to a range of organs and tissues 
following exposure through inhalation, ingestion and injection [186-188], where they will 
be encountered by immune cells. An effective means of assessing immunomodulatory 
effects of NPs is to observe the production of cytokines, being the cell-signalling 
molecules which coordinate immune responses [318]. Among the limited number of 
published studies investigating cytokine production by human immune cells exposed to 
nanosilver: Martinez-Gutierrez et al. (2012) showed significant stimulation in THP-1 PMA-
stimulated macrophages of pro inflammatory cytokines IL-6, IL-10 and TNF [226]; Greulich 
et al. (2011) showed significant stimulation in PBMC of pro inflammatory cytokines IL-6 
and IL-8, but no change in TNF expression, or expression of Th1 cytokine IL-2 or Th2 
cytokine IL-4 [233]; and Lim et al. (2012) showed significant stimulation in U937 human 
macrophages of pro inflammatory cytokines IL-8 and IL-1β [168]. 
These observed pro inflammatory responses agree in some cases with the results shown 
here in Chapter 7, in which THP-1 PMA-stimulated macrophages exposed to nanosilver 
showed significant increases in pro inflammatory cytokines IL-6, IL-1β and IL-8, while the 
primary human monocytes showed stimulation of IL-8 and TNF that varied between 
donors, and the primary human PMA-stimulated macrophages showed stimulation and 
suppression of IL-8 and TNF in different donors. No significant stimulation of Th1 or Th2 
specific cytokines was observed in this project in agreement with the lack of any evidence 
of Th1 or Th2 responses in published in vitro investigations of nanosilver 
immunomodulation – in contrast to one in vivo study by Park et al. (2011) involving 
intratracheal instillation of nanosilver in mice showed a small Th2, response as well as 
increased pro inflammatory cytokine expression [364]. 
It appears that nanosilver has the potential to elicit an inflammatory response, although 
this has been seen for other types of NPs and may be unrelated to composition [78, 192, 
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194, 196]. There is also some evidence that exposure to nanosilver can suppress pro 
inflammatory cytokine expression in pre-stimulated cells [232]. What remains unclear 
from in vitro testing of nanosilver is whether exposure can stimulate a specific Th1 or Th2 
immune response. Although this in vitro system indicates that direct nanosilver exposure 
of important immune cells does not result in cytokine expression suggestive of a Th1 or 
Th2 response, it is likely that the test systems investigated previously and here are too 
simple to fully reflect the complex multicellular interactions that result in this kind of 
immune response. Co-culture systems consisting of multiple types of immune cells, as 
well as in vivo exposure models, will be required to further investigate the immunogenic 
potential of nanosilver more thoroughly. 
From this research and other published investigations, it appears that the major 
immunomodulatory hazard of exposure to nanosilver may be in the stimulation of a 
severe acute inflammatory response, likely through inhalation. This is most probable in 
people exposed to large doses of nanosilver, such as in an accidental workplace spill, and 
in susceptible individuals, such as asthma sufferers, but more research is required to 
better understand this risk.  
Discounting the use of colloidal silver as a dietary supplement, as described in section 
1.4.3, it is likely that one of the most significant exposure routes to nanosilver for 
consumers would be inhalational, especially with the use of aerosolised products such as 
disinfectant spray [138]. Considering the results discussed above, especially the potential 
for oxidative stress-mediated inflammatory responses to inhalational exposure of 
nanosilver, there is a need for a better understanding of possible risks to consumers. In 
particular, whether pre-existing respiratory conditions can be exacerbated by chronic or 
acute inhalation of nanosilver. 
9.1.4 In vitro methods of nanosilver immunotoxicology 
A range of common in vitro toxicology techniques were employed to assess various 
endpoints relating to the investigation of nanosilver immunotoxicology, such as the MTS 
cell viability assay, oxidation of intracellular H2DCF-DA for ROS (peroxide) production, 
ELISA for cytokine expression and ultra-thin section TEM for intracellular localisation of 
NPs. Many of these techniques, among others, have just recently been described for use 
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in nanotoxicology testing in general in the Quality Handbook: Standard Procedures for 
Nanoparticle Testing edited by Krug and published by the NANOMMUNE consortium in 
2011 under the Seventh Framework Programme of the European Union [280].  
When developing and implementing these techniques, it has been important to control 
for any possible interferences of the NP test materials with the assay. This is a particular 
difficulty for testing nanosilver using some assays that rely on spectrophotometric or 
spectrofluorometric detection methods, such as the MTS cell viability assay and the 
intracellular H2DCF-DA ROS assay, as some nanosilver suspensions have very strong light-
absorbing properties across the wavelengths of interest. Although nanosilver suspensions 
are certainly among the most opaque, this can be a problem for many other different 
nanomaterials during in vitro testing. It can be overcome to some degree by using 
centrifugation to remove the NPs from suspension, as described in Chapter 2 and in the 
Quality Handbook: Standard Procedures for Nanoparticle Testing, but this may not 
overcome the problem in all cases, especially when the NPs are small and well-dispersed, 
making it difficult to sediment them by centrifugation within a reasonable time. 
Overall, the techniques employed here to assess the immunotoxicology of nanosilver in 
vitro worked well and were able to provide useful data about relevant end-points. There 
has been some question as to the utility of in vitro testing techniques in the investigation 
of nanotoxicology [24, 25, 241, 365, 366], and in this complicated area extra care needs to 
be taken to ensure reproducibility of results through employed standardised preparation 
of NP suspensions and dosing, as well as checking NP interference with assays. The use of 
standardised methods and reference materials will improve the quality and intra-
laboratory comparability of in vitro nanotoxicology testing, but it is clear that, with 
adequate experimental design and test material characterisation, in vitro models can 
contribute significant knowledge and understanding to the field of nanotoxicology. 
 
 
 
 
204 
 
9.2 Conclusions 
This project was successfully able to use common in vitro toxicology techniques to 
investigate the immunotoxicology of silver nanoparticles in the THP-1 human acute 
leukemia cell line and primary human immune cells. 
Nanosilver test materials were characterised in pristine condition and in TCM suspensions 
to determine their primary particle size distributions, particle morphology, agglomeration 
state under in vitro test conditions, and surface charge. Some characterisation techniques 
were more successful than others, with TEM being most useful for particle morphology 
and primary particle size distributions (for well dispersed test materials), and cryo-TEM 
allowing the qualitative assessment of particle aggregation in TCM suspensions. Attempts 
to characterise the primary particle distributions using DLS were less successful due to 
interference from particle agglomerates, and DCS provided useful, but not definitive, data 
on the size distribution of particle agglomerates in TCM suspensions. By comparing 
particle agglomerate sizes observed by cryo-TEM with data acquired using DCS, it was 
clear that this method alone is not sufficient to understand the agglomerate sizes that 
cells will be exposed to in an in vitro test system. Cryo-TEM was highly effective in 
visualising the size distribution and extent of agglomeration of nanosilver suspensions in 
TCM, and should be considered for all in vitro (and in vivo where applicable) 
nanotoxicology testing. 
It was demonstrated that nanosilver has significant cytotoxic potential to human immune 
cells and keratinocytes above certain concentration thresholds. The observed cytotoxicity 
occurred rapidly at higher concentrations, mostly within the first four hours following 
exposure. The extent of cytotoxicity exhibited by nanosilver in vivo will depend on the 
cellular dose, which will vary according to the exposure route and the formulation or state 
of the NPs during exposure. The THP-1 monocytes and PMA-stimulated macrophages 
were observed to take up significant amounts of nanosilver when exposed in vitro, and 
this is likely to have contributed to the observed cytotoxicity by a ‘Trojan-horse’ effect 
[166]. 
Upon uptake by the cells, likely facilitated through opsonisation by a nanoparticle-protein 
corona [367], the nanosilver agglomerates could partially dissolve and destabilise the 
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degradative vesicle [84], releasing silver ions and nanosilver into the cytosol. As well as 
producing ROS, the silver ions and nanosilver can then disrupt intracellular thiol 
homeostasis, depleting stores of the protective molecule glutathione, and impair 
mitochondrial function that can also increase the rate of intracellular ROS production. 
This can then lead to severe oxidative stress and cell death by apoptosis or necrosis. All of 
these factors were observed in this project for cells exposed to nanosilver: uptake of 
nanosilver into intracellular vesicles; increased mitochondrial ROS production; depleted 
intracellular stores of reduced glutathione; an increase in levels of oxidative stress 
biomarker 8-isoprostane; and cell death primarily by apoptosis in THP-1 PMA-stimulated 
macrophages and necrosis in THP-1 monocytes. 
Exposure to nanosilver was also observed to stimulate the expression of pro inflammatory 
cytokines in human immune cells, but not Th1 or Th2 immune response-specific 
cytokines. It may be possible that exposure to nanosilver could induce a Th1 or Th2 
immune response and that this model was not sophisticated enough to show that, but it 
is likely that a strong inflammatory response will follow exposure to high levels of 
nanosilver in humans, especially through inhalational exposure and in susceptible 
individuals. 
The potential for a strong inflammatory response caused by the inhalation of nanosilver 
will be an important area of research to resolve concerns for public and occupational 
safety. Adverse effects need to be considered for different consumer groups and 
potentially susceptible populations, such as sufferers of lung disease, asthma, and cystic 
fibrosis, young children, and chronically-exposed workers. Research along these lines will 
require the use of appropriate animal models, but there is also potential for 
epidemiological investigations, especially among workers involved in manufacture of 
nanosilver and nanosilver-containing products. 
This project also demonstrated, for the first time, the use of synchrotron XFM and SERS 
intensity mapping techniques to visualise the uptake of nanosilver in human cells. SERS 
intensity mapping has significant potential for monitoring the uptake of nanosilver in live 
cells, due to its ambient operating conditions and the ability to analyse cells immersed in 
liquid.  
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Overall, this project was able to demonstrate the hazardous potential of nanosilver to 
human immune cells under certain conditions. It is, however, unlikely that consumers will 
be exposed to sufficiently high levels of nanosilver to cause toxicity as observed here. A 
risk of exposure to high levels of nanosilver is most likely to exist in occupational settings 
where nanosilver, or products containing nanosilver, are being manufactured, such as in 
the case of a significant spill of nanomaterials. These risks can be effectively managed 
through appropriate occupational health and safety procedures and safe handling 
guidelines to limit exposure [368]. 
9.3 Future directions 
The field of nanotoxicology research is young, and scientists are still learning how to 
undertake effective and reproducible experiments in this area. There remains a great deal 
still to be understood about the hazards of nanomaterials in general, and specific hazards 
due to NP composition. Areas of potential future research arising out of this project will 
cover many aspects of nanotoxicological in vitro testing generally, as well as the potential 
hazards of nanosilver specifically. 
One of the most important areas in nanotoxicology generally is the characterisation of NP 
test materials for in vitro and in vivo testing. This project demonstrated the difficulty of 
adequately assessing the agglomeration of the nanosilver test materials in TCM 
suspension, a parameter which has the potential to provide much greater understanding 
of in vitro nanotoxicological testing. Understanding the rate of agglomeration and 
agglomerate size distributions will allow researchers to more accurately understand the 
effective NP dose per cell and dose rate, as settling under gravity is likely to have a 
significant effect on these parameters for agglomerated suspensions [244]. The size 
distribution range of NP agglomerates in an in vitro system will also have an effect on the 
rate of uptake by cells, and the dominant uptake mechanisms. The agglomeration rate of 
NPs in suspension in biological fluids may be able to be measured by monitoring the 
specific surface area, another important characteristic for nanotoxicology [69]. It may be 
possible to monitor specific surface area in solution by using an NMR surface relaxation 
technique [218], for which there is at least one commercially available tool, which would 
not appear to be beyond the reach of most laboratories [219]. The potential for this 
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technique to quickly and accurately measure the surface area of NP suspensions [369] in 
biological fluids needs to be further investigated, but if it proves to be effective this may 
be a powerful tool for characterisation of test material suspensions for nanotoxicology. By 
combining changes in surface area in solution over time with cryo-TEM images of the 
same suspensions, a good understanding of the rate of agglomeration and agglomeration 
size distributions should be possible. 
An area of nanosilver toxicology research that requires further investigation is the use of 
Ag+ as a positive cytotoxic control for in vitro testing. This project has demonstrated that 
Ag+ added to TCM can form polydisperse NPs of unknown composition. The interactions 
of Ag+ with cell culture media in the in vitro test systems need to be more fully 
characterised to better understand the role of silver ions in the cytotoxicity of nanosilver. 
This study examined the cytotoxicity of nanosilver to human immune cells in vitro every 4 
hours following exposure for 24 hours. However, much of the observed cytotoxicity 
occurred within the first 4 hours after the cells were exposed. Therefore, more research 
into the events leading to cytotoxicity within the first few hours following nanosilver 
exposure in vitro would provide a better understanding of the mechanisms involved. 
Examining the uptake of nanosilver by cells within the first 60 minutes following exposure 
would provide insight into the role of intracellular dissolution and the ‘Trojan-horse’ 
effect in the cytotoxicity of nanosilver. This could be achieved in part by using flow 
cytometry to examine the change in side-scatter intensity over time, possibly at intervals 
as small as 5 minutes, as an indicator of particle uptake, as described in Chapter 8 [271], 
due to the minimal sample preparation required and the high throughput nature of the 
technique. Monitoring early indications of mitochondrial dysfunction in the first few 
hours following exposure could also provide valuable information about the causality of 
cytotoxic events. 
In addition to early cytotoxic effects, this project did not investigate cellular changes at 
subtoxic exposures to nanosilver. It is likely that in a real-life exposure situation, many 
cells will receive subtoxic doses of nanosilver, as compared to the high cytotoxic doses 
employed here. Most interesting would be what changes in gene expression are elicited 
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by low concentration exposures to nanosilver, as the activation of specific cellular repair 
functions may shed more light on the kinds of cell damage caused by nanosilver. 
The role of ROS production and oxidative stress in the cytotoxicity of nanosilver requires 
further investigation. Despite the significant focus on ROS to date in nanosilver toxicology 
research, it still remains ambiguous as to the exact causality of increased ROS production 
in the observed cytotoxicity. As in this project, most research has been unable to resolve 
whether increased ROS production by nanosilver is causing cytotoxicity [165], or whether 
mitochondrial dysfunction and membrane damage caused through other mechanisms, or 
the depletion of glutathione, results in an increased rate of intracellular ROS production 
leading to oxidative stress. To better understand the ROS causality in nanosilver 
cytotoxicity, high frequency time-resolved monitoring of intracellular ROS production in 
the first few hours following exposure is required. By defining exactly when after exposure 
the increase in ROS production occurs, and combining this data with the early indications 
of mitochondrial dysfunction, a much more complete understanding of the importance of 
oxidative stress in nanosilver cytotoxicity should be possible. 
The potential immunomodulatory behaviour of NPs is still poorly understood, but much in 
vitro nanotoxicology research has shown the pro inflammatory responses caused by 
exposure to NPs, including this project specifically concerning nanosilver. A subchronic 
exposure study in rats by Sung et al. (2009) showed that inhalational nanosilver exposure 
can cause lung inflammation [29], so this is likely to be a significant hazard associated 
with nanosilver that needs to be avoided by people at risk of exposure, such as 
manufacturing workers making products containing nanosilver. As workplace allergies 
may be exacerbated by concurrent NP exposure [370], a better understanding of this pro 
inflammatory hazard could be gained by studying animal models of conditions that are at 
higher risk for pulmonary inflammation, such as asthma. 
Another area of immunomodulation by NPs that requires further research is the potential 
of NPs to stimulate a Th1 or Th2 specific immune response. This project did not see any 
evidence for Th1 or Th2 cytokine production in human monocytes or PMA-stimulated 
macrophages, but this may be due to the simplistic nature of the in vitro test system. To 
more thoroughly investigate the potential immune responses to nanosilver, cytokine 
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production and T-cell proliferation should be monitored in in vivo animal models 
following exposure. The immune system is highly complex, and its many parts need to 
interact to produce these types of responses, which is impossible to replicate in a single 
cell exposure system. It may also be possible to use co-culture in vitro test systems to 
examine the response of the human immune system, which may not be adequately 
modelled by animal tests. These more complicated and complete investigations into the 
immunomodulatory potential of nanosilver are required before this possible hazard can 
be ruled out. 
As with many aspects of nanotoxicology research, the possible hazards of nanosilver 
exposure to humans are still poorly understood, and the future research described above 
will help to continue to inform the safe production, handling and use of these innovative 
nanomaterials. 
210 
 
References 
[1] Schmidt KF. NanoFrontiers: Visions for the Future of Nanotechnology. Washington: 
Woodrow Wilson International Centre for Scholars: Project on Emerging 
Nanotechnologies; 2007 March, 2007. 
[2] Loevestam G, Rauscher H, Roebben G, Sokull-Kluettgen B, Gibson P, Putaud J-P, 
Stamm H. Considerations on a Definition of Nanomaterial for Regulatory Purposes. 
JRC Reference Reports: Publications Office of the European Union; 2010. Report 
No.: JRC58726. 
[3] Amato I. Making the right stuff. Sci News. 1989;136:108-110. 
[4] Park J, Joo J, Kwon SG, Jang Y, Hyeon T. Synthesis of Monodisperse Spherical 
Nanocrystals. Angew Chem-Int Edit. 2007;46:4630-4660. 
[5] Nanotechnology Consumer Products Inventory. Woodrow Wilson International 
Centre for Scholars: Project on Emerging Nanotechnologies 2011  [cited January 
2012]; Available from: http://www.nanotechproject.org/inventories/consumer/ 
[6] Dowling A, Clift R, Grobert N, Hutton D, Oliver R, O'Niell O, Pethica J, Pidgeon N, 
Porritt P, Ryan J, Seaton A, Tendler S, Welland M, Whatmore R. Nanoscience and 
nanotechnologies: opportunities and uncertainties. London: The Royal Society; 
2004. 
[7] Seaton A, Tran L, Aitken R, Donaldson K. Nanoparticles, human health hazard and 
regulation. J Royal Soc Interface. 2010;7:S119-S129. 
[8] Oberdorster G, Oberdorster E, Oberdorster J. Nanotoxicology: An Emerging 
Discipline Evolving from Studies of Ultrafine Particles. Environ Health Perspect. 
2005;113:823-839. 
[9] Stone V. Introduction from the Editor. Nanotoxicology. 2007;1:1-1. 
211 
 
[10] Sponsorship Programme for the Testing of Manufactured Nanomaterials: 
Countries and Stakeholders. Organisation for Economic Cooperation and 
Development 2011  [cited May 2012]; Available from: 
http://www.oecd.org/document/47/0,3746,en_2649_37015404_41197295_1_1_
1_1,00.html 
[11] List of manufactured nanomaterials and list of endpoints for phase one of the 
sponsorship programme for the testing of manufactured nanomaterials: Revision. 
Series on the Safety of Manufactured Nanomaterials. Paris: OECD Environment, 
Health and Safety Publications; 2010. 
[12] Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA. Nanotoxicology. Occup 
Environ Med. 2004;61:727-728. 
[13] Thomas K, Sayre P. Research Strategies for Safety Evaluation of Nanomaterials, 
Part I: Evaluating the Human Health Implications of Exposure to Nanoscale 
Materials. Toxicol Sci. 2005;87:316-321. 
[14] Holsapple MP, Farland WH, Landry TD, Monteiro-Riviere NA, Carter JM, Walker NJ, 
Thomas KV. Research Strategies for Safety Evaluation of Nanomaterials, Part II: 
Toxicological and Safety evaluation of Nanomaterials, Current Challenges and Data 
Needs. Toxicol Sci. 2005;88:12-17. 
[15] Balshaw DM, Philbert M, Suk WA. Research Strategies for Safety Evaluation of 
Nanomaterials, Part III: Nanoscale Technologies for Assessing Risk and Improving 
Public Health. Toxicol Sci. 2005;88:298-306. 
[16] Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB. 
Research Strategies for Safety Evaluation of Nanomaterials, Part IV: Risk 
Assessment of Nanoparticles. Toxicol Sci. 2006;89:42-50. 
[17] Borm P, Klaessig FC, Landry TD, Moudgil B, Pauluhn J, Thomas K, Trottier R, Wood 
S. Research Strategies for Safety Evaluation of Nanomaterials, Part V: Role of 
Dissolution in Biological Fate and Effects of Nanoscale Particles. Toxicol Sci. 
2006;90:23-32. 
212 
 
[18] Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM. Research 
Strategies for Safety Evaluation of Nanomaterials. Part VI. Characterization of 
Nanoscale Particles for Toxicological Evaluation. Toxicol Sci. 2006;90:296-303. 
[19] Thomas T, Thomas K, Sadrieh N, Savage N, Adair P, Bronaugh R. Research 
Strategies for Safety Evaluation of Nanomaterials, Part VII: Evaluating Consumer 
Exposure to Nanoscale Materials. Toxicol Sci. 2006;91:14-19. 
[20] Thomas K, Aguar P, Kawasaki H, Morris J, Nakanishi J, Savage N. Research 
Strategies for Safety Evaluation of Nanomaterials, Part VIII: International Efforts to 
Develop Risk-Based Safety Evaluations for Nanomaterials. Toxicol Sci. 2006;92:23-
32. 
[21] Oberdorster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, 
Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H. 
Principles for characterizing the potential human health effects from exposure to 
nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005;2:8. 
[22] Sayes CM, Warheit DB. Characterization of nanomaterials for toxicity assessment. 
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:660-670. 
[23] Eisenbrand G, Pool-Zobel B, Baker V, Balls M, Blaauboer BJ, Boobis A, Carere A, 
Kevekordes S, Lhuguenot JC, Pieters R, Kleiner J. Methods of in vitro toxicology. 
Food Chem Toxicol. 2002;40:193-236. 
[24] Stone V, Johnston H, Schins RPF. Development of in vitro systems for 
nanotoxicology: methodological considerations. Crit Rev Toxicol. 2009;39:613-626. 
[25] Jones CF, Grainger DW. In vitro assessments of nanomaterial toxicity. Adv Drug 
Delivery Rev. 2009;61:438-456. 
[26] Rothen-Rutishauser B, Muhlfeld C, Blank F, Musso C, Gehr P. Translocation of 
particles and inflammatory responses after exposure to fine particles and 
nanoparticles in an epithelial airway model. Part Fibre Toxicol. 2007;4:9. 
213 
 
[27] Fischer HC, Chan WCW. Nanotoxicity: the growing need for in vivo study. Curr Opin 
Biotechnol. 2007;18:565-571. 
[28] Ji JH, Jung JH, Kim SS, Yoon JU, Park JD, Choi BS, Chung YH, Kwon IH, Jeong J, Han 
BS, Shin JH, Sung JH, Song KS, Yu IJ. Twenty-Eight-Day Inhalation Toxicity Study of 
Silver Nanoparticles in Sprague-Dawley Rats. Inhalation Toxicol. 2007;19:857-871. 
[29] Sung JH, Ji JH, Park JD, Yoon JU, Kim DS, Jeon KS, Song MY, Jeong J, Han BS, Han JH, 
Chung YH, Chang HK, Lee JH, Cho MH, Kelman BJ, Yu IJ. Subchronic Inhalation 
Toxicity of Silver Nanoparticles. Toxicol Sci. 2009;108:452-461. 
[30] Kim YS, Kim JS, Cho HS, Rha DS, Kim JM, Park JD, Choi BS, Lim R, Chang HK, Chung 
YH, Kwon IH, Jeong J, Han BS, Yu IJ. Twenty-Eight-Day Oral Toxicity, Genotoxicity, 
and Gender-Related Tissue Distribution of Silver Nanoparticles in Sprague-Dawley 
Rats. Inhalation Toxicol. 2008;20:575-583. 
[31] Kim YS, Song MY, Park JD, Song KS, Ryu HR, Chung YH, Chang HK, Lee JH, Oh KH, 
Kelman BJ, Hwang IK, Yu IJ. Subchronic oral toxicity of silver nanoparticles. Part 
Fibre Toxicol. 2010;7:11. 
[32] Organisation for Economic Cooperation and Development. Test No. 407: Repeated 
Dose 28-day Oral Toxicity Study in Rodents.  OECD Guidelines for the Testing of 
Chemicals, Section 4. Paris: OECD Publishing 1995. 
[33] Organisation for Economic Cooperation and Development. Test No. 408: Repeated 
Dose 90-Day Oral Toxicity Study in Rodents.  OECD Guidelines for the Testing of 
Chemicals, Section 4. Paris: OECD Publishing 1998. 
[34] Organisation for Economic Cooperation and Development. Test No. 412: Subacute 
Inhalation Toxicity: 28-Day Study.  OECD Guidelines for the Testing of Chemicals, 
Section 4. Paris: OECD Publishing 1993. 
[35] Organisation for Economic Cooperation and Development. Test No. 413: 
Subchronic Inhalation Toxicity: 90-day Study.  OECD Guidelines for the Testing of 
Chemicals, Section 4. Paris: OECD Publishing 1995. 
214 
 
[36] Service RF. Can High-Speed Tests Sort Out Which Nanomaterials Are Safe? Science. 
2008;321:1036-1037. 
[37] Burello E, Worth A. Computational nanotoxicology: Predicting toxicity of 
nanoparticles. Nat Nanotechnol. 2011;6:138-139. 
[38] Tropsha A, Golbraikh A. Predictive QSAR Modeling Workflow, Model Applicability 
Domains, and Virtual Screening. Curr Pharm Des. 2007;13:3494-3504. 
[39] Cronin MTD, Jaworska JS, Walker JD, Comber MHI, Watts CD, Worth AP. Use of 
QSARs in International Decision-Making Frameworks to Predict Health Effects of 
Chemical Substances. Environ Health Perspect. 2003;111:1391-1401. 
[40] Cronin MTD, Walker JD, Jaworska JS, Comber MHI, Watts CD, Worth AP. Use of 
QSARs in International Decision-Making Frameworks to Predict Ecologic Effects 
and Environmental Fate of Chemical Substances. Environ Health Perspect. 
2003;111:1376-1390. 
[41] Meng H, Xia T, George S, Nel AE. A Predictive Toxicological Paradigm for the Safety 
Assessment of Nanomaterials. ACS Nano. 2009;3:1620-1627. 
[42] Fourches D, Pu D, Tassa C, Weissleder R, Shaw SY, Mumper RJ, Tropsha A. 
Quantitative Nanostructure-Activity Relationship Modeling. ACS Nano. 
2010;4:5703-5712. 
[43] Weissleder R, Kelly K, Sun EY, Shtatland T, Josephson L. Cell-specific targeting of 
nanoparticles by multivalent attachment of small molecules. Nat Biotechnol. 
2005;23:1418-1423. 
[44] Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. 
Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci U S A. 
2008;105:7387-7392. 
[45] Sayes C, Ivanov I. Comparative Study of Predictive Computational Models for 
Nanoparticle-Induced Cytotoxicity. Risk Anal. 2010;30:1723-1734. 
215 
 
[46] Burello E, Worth AP. A theoretical framework for predicting the oxidative stress 
potential of oxide nanoparticles. Nanotoxicology. 2011;5:228-235. 
[47] Dobay MPD, Alberola AP, Mendoza ER, Raedler JO. Modeling nanoparticle uptake 
and intracellular distribution using stochastic process algebras. J Nanopart Res. 
2012;14. 
[48] Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, Dawson KA, Linse 
S. Understanding the nanoparticle-protein corona using methods to quantify 
exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S 
A. 2007;104:2050-2055. 
[49] Oberdorster G. Safety assessment for nanotechnology and nanomedicine: 
concepts of nanotoxicology. J Intern Med. 2010;267:89-105. 
[50] Kreyling WG, Semmler-Behnke M, Seitz J, Scymczak W, Wenk A, Mayer P, Takenaka 
S, Oberdorster G. Size dependence of the translocation of inhaled iridium and 
carbon nanoparticle aggregates from the lung of rats to the blood and secondary 
target organs. Inhalation Toxicol. 2009;21 Suppl 1:55-60. 
[51] Geiser M, Kreyling WG. Deposition and biokinetics of inhaled nanoparticles. Part 
Fibre Toxicol. 2010;7. 
[52] Semmler-Behnke M, Kreyling WG, Lipka J, Fertsch S, Wenk A, Takenaka S, Schmid 
G, Brandau W. Biodistribution of 1.4- and 18-nm Gold Particles in Rats. Small. 
2008;4:2108-2111. 
[53] Hadrup N, Loeschner K, Bergstrom A, Wilcks A, Gao X, Vogel U, Frandsen HL, 
Larsen EH, Lam HR, Mortensen A. Subacute oral toxicity investigation of 
nanoparticulate and ionic silver in rats. Arch Toxicol. 2012;86:543-551. 
[54] Schrand AM, Rahman MF, Hussain SM, Schlager JJ, Smith DA, Syed AF. Metal-based 
nanoparticles and their toxicity assessment. Wiley Interdiscip Rev Nanomed 
Nanobiotechnol. 2010;2:544-568. 
216 
 
[55] Cho WS, Cho MJ, Jeong J, Choi M, Cho HY, Han BS, Kim SH, Kim HO, Lim YT, Chung 
BH. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold 
nanoparticles. Toxicol Appl Pharmacol. 2009;236:16-24. 
[56] Crispe IN. The Liver as a Lymphoid Organ.  Annual Review of Immunology. Palo 
Alto: Annual Reviews 2009:147-163. 
[57] Delves PJ, Martin SJ, Burton DR, Roitt IM. Roitt's Essential Immunology: John Wiley 
& Sons 2011. 
[58] Muehlfeld C, Gehr P, Rothen-Rutishauser B. Translocation and cellular entering 
mechanisms of nanoparticles in the respiratory tract. Swiss Med Wkly. 
2008;138:387-391. 
[59] Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, Mortensen A, Lam 
HR, Larsen EH. Distribution of silver in rats following 28 days of repeated oral 
exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol. 2011;8. 
[60] Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. Silver-Coated Dressing 
Acticoat Caused Raised Liver Enzymes and Argyria-like Symptoms in Burn Patient. J 
Trauma-Injury Infect Crit Care. 2006;60:648-652. 
[61] Prow TW, Monteiro-Riviere NA, Inman AO, Grice JE, Chen X, Zhao X, Sanchez WH, 
Gierden A, Kendall MAF, Zvyagin AV, Erdmann D, Riviere JE, Roberts MS. Quantum 
dot penetration into viable human skin. Nanotoxicology. 2012;6:173-185. 
[62] Ravichandran S, Mortensen LJ, Delouise LA. Quantification of human skin barrier 
function and susceptibility to quantum dot skin penetration. Nanotoxicology. 
2011;5:675-686. 
[63] Bolzinger M-A, Brianc S, Chevalier Y. Nanoparticles through the skin: managing 
conflicting results of inorganic and organic particles in cosmetics and 
pharmaceutics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011;3:463-478. 
[64] Labouta HI, El-Khordagui LK, Kraus T, Schneider M. Mechanism and determinants 
of nanoparticle penetration through human skin. Nanoscale. 2011;3:4989-4999. 
217 
 
[65] Filon FL, Crosera M, Adami G, Bovenzi M, Rossi F, Maina G. Human skin 
penetration of gold nanoparticles through intact and damaged skin. 
Nanotoxicology. 2011;5:493-501. 
[66] Hubbs AF, Mercer RR, Benkovic SA, Harkema J, Sriram K, Schwegler-Berry D, 
Goravanahally MP, Nurkiewicz TR, Castranova V, Sargent LM. Nanotoxicology―A 
Pathologist's Perspective. Toxicol Pathol. 2011;39:301-324. 
[67] Donaldson K, Li XY, MacNee W. Ultrafine (nanometre) particle mediated lung 
injury. J Aerosol Sci. 1998;29:553-560. 
[68] Donaldson K, Stone V, Gilmour PS, Brown DM, MacNee W. Ultrafine particles: 
mechanisms of lung injury. Philos Trans R Soc Lond Ser A-Math Phys Eng Sci. 
2000;358:2741-2748. 
[69] Duffin R, Tran CL, Clouter A, Brown DM, MacNee W, Stone V, Donaldson K. The 
Importance of Surface Area and Specific Reactivity in the Acute Pulmonary 
Inflammatory Response to Particles. Ann Occup Hyg. 2002;46:242-245. 
[70] Maynard AD, Kuempel ED. Airborne nanostructured particles and occupational 
health. J Nanopart Res. 2005;7:587-614. 
[71] Nel A, Xia T, Madler L, Li N. Toxic Potential of Materials at the Nanolevel. Science. 
2006;311:622-627. 
[72] Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner 
MR, Nel AE. Comparison of the Abilities of Ambient and Manufactured 
Nanoparticles To Induce Cellular Toxicity According to an Oxidative Stress 
Paradigm. Nano Lett. 2006;6:1794-1807. 
[73] Singh S, Shi TM, Duffin R, Albrecht C, van Berlo D, Hoehr D, Fubini B, Martra G, 
Fenoglio I, Borm PJA, Schins RPF. Endocytosis, oxidative stress and IL-8 expression 
in human lung epithelial cells upon treatment with fine and ultrafine TiO2: Role of 
the specific surface area and of surface methylation of the particles. Toxicol Appl 
Pharmacol. 2007;222:141-151. 
218 
 
[74] Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager 
JJ. Unique Cellular Interaction of Silver Nanoparticles: Size-Dependent Generation 
of Reactive Oxygen Species. J Phys Chem B. 2008;112:13608-13619. 
[75] Soenen SJ, Rivera-Gil P, Montenegro JM, Parak WJ, De Smedt SC, Braeckmans K. 
Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for 
improved nanotoxicity evaluation. Nano Today. 2011;6:446-465. 
[76] Singh N, Manshian B, Jenkins GJS, Griffiths SM, Williams PM, Maffeis TGG, Wright 
CJ, Doak SH. NanoGenotoxicology: The DNA damaging potential of engineered 
nanomaterials. Biomaterials. 2009;30:3891-3914. 
[77] Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, 
Castranova V, Thompson M. Understanding biophysicochemical interactions at the 
nano-bio interface. Nat Mater. 2009;8:543-557. 
[78] Deng ZJ, Liang MT, Monteiro M, Toth I, Minchin RF. Nanoparticle-induced 
unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nat 
Nanotechnol. 2011;6:39-44. 
[79] Bailey RE, Smith AM, Nie SM. Quantum dots in biology and medicine. Physica E 
Low Dimens Syst Nanostruct. 2004;25:1-12. 
[80] Hardman R. A Toxicologic Review of Quantum Dots: Toxicity Depends on 
Physicochemical and Environmental Factors. Environ Health Perspect. 
2006;114:165-172. 
[81] Gao JH, Chen K, Xie RG, Xie J, Yan YJ, Cheng Z, Peng XG, Chen XY. In Vivo Tumor-
Targeted Fluorescence Imaging Using Near-Infrared Non-Cadmium Quantum Dots. 
Bioconjug Chem. 2010;21:604-609. 
[82] Chang E, Thekkek N, Yu WW, Colvin VL, Drezek R. Evaluation of Quantum Dot 
Cytotoxicity Based on Intracellular Uptake. Small. 2006;2:1412-1417. 
[83] Zhang LW, Monteiro-Riviere NA. Mechanisms of Quantum Dot Nanoparticle 
Cellular Uptake. Toxicol Sci. 2009;110:138-155. 
219 
 
[84] Cho WS, Duffin R, Howie SEM, Scotton CJ, Wallace WAH, MacNee W, Bradley M, 
Megson IL, Donaldson K. Progressive severe lung injury by zinc oxide 
nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol. 
2011;8. 
[85] Borovansky J, Riley PA. Cytotoxicity of zinc in vitro. Chem-Biol Interact. 
1989;69:279-291. 
[86] Poon VKM, Burd A. In vitro cytotoxity of silver: implication for clinical wound care. 
Burns. 2004;30:140-147. 
[87] Russell AD, Hugo WB. Antimicrobial Activity and Action of Silver. Prog Med Chem. 
1994;31:351-370. 
[88] Gibbard J. Public Health Aspects of the Treatment of Water and Beverages With 
Silver. Am J Public Health Nation Health. 1937;27:112-119. 
[89] Marambio-Jones C, Hoek EMV. A review of the antibacterial effects of silver 
nanomaterials and potential implications for human health and the environment. J 
Nanopart Res. 2010;12:1531-1551. 
[90] Bragg PD, Rainnie DJ. Effect of silver ions on respiratory chain of Escherichia coli. 
Can J Microbiol. 1974;20:883-889. 
[91] Holt KB, Bard AJ. Interaction of Silver(I) Ions with the Respiratory Chain of 
Escherichia coli: An 
Electrochemical and Scanning Electrochemical Microscopy Study of the 
Antimicrobial Mechanism of Micromolar Ag+. Biochemistry. 2005;44:13214-13223. 
[92] Hwang ET, Lee JH, Chae YJ, Kim YS, Kim BC, Sang BI, Gu MB. Analysis of the Toxic 
Mode of Action of Silver Nanoparticles Using Stress-Specific Bioluminescent 
Bacteria. Small. 2008;4:746-750. 
220 
 
[93] Park HJ, Kim JY, Kim J, Lee JH, Hahn JS, Gu MB, Yoon J. Silver-ion-mediated reactive 
oxygen species generation affecting bactericidal activity. Water Res. 2009;43:1027-
1032. 
[94] Garner M, Reglinski J, Smith WE, Stewart MJ. The Interaction of Colloidal Metals 
with Erythrocytes. J Inorg Biochem. 1994;56:283-290. 
[95] Chen X, Schluesener HJ. Nanosilver: A nanoproduct in medical application. Toxicol 
Lett. 2008;176:1-12. 
[96] Furno F, Morley KS, Wong B, Sharp BL, Arnold PL, Howdle SM, Bayston R, Brown 
PD, Winship PD, Reid HJ. Silver nanoparticles and polymeric medical devices: a 
new approach to prevention of infection? J Antimicrob Chemother. 2004;54:1019-
1024. 
[97] White JML, Powell AM, Brady K, Russell-Jones R. Severe generalized argyria 
secondary to ingestion of colloidal silver protein. Clin Exp Dermatol. 2003;28:254-
256. 
[98] Panyala NR, Pena-Mendez EM, Havel J. Silver or silver nanoparticles: a hazardous 
threat to the environment and human health? J Appl Biomed. 2008;6:117-129. 
[99] Bleehen SS, Gould DJ, Harrington CI, Durrant TE, Slater DN, Underwood JCE. 
Occupational argyria; light and electron microscopic studies and X-ray 
microanalysis. Br J Dermatol. 1981;104:19-26. 
[100] Shelley WB, Shelley ED, Burmeister V. Argyria: The intradermal "photograph," a 
manifestation of passive photosensitivity. J Am Acad Dermatol. 1987;16:211-217. 
[101] Drake PL, Hazelwood KJ. Exposure-Related Health Effects of Silver and Silver 
Compounds: A Review. Ann Occup Hyg. 2005;49:575-585. 
[102] Luckey T, Venugopal B. Metal Toxicity in Mammals, Vol. 2: Chemical Toxicity of 
Metals and Metalloids. New York: Plenum Press 1978. 
221 
 
[103] Rosenman KD, Seixas N, Jacobs I. Potential nephrotoxic effects of exposure to 
silver. Br J Ind Med. 1987;44:267-272. 
[104] Naqvi AH, Shields JW, Abraham JL. Nasal argyria (deposition of silver-selenium) in 
the photographic film industry: histopathology and microanalysis. Am J 
Otolaryngol. 2007;28:430-432. 
[105] Rosenman KD, Moss A, Kon S. Argyria: Clinical Implications of Exposure to Silver 
Nitrate and Silver Oxide. J Occup Environ Med. 1979;21:430-435. 
[106] East BW, Boddy K, Williams ED, Macintyre D, McLay ALC. Silver retention, total 
body silver and tissue silver concentrations in argyria associated with exposure to 
an anti-smoking remedy containing silver acetate. Clin Exp Dermatol. 1980;5:305-
311. 
[107] Van de Voorde K, Nijsten T, Schelfhout K, Moorkens G, Lambert J. Long-term use of 
silver containing nose-drops resulting in systemic argyria. Acta Clin Belg. 
2005;60:33-35. 
[108] Jonas L, Bloch C, Zimmermann R, Stadie V, Gross GE, Schad SG. Detection of Silver 
Sulfide Deposits in the Skin of Patients with Argyria After Longterm Use of Silver-
containing Drugs. Ultrastruct Pathol. 2007;31:379-384. 
[109] Fuller FW. The Side Effects of Silver Sulfadiazine. J Burn Care Res. 2009;30:464-470. 
[110] Lansdown ABG. Silver in Health Care: Antimicrobial Effects and Safety in Use. Curr 
Probl Dermatol. 2006;33:17-34. 
[111] Gulbranson SH, Hud JA, Hansen RC. Argyria following the use of dietary 
supplements containing colloidal silver protein. Cutis. 2000;66:373-374. 
[112] Bowden LP, Royer MC, Hallman JR, Lewin-Smith M, Lupton GP. Rapid onset of 
argyria induced by a silver-containing dietary supplement. J Cutan Pathol. 
2011;38:832-835. 
222 
 
[113] Travis C, Criddle LM. Differential Diagnosis Cyanosis Versus Argyria: When Your 
Patient Remains Blue—A 48-year-old Trauma Patient With Persistent Cyanosis. J 
Emerg Nurs. 2010;36:466-467. 
[114] Eisler R. Silver hazards to fish, wildlife, and invertebrates: a synoptic review. 
Contaminant Hazard Reviews: National Biological Service, U.S. Dept. of the 
Interior; 1996. Report No.: 32. 
[115] Bowen HJM. Trace elements in biochemistry: Academic Press 1966. 
[116] Eckelman MJ, Graedel TE. Silver Emissions and Their Environmental Impacts: A 
Multilevel Assessment. Environ Sci Technol. 2007;41:6283-6289. 
[117] Smith GJ, Flegal AR. Silver in San Francisco Bay Estuarine Waters. Estuaries. 
1993;16:547-558. 
[118] Ratte HT. Bioaccumulation and toxicity of silver compounds: A review. Environ 
Toxicol Chem. 1999;18:89-108. 
[119] Purcell TW, Peters JJ. Sources of silver in the environment. Environ Toxicol Chem. 
1998;17:539-546. 
[120] Hogstrand C, Wood CM. Toward a better understanding of the bioavailability, 
physiology, and toxicity of silver in fish: Implications for water quality criteria. 
Environ Toxicol Chem. 1998;17:547-561. 
[121] Hirsch MP. Toxicity of silver sulfide-spiked sediments to the freshwater amphipod 
(Hyalella azteca). Environ Toxicol Chem. 1998;17:601-604. 
[122] Hirsch MP. Bioaccumulation of silver from laboratory-spiked sediments in the 
oligochaete (Lumbriculus variegatus). Environ Toxicol Chem. 1998;17:605-609. 
[123] Lanzano T, Bertram M, De Palo M, Wagner C, Zyla K, Graedel TE. The 
contemporary European silver cycle. Resour Conserv Recycl. 2006;46:27-43. 
223 
 
[124] Luoma SN. Silver nanotechnologies and the envrionment: Old problems or new 
challenges? Washington: Woodrow Wilson International Centre for Scholars: 
Project on Emerging Nanotechnologies; 2008. 
[125] Limbach LK, Wick P, Manser P, Grass RN, Bruinink A, Stark WJ. Exposure of 
Engineered Nanoparticles to Human Lung Epithelial Cells: Influence of Chemical 
Composition and Catalytic Activity on Oxidative Stress. Environ Sci Technol. 
2007;41:4158-4163. 
[126] Lapresta-Fernandez A, Fernandez A, Blasco J. Nanoecotoxicity effects of 
engineered silver and gold nanoparticles in aquatic organisms. TrAC, Trends Anal 
Chem. 2012;32:40-59. 
[127] Fabrega J, Luoma SN, Tyler CR, Galloway TS, Lead JR. Silver nanoparticles: 
Behaviour and effects in the aquatic environment. Environ Int. 2011;37:517-531. 
[128] Benn TM, Westerhoff P. Nanoparticle Silver Released into Water from 
Commercially Available Sock Fabrics. Environ Sci Technol. 2008;42:4133-4139. 
[129] Geranio L, Heuberger M, Nowack B. The Behavior of Silver Nanotextiles during 
Washing. Environ Sci Technol. 2009;43:8113-8118. 
[130] Blaser SA, Scheringer M, MacLeod M, Hungerbuhler K. Estimation of cumulative 
aquatic exposure and risk due to silver: Contribution of nano-functionalized 
plastics and textiles. Sci Total Environ. 2008;390:396-409. 
[131] Kim B, Park C-S, Murayama M, Hochella MF, Jr. Discovery and Characterization of 
Silver Sulfide Nanoparticles in Final Sewage Sludge Products. Environ Sci Technol. 
2010;44:7509-7514. 
[132] Kaegi R, Voegelin A, Sinnet B, Zuleeg S, Hagendorfer H, Burkhardt M, Siegrist H. 
Behavior of Metallic Silver Nanoparticles in a Pilot Wastewater Treatment Plant. 
Environ Sci Technol. 2011;45:3902-3908. 
224 
 
[133] Tiede K, Boxall ABA, Wang XM, Gore D, Tiede D, Baxter M, David H, Tear SP, Lewis 
J. Application of hydrodynamic chromatography-ICP-MS to investigate the fate of 
silver nanoparticles in activated sludge. J Anal At Spectrom. 2010;25:1149-1154. 
[134] Chinnapongse SL, MacCuspie RI, Hackley VA. Persistence of singly dispersed silver 
nanoparticles in natural freshwaters, synthetic seawater, and simulated estuarine 
waters. Sci Total Environ. 2011;409:2443-2450. 
[135] Delay M, Dolt T, Woellhaf A, Sembritzki R, Frimmel FH. Interactions and stability of 
silver nanoparticles in the aqueous phase: Influence of natural organic matter 
(NOM) and ionic strength. J Chromatogr A. 2011;1218:4206-4212. 
[136] Quadros ME, Marr LC. Environmental and Human Health Risks of Aerosolized 
Silver Nanoparticles. J Air Waste Manage Assoc. 2010;60:770-781. 
[137] Lee JH, Kwon M, Ji JH, Kang CS, Ahn KH, Han JH, Yu IJ. Exposure assessment of 
workplaces manufacturing nanosized TiO2 and silver. Inhalation Toxicol. 
2011;23:226-236. 
[138] Hagendorfer H, Lorenz C, Kaegi R, Sinnet B, Gehrig R, Goetz NV, Scheringer M, 
Ludwig C, Ulrich A. Size-fractionated characterization and quantification of 
nanoparticle release rates from a consumer spray product containing engineered 
nanoparticles. J Nanopart Res. 2010;12:2481-2494. 
[139] Tsai S-J, Ada E, Isaacs JA, Ellenbecker MJ. Airborne nanoparticle exposures 
associated with the manual handling of nanoalumina and nanosilver in fume 
hoods. J Nanopart Res. 2009;11:147-161. 
[140] Park J, Kwak BK, Bae E, Lee J, Kim Y, Choi K, Yi J. Characterization of exposure to 
silver nanoparticles in a manufacturing facility. J Nanopart Res. 2009;11:1705-
1712. 
[141] Bakand S, Hayes A, Dechsakulthorn F. Nanoparticles: a review of particle 
toxicology following inhalation exposure. Inhalation Toxicol. 2012;24:125-135. 
225 
 
[142] Takenaka S, Karg E, Roth C, Schulz H, Ziesenis A, Heinzmann U, Schramel P, Heyder 
J. Pulmonary and Systemic Distribution of Inhaled Ultrafine Silver Particles in Rats. 
Environ Health Perspect. 2001;109:547-551. 
[143] Rogers KR, Bradham K, Tolaymat T, Thomas DJ, Hartmann T, Ma L, Williams A. 
Alterations in physical state of silver nanoparticles exposed to synthetic human 
stomach fluid. Sci Total Environ. 2012;420:334-339. 
[144] Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, 
Vanbilloen H, Mortelmans L, Nemery B. Passage of Inhaled Particles Into the Blood 
Circulation in Humans. Circulation. 2002;105:411-414. 
[145] Hillyer JF, Albrecht RM. Gastrointestinal Persorption and Tissue Distribution of 
Differently Sized Colloidal Gold Nanoparticles. J Pharm Sci. 2001;90:1927-1936. 
[146] Mills NL, Amin N, Robinson SD, Anand A, Davies J, Patel D, de la Fuente JM, Cassee 
FR, Boon NA, MacNee W, Millar AM, Donaldson K, Newby DE. Do Inhaled Carbon 
Nanoparticles Translocate Directly into the Circulation in Humans? Am J Respir Crit 
Care Med. 2006;173:426-431. 
[147] Semmler-Behnke M, Takenaka S, Fertsch S, Wenk A, Seitz J, Mayer P, Oberdoerster 
G, Kreyling WG. Efficient Elimination of Inhaled Nanoparticles from the Alveolar 
Region: Evidence for Interstitial Uptake and Subsequent Reentrainment onto 
Airways Epithelium. Environ Health Perspect. 2007;115:728-733. 
[148] Yu LE, Yung L-YL, Ong C-N, Tan Y-L, Balasubramaniam KS, Hartono D, Shui G, Wenk 
MR, Ong W-Y. Translocation and effects of gold nanoparticles after inhalation 
exposure in rats. Nanotoxicology. 2007;1:235-242. 
[149] Baker GL, Gupta A, Clark ML, Valenzuela BR, Staska LM, Harbo SJ, Pierce JT, Dill JA. 
Inhalation toxicity and lung toxicokinetics of C60 fullerene nanoparticles and 
microparticles. Toxicol Sci. 2008;101:122-131. 
[150] Reijnders L. Human health hazards of persistent inorganic and carbon 
nanoparticles. J Mater Sci. 2012;47:5061-5073. 
226 
 
[151] Suico MA, Tanaka A, Shuto T, Kai H. The Expression of Antimicrobial Peptide 
Lysozyme is Increased by Treatment with Silver Nanoparticle (Atomyball S®) in 
Mammalian Epithelial Cells. J Health Sci. 2009;55:456-462. 
[152] Deng F, Olesen P, Foldbjerg R, Dang DA, Guo X, Autrup H. Silver nanoparticles up-
regulate Connexin43 expression and increase gap junctional intercellular 
communication in human lung adenocarcinoma cell line A549. Nanotoxicology. 
2010;4:186-195. 
[153] Liu W, Wu YA, Wang C, Li HC, Wang T, Liao CY, Cui L, Zhou QF, Yan B, Jiang GB. 
Impact of silver nanoparticles on human cells: Effect of particle size. 
Nanotoxicology. 2010;4:319-330. 
[154] Sur I, Cam D, Kahraman M, Baysal A, Culha M. Interaction of multi-functional silver 
nanoparticles with living cells. Nanotechnology. 2010;21. 
[155] Foldbjerg R, Dang DA, Autrup H. Cytotoxicity and genotoxicity of silver 
nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011;85:743-
750. 
[156] Lee YS, Kim DW, Lee YH, Oh JH, Yoon S, Choi MS, Lee SK, Kim JW, Lee K, Song C-W. 
Silver nanoparticles induce apoptosis and G2/M arrest via PKCζ-dependent 
signaling in A549 lung cells. Arch Toxicol. 2011;85:1529-1540. 
[157] Stoehr LC, Gonzalez E, Stampfl A, Casals E, Duschl A, Puntes V, Oostingh GJ. Shape 
matters: effects of silver nanospheres and wires on human alveolar epithelial cells. 
Part Fibre Toxicol. 2011;8. 
[158] Valodkar M, Jadeja RN, Thounaojam MC, Devkar RV, Thakore S. In vitro toxicity 
study of plant latex capped silver nanoparticles in human lung carcinoma cells. 
Mater Sci Eng C Mater Biol Appl. 2011;31:1723-1728. 
[159] Beer C, Foldbjerg R, Hayashi Y, Sutherland DS, Autrup H. Toxicity of silver 
nanoparticles – Nanoparticle or silver ion? Toxicol Lett. 2012;208:286-292. 
227 
 
[160] Koch M, Kiefer S, Cavelius C, Kraegeloh A. Use of a silver ion selective electrode to 
assess mechanisms responsible for biological effects of silver nanoparticles. J 
Nanopart Res. 2012;14. 
[161] Lankoff A, Sandberg WJ, Wegierek-Ciuk A, Lisowska H, Refsnes M, Sartowska B, 
Schwarze PE, Meczynska-Wielgosz S, Wojewodzka M, Kruszewski M. The effect of 
agglomeration state of silver and titanium dioxide nanoparticles on cellular 
response of HepG2, A549 and THP-1 cells. Toxicol Lett. 2012;208:197-213. 
[162] Soto K, Garza KM, Murr LE. Cytotoxic effects of aggregated nanomaterials. Acta 
Biomater. 2007;3:351-358. 
[163] Skebo JE, Grabinski CM, Schrand AM, Schlager JJ, Hussain SM. Assessment of 
Metal Nanoparticle Agglomeration, Uptake, and Interaction Using High-
Illuminating System. Int J Toxicol. 2007;26:135-141. 
[164] Yen HJ, Hsu SH, Tsai CL. Cytotoxicity and Immunological Response of Gold and 
Silver Nanoparticles of Different Sizes. Small. 2009;5:1553-1561. 
[165] Park M, Neigh AM, Vermeulen JP, de la Fonteyne LJJ, Verharen HW, Briede JJ, van 
Loveren H, de Jong WH. The effect of particle size on the cytotoxicity, 
inflammation, developmental toxicity and genotoxicity of silver nanoparticles. 
Biomaterials. 2011;32:9810-9817. 
[166] Park EJ, Yi J, Kim Y, Choi K, Park K. Silver nanoparticles induce cytotoxicity by a 
Trojan-horse type mechanism. Toxicol In Vitro. 2010;24:872-878. 
[167] Kim S, Choi I-H. Phagocytosis and Endocytosis of Silver Nanoparticles Induce 
Interleukin-8 Production in Human Macrophages. Yonsei Med J. 2012;53:654-657. 
[168] Lim D-H, Jang J, Kim S, Kang T, Lee K, Choi I-H. The effects of sub-lethal 
concentrations of silver nanoparticles on inflammatory and stress genes in human 
macrophages using cDNA microarray analysis. Biomaterials. 2012;33:4690-4699. 
228 
 
[169] Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated 
silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and 
necrosis in THP-1 monocytes. Toxicol Lett. 2009;190:156-162. 
[170] Hayashi Y, Engelmann P, Foldbjerg R, Szabo M, Somogyi I, Pollak E, Molnar L, 
Autrup H, Sutherland DS, Scott-Fordsmand J, Heckmann L-H. Earthworms and 
Humans in Vitro: Characterizing Evolutionarily Conserved Stress and Immune 
Responses to Silver Nanoparticles. Environ Sci Technol. 2012;46:4166-4173. 
[171] Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of 
nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro. 2005;19:975-983. 
[172] Kawata K, Osawa M, Okabe S. In Vitro Toxicity of Silver Nanoparticles at 
Noncytotoxic Doses to HepG2 Human Hepatoma Cells. Environ Sci Technol. 
2009;43:6046-6051. 
[173] Kim S, Choi JE, Choi J, Chung KH, Park K, Yi J, Ryu DY. Oxidative stress-dependent 
toxicity of silver nanoparticles in human hepatoma cells. Toxicol In Vitro. 
2009;23:1076-1084. 
[174] Nowrouzi A, Meghrazi K, Golmohammadi T, Golestani A, Ahmadian S, Shafiezadeh 
M, Shajary Z, Khaghani S, Amiri AN. Cytotoxicity of subtoxic AgNP in human 
hepatoma cell line (HepG2) after long-term exposure. Iranian biomedical journal. 
2010;14:23-32. 
[175] Wojewodzka M, Lankoff A, Dusinska M, Brunborg G, Czerwinska J, Iwanenko T, 
Stepkowski T, Szumiel I, Kruszewski M. Treatment with silver nanoparticles delays 
repair of X-ray induced DNA damage in HepG2 cells. Nukleonika. 2011;56:29-33. 
[176] Lin J-J, Lin W-C, Dong R-X, Hsu S-h. The cellular responses and antibacterial 
activities of silver nanoparticles stabilized by different polymers. Nanotechnology. 
2012;23. 
229 
 
[177] Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, Ryu G, Myung H. Comparison 
of acute responses of mice livers to short-term exposure to nano-sized or micro-
sized silver particles. Biotechnol Lett. 2008;30:1893-1899. 
[178] Lam PK, Chan ESY, Ho WS, Liew CT. In vitro cytotoxicity testing of a nanocrystalline 
silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci. 2004;61:125-
127. 
[179] Supp AP, Neely AN, Supp DM, Warden GD, Boyce ST. Evaluation of Cytotoxicity and 
Antimicrobial Activity of Acticoat® Burn Dressing for Management of Microbial 
Contamination in Cultured Skin Substitutes Grafted to Athymic Mice. J Burn Care 
Rehabil. 2005;26:238-246. 
[180] Paddle-Ledinek JE, Nasa Z, Cleland HJ. Effect of Different Wound Dressings on Cell 
Viability and Proliferation. Plast Reconstr Surg. 2006;117:110S-118S. 
[181] Samberg ME, Oldenburg SJ, Monteiro-Riviere NA. Evaluation of Silver Nanoparticle 
Toxicity in Skin in Vivo and Keratinocytes in Vitro. Environ Health Perspect. 
2010;118:407-413. 
[182] Zanette C, Pelin M, Crosera M, Adami G, Bovenzi M, Larese FF, Florio C. Silver 
nanoparticles exert a long-lasting antiproliferative effect on human keratinocyte 
HaCaT cell line. Toxicol In Vitro. 2011;25:1053-1060. 
[183] Mukherjee SG, O'Claonadh N, Casey A, Chambers G. Comparative in vitro 
cytotoxicity study of silver nanoparticle on two mammalian cell lines. Toxicol In 
Vitro. 2012;26:238-251. 
[184] Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. A review of 
the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes 
and biological mechanisms responsible for the observed toxicity. Crit Rev Toxicol. 
2010;40:328-346. 
[185] Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW. Silver 
nanoparticles induce oxidative cell damage in human liver cells through inhibition 
230 
 
of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol 
Lett. 2011;201:92-100. 
[186] Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, Semmler 
M, Hof VI, Heyder J, Gehr P. Ultrafine Particles Cross Cellular Membranes by 
Nonphagocytic Mechanisms in Lungs and in Cultured Cells. Environ Health 
Perspect. 2005;113:1555-1560. 
[187] De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. Particle 
size-dependent organ distribution of gold nanoparticles after intravenous 
administration. Biomaterials. 2008;29:1912-1919. 
[188] Hagens WI, Oomen AG, de Jong WH, Cassee FR, Sips AJAM. What do we (need to) 
know about the kinetic properties of nanoparticles in the body? Regul Toxicol 
Pharmacol. 2007;49:217-229. 
[189] Tiwari DK, Jin T, Behari J. Dose-dependent in-vivo toxicity assessment of silver 
nanoparticle in Wistar rats. Toxicol Mech Methods. 2011;21:13-24. 
[190] Zolnik BS, Gonzalez-Fernandez A, Sadrieh N, Dobrovolskaia MA. Minireview: 
Nanoparticles and the Immune System. Endocrinology. 2010;151:458-465. 
[191] Dobrovolskaia MA, McNeil SE. Immunological properties of engineered 
nanomaterials. Nat Nanotechnol. 2007;2:469-478. 
[192] Feltis BN, O'Keefe SJ, Harford AJ, Piva TJ, Turney TW, Wright PFA. Independent 
cytotoxic and inflammatory responses to zinc oxide nanoparticles in human 
monocytes and macrophages. Nanotoxicology. 2012;6:762-770. 
[193] Brown DM, Kinloch IA, Bangert U, Windle AH, Walter DM, Walker GS, Scotchford 
CA, Donaldson K, Stone V. An in vitro study of the potential of carbon nanotubes 
and nanofibres to induce inflammatory mediators and frustrated phagocytosis. 
Carbon. 2007;45:1743-1756. 
231 
 
[194] Park EJ, Yoon J, Choi K, Yi J, Park K. Induction of chronic inflammation in mice 
treated with titanium dioxide nanoparticles by intratracheal instillation. 
Toxicology. 2009;260:37-46. 
[195] Park E-J, Bae E, Yi J, Kim Y, Choi K, Lee SH, Yoon J, Lee BC, Park K. Repeated-dose 
toxicity and inflammatory responses in mice by oral administration of silver 
nanoparticles. Environ Toxicol Pharmacol. 2010;30:162-168. 
[196] Taira M, Kagiya T, Harada H, Sasaki M, Kimura S, Narushima T, Nezu T, Araki Y. 
Microscopic observations and inflammatory cytokine productions of human 
macrophage phagocytising submicron titanium particles. J Mater Sci-Mater Med. 
2010;21:267-275. 
[197] Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The 
nanoparticle—protein complex as a biological entity; a complex fluids and surface 
science challenge for the 21st century. Adv Colloid Interface Sci. 2007;134-35:167-
174. 
[198] Lynch I, Dawson KA. Protein-nanoparticle interactions. Nano Today. 2008;3:40-47. 
[199] Xiang SD, Scholzen A, Minigo G, David C, Apostolopoulos V, Mottram PL, Plebanski 
M. Pathogen recognition and development of particulate vaccines: Does size 
matter? Methods. 2006;40:1-9. 
[200] Hussain S, Vanoirbeek JAJ, Hoet PHM. Interactions of nanomaterials with the 
immune system. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012;4:169-183. 
[201] Noonan FP, Defabo EC. Immunosuppression by ultraviolet B radiation: initiation by 
urocanic acid. Immunol Today. 1992;13:250-254. 
[202] Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, 
Schubert MM, Atkinson K, Thomas ED. Chronic graft-versus-host disease in 52 
patients: adverse natural course and successful treatment with combination 
immunosuppression. Blood. 1981;57:267-276. 
232 
 
[203] Fauci AS. The Human Immunodeficiency Virus: Infectivity and Mechanisms of 
Pathogenesis. Science. 1988;239:617-622. 
[204] Mitchell LA, Gao J, Wal RV, Gigliotti A, Burchiel SW, McDonald JD. Pulmonary and 
Systemic Immune Response to Inhaled Multiwalled Carbon Nanotubes. Toxicol Sci. 
2007;100:203-214. 
[205] Dwivedi PD, Misra A, Shanker R, Das M. Are nanomaterials a threat to the immune 
system? Nanotoxicology. 2009;3:19-26. 
[206] Zogovic NS, Nikolic NS, Vranjes-Djuric SD, Harhaji LM, Vucicevic LM, Janjetovic KD, 
Misirkic MS, Todorovic-Markovic BM, Markovic ZM, Milonjic SK, Trajkovic VS. 
Opposite effects of nanocrystalline fullerene (C60) on tumour cell growth in vitro 
and in vivo and a possible role of immunosupression in the cancer-promoting 
activity of C60. Biomaterials. 2009;30:6940-6946. 
[207] Tkach AV, Shurin GV, Shurin MR, Kisin ER, Murray AR, Young S-H, Star A, Fadeel B, 
Kagan VE, Shvedova AA. Direct Effects of Carbon Nanotubes on Dendritic Cells 
Induce Immune Suppression Upon Pulmonary Exposure. ACS Nano. 2011;5:5755-
5762. 
[208] Lankveld DPK, Van Loveren H, Baken KA, Vandebriel RJ. In Vitro Testing for Direct 
Immunotoxicity: State of the Art. In: Dietert RR, ed. Immunotoxicity Testing: 
Methods and Protocols. Totowa: Humana Press Inc 2010:401-423. 
[209] Rivera Gil P, Oberdorster G, Elder A, Puntes V, Parak WJ. Correlating Physico-
Chemical with Toxicological Properties of Nanoparticles: The Present and the 
Future. ACS Nano. 2010;4:5527-5531. 
[210] Bouwmeester H, Lynch I, Marvin HJP, Dawson KA, Berges M, Braguer D, Byrne HJ, 
Casey A, Chambers G, Clift MJD, Elia G, Fernandes TF, Fjellsbo LB, Hatto P, Juillerat 
L, Klein C, Kreyling WG, Nickel C, Riediker M, Stone V. Minimal analytical 
characterization of engineered nanomaterials needed for hazard assessment in 
biological matrices. Nanotoxicology. 2011;5:1-11. 
233 
 
[211] MacCuspie RI, Rogers K, Patra M, Suo Z, Allen AJ, Martin MN, Hackley VA. 
Challenges for physical characterization of silver nanoparticles under pristine and 
environmentally relevant conditions. J Environ Monit. 2011;13:1212-1226. 
[212] Poda AR, Bednar AJ, Kennedy AJ, Harmon A, Hull M, Mitrano DM, Ranville JF, 
Steevens J. Characterization of silver nanoparticles using flow-field flow 
fractionation interfaced to inductively coupled plasma mass spectrometry. J 
Chromatogr A. 2011;1218:4219-4225. 
[213] Hagendorfer H, Kaegi R, Parlinska M, Sinnet B, Ludwig C, Ulrich A. Characterization 
of Silver Nanoparticle Products Using Asymmetric Flow Field Flow Fractionation 
with a Multidetector Approach – a Comparison to Transmission Electron 
Microscopy and Batch Dynamic Light Scattering. Anal Chem. 2012;84:2678-2685. 
[214] Montes-Burgos I, Walczyk D, Hole P, Smith J, Lynch I, Dawson K. Characterisation of 
nanoparticle size and state prior to nanotoxicological studies. J Nanopart Res. 
2010;12:47-53. 
[215] Tsai DH, DelRio FW, Keene AM, Tyner KM, MacCuspie RI, Cho TJ, Zachariah MR, 
Hackley VA. Adsorption and Conformation of Serum Albumin Protein on Gold 
Nanoparticles Investigated Using Dimensional Measurements and in Situ 
Spectroscopic Methods. Langmuir. 2011;27:2464-2477. 
[216] Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time Evolution of the 
Nanoparticle Protein Corona. ACS Nano. 2010;4:3623-3632. 
[217] Holdich RG. Fundamentals of Particle Technology. Leicestershire: Midland 
Information Technology and Publishing 2002. 
[218] Davis PJ, Gallegos DP, Smith DM. Rapid Surface Area Determination via NMR Spin-
Lattice Relaxation Measurements. Powder Technol. 1987;53:39-47. 
[219] Particle Surface Area Analyzer. XiGo Nanotools 2012  [cited May 2012]; Available 
from: http://www.xigonanotools.com/products/surface_area/acorn_area.asp 
234 
 
[220] Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K. Induction of 
Maturation in Cultured Human Monocytic Leukemia Cells by a Phorbol Diester. 
Cancer Res. 1982;42:1530-1536. 
[221] Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment 
and characterization of a human acute monocytic leukemia cell line (THP-1). Int J 
Cancer. 1980;26:171-176. 
[222] Auwerx J. The human leukemia-cell line, THP-1: a multifaceted model for the study 
of monocyte-macrophage differentiation. Experientia. 1991;47:22-31. 
[223] Wataha JC, Ratanasathien S, Hanks CT, Sun ZL. In vitro IL-1β and TNF-α release 
from THP-1 monocytes in response to metal ions. Dent Mater. 1996;12:322-327. 
[224] Wataha JC, Lockwood PE, Schedle A. Effect of silver, copper, mercury, and nickel 
ions on cellular proliferation during extended, low-dose exposures. J Biomed 
Mater Res. 2000;52:360-364. 
[225] Wataha JC, Lockwood PE, Schedle A, Noda M, Bouillaguet S. Ag, Cu, Hg and Ni ions 
alter the metabolism of human monocytes during extended low-dose exposures. J 
Oral Rehabil. 2002;29:133-139. 
[226] Martinez-Gutierrez F, Thi EP, Silverman JM, de Oliveira CC, Svensson SL, Hoek AV, 
Morales Sanchez E, Reiner NE, Gaynor EC, Pryzdial ELG, Conway EM, Orrantia E, 
Ruiz F, Av-Gay Y, Bach H. Antibacterial activity, inflammatory response, coagulation 
and cytotoxicity effects of silver nanoparticles. Nanomed-Nanotechnol Biol Med. 
2012;8:328-336. 
[227] de Almeida MC, Silva AC, Barral A, Netto MB. A Simple Method for Human 
Peripheral Blood Monocyte Isolation. Mem Inst Oswaldo Cruz. 2000;95:221-223. 
[228] Danciger JS, Lutz M, Hama S, Cruz D, Castrillo A, Lazaro J, Phillips R, Premack B, 
Berliner J. Method for large scale isolation, culture and cryopreservation of human 
monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and 
dendritic cell differentiation. J Immunol Methods. 2004;288:123-134. 
235 
 
[229] Zuckerman SH, Ackerman SK, Douglas SD. Long-term human peripheral blood 
monocyte cultures: establishment, metabolism and morphology of primary 
human monocyte-macrophage cell cultures. Immunology. 1979;38:401-411. 
[230] Salahuddin SZ, Markham PD, Gallo RC. Establishment of long-term monocyte 
suspension-cultures from normal human peripheral blood. J Exp Med. 
1982;155:1842-1857. 
[231] Lund PK, Namork E, Brorson SH, Westvik AB, Joo GB, Ovstebo R, Kierulf P. The fate 
of monocytes during 24 h of culture as revealed by flow cytometry and electron 
microscopy. J Immunol Methods. 2002;270:63-76. 
[232] Shin SH, Ye MK, Kim HS, Kang HS. The effects of nano-silver on the proliferation 
and cytokine expression by peripheral blood mononuclear cells. Int 
Immunopharmacol. 2007;7:1813-1818. 
[233] Greulich C, Diendorf J, Gessmann J, Simon T, Habijan T, Eggeler G, Schildhauer TA, 
Epple M, Koller M. Cell type-specific responses of peripheral blood mononuclear 
cells to silver nanoparticles. Acta Biomater. 2011;7:3505-3514. 
[234] Flower NAL, Brabu B, Revathy M, Gopalakrishnan C, Raja SVK, Murugan SS, 
Kumaravel TS. Characterization of synthesized silver nanoparticles and assessment 
of its genotoxicity potentials using the alkaline comet assay. Mutat Res, Genet 
Toxicol Environ Mutagen. 2012;742:61-65. 
[235] Dunn K, Edwards-Jones V. The role of ActicoatTM with nanocrystalline silver in the 
management of burns. Burns. 2004;30:S1-S9. 
[236] Kock A, Schwarz T, Kirnbauer R, Urbanski A, Perry P, Ansel JC, Luger TA. Human 
Keratinocytes Are a Source for Tumor Necrosis Factor α: Evidence for Synthesis 
and Release upon Stimulation with Endotoxin or Ultraviolet Light. J Exp Med. 
1990;172:1609-1614. 
236 
 
[237] Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. 
Normal Keratinization in a Spontaneously Immortalized Aneuploid Human 
Keratinocyte Cell Line. J Cell Biol. 1988;106:761-771. 
[238] Lu W, Senapati D, Wang S, Tovmachenko O, Singh AK, Yu H, Ray PC. Effect of 
surface coating on the toxicity of silver nanomaterials on human skin 
keratinocytes. Chem Phys Lett. 2010;487:92-96. 
[239] Busch W, Bastian S, Trahorsch U, Iwe M, Kuhnel D, Meissner T, Springer A, Gelinsky 
M, Richter V, Ikonomidou C, Potthoff A, Lehmann I, Schirmer K. Internalisation of 
engineered nanoparticles into mammalian cells in vitro: influence of cell type and 
particle properties. J Nanopart Res. 2011;13:293-310. 
[240] Srivastava M, Singh S, Self WT. Exposure to Silver Nanoparticles Inhibits 
Selenoprotein Synthesis and the Activity of Thioredoxin Reductase. Environ Health 
Perspect. 2012;120:56-61. 
[241] Park M, Lankveld DPK, van Loveren H, de Jong WH. The status of in vitro toxicity 
studies in the risk assessment of nanomaterials. Nanomed. 2009;4:669-685. 
[242] Teeguarden JG, Hinderliter PM, Orr G, Thrall BD, Pounds JG. Particokinetics In 
Vitro: Dosimetry Considerations for In Vitro Nanoparticle Toxicity Assessments. 
Toxicol Sci. 2007;95:300-312. 
[243] Lison D, Thomassen LCJ, Rabolli V, Gonzalez L, Napierska D, Seo JW, Kirsch-Volders 
M, Hoet P, Kirschhock CEA, Martens JA. Nominal and Effective Dosimetry of Silica 
Nanoparticles in Cytotoxicity Assays. Toxicol Sci. 2008;104:155-162. 
[244] Hinderliter PM, Minard KR, Orr G, Chrisler WB, Thrall BD, Pounds JG, Teeguarden 
JG. ISDD: A computational model of particle sedimentation, diffusion and target 
cell dosimetry for in vitro toxicity studies. Part Fibre Toxicol. 2010;7. 
[245] Summers HD, Rees P, Holton MD, Brown MR, Chappell SC, Smith PJ, Errington RJ. 
Statistical analysis of nanoparticle dosing in a dynamic cellular system. Nat 
Nanotechnol. 2011;6:170-174. 
237 
 
[246] Wittmaack K. Novel Dose Metric for Apparent Cytotoxicity Effects Generated by in 
Vitro Cell Exposure to Silica Nanoparticles. Chem Res Toxicol. 2011;24:150-158. 
[247] Mosmann T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application 
to Proliferation and Cytotoxicity Assays. J Immunol Methods. 1983;65:55-63. 
[248] Eruslanov E, Kusmartsev S. Identification of ROS Using Oxidized DCFDA and Flow-
Cytometry. Methods Mol Biol. 2010;594:57-72. 
[249] Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, Pacher P. Simple quantitative 
detection of mitochondrial superoxide production in live cells. Biochem Biophys 
Res Commun. 2007;358:203-208. 
[250] Arora S, Jain J, Rajwade JM, Paknikar KM. Cellular responses induced by silver 
nanoparticles: In vitro studies. Toxicol Lett. 2008;179:93-100. 
[251] Unfried K, Albrecht C, Klotz LO, Von Mikecz A, Grether-Beck S, Schins RPF. Cellular 
responses to nanoparticles: Target structures and mechanisms. Nanotoxicology. 
2007;1:52-71. 
[252] Schrand AM, Schlager JJ, Dai LM, Hussain SM. Preparation of cells for assessing 
ultrastructural localization of nanoparticles with transmission electron microscopy. 
Nat Protoc. 2010;5:744-757. 
[253] Zeiri L, Bronk BV, Shabtai Y, Eichler J, Efrima S. Surface-Enhanced Raman 
Spectroscopy as a Tool for Probing Specific Biochemical Components in Bacteria. 
Appl Spectrosc. 2004;58:33-40. 
[254] Kneipp J, Kneipp H, McLaughlin M, Brown D, Kneipp K. In Vivo Molecular Probing 
of Cellular Compartments with Gold Nanoparticles and Nanoaggregates. Nano 
Lett. 2006;6:2225-2231. 
[255] Thurn KT, Brown EMB, Wu A, Vogt S, Lai B, Maser J, Paunesku T, Woloschak GE. 
Nanoparticles for Applications in Cellular Imaging. Nanoscale Res Lett. 2007;2:430-
441. 
238 
 
[256] Kneipp J, Kneipp H, Wittig B, Kneipp K. Novel optical nanosensors for probing and 
imaging live cells. Nanomed-Nanotechnol Biol Med. 2010;6:214-226. 
[257] Choi J, Reipa V, Hitchins VM, Goering PL, Malinauskas RA. Physicochemical 
Characterization and In Vitro Hemolysis Evaluation of Silver Nanoparticles. Toxicol 
Sci. 2011;123:133-143. 
[258] Stensberg MC, Wei QS, McLamore ES, Porterfield DM, Wei A, Sepulveda MS. 
Toxicological studies on silver nanoparticles: challenges and opportunities in 
assessment, monitoring and imaging. Nanomed. 2011;6:879-898. 
[259] AshaRani PV, Mun GLK, Hande MP, Valiyaveettil S. Cytotoxicity and Genotoxicity of 
Silver Nanoparticles in Human Cells. ACS Nano. 2009;3:279-290. 
[260] Kim Y-J, Yang SI, Ryu J-C. Cytotoxicity and genotoxicity of nano-silver in 
mammalian cell lines. Mol Cell Toxicol. 2010;6:119-125. 
[261] Frens G, Overbeek JT. Carey Lea's colloidal silver. Colloid Polym Sci. 1969;233:922-
929. 
[262] Particle Size Analysis – Standard Operating Protocol v1.1. Eugene, Oregon: Dune 
Sciences, Inc.; 2011 February, 2012. Available from: 
http://www.dunesciences.com/files/Particle_Size_Analysis_SOP.pdf 
[263] Haynes WM, Lide DR. CRC Handbook of Chemistry and Physics. 91 ed. Boca Raton: 
CRC Press 2011. 
[264] Park EK, Jung HS, Yang HI, Yoo MC, Kim C, Kim KS. Optimized THP-1 differentiation 
is required for the detection of responses to weak stimuli. Inflamm Res. 
2007;56:45-50. 
[265] Strober W. Trypan Blue Exclusion Test of Cell Viability. Curr Protoc Immunol. 
2001;21:A.3B.1–A.3B.2. 
[266] CellTiter 96® AQueous Non-Radioactive Cell Proliferation Assay Technical Bulletin. 
Promega 2009  [cited August 2012]; Available from: 
239 
 
http://www.promega.com/resources/protocols/technical-bulletins/0/celltiter-96-
aqueous-nonradioactive-cell-proliferation-assay-protocol/ 
[267] Renka RJ, Cline AK. A Triangle-based C1 Interpolation Method. Rocky Mt J Math. 
1984;14:223-237. 
[268] Vermes I, Haanen C, Steffensnakken H, Reutelingsperger C. A novel assay for 
apoptosis: Flow cytometric detection of phosphatidylserine early apoptotic cells 
using fluorescein labelled expression on Annexin V. J Immunol Methods. 
1995;184:39-51. 
[269] Enten J, Monson M. Evaluation of Apoptosis with Annexin V and Propidium Iodide 
or 7-Amino-Actinomycin D. Beckman Coulter 2005  [cited August 2012]; Available 
from: https://www.beckmancoulter.com/wsrportal/bibliography?docname=a-
2014a.pdf 
[270] Product Information & Manual: Human Th1/Th2/Th9/Th17/Th22 13plex Kit 
FlowCytomix. eBioscience 2012  [cited August 2012]; Available from: 
http://www.bendermedsystems.org/bm_products/MAN/817FF.pdf 
[271] Suzuki H, Toyooka T, Ibuki Y. Simple and Easy Method to Evaluate Uptake Potential 
of Nanoparticles in Mammalian Cells Using a Flow Cytometric Light Scatter 
Analysis. Environ Sci Technol. 2007;41:3018-3024. 
[272] Sato T. A Modified Method for Lead Staining of Thin Sections. J Electron Microsc. 
1968;17:158-159. 
[273] Maynard AD, Warheit DB, Philbert MA. The New Toxicology of Sophisticated 
Materials: Nanotoxicology and Beyond. Toxicol Sci. 2011;120:S109-S129. 
[274] Recommended Minimum Physical and Chemical Parameters for Characterizing 
Nanomaterials on Toxicology Studies. MINChar Initiative 2008  [cited January 
2012]; Available from: http://characterizationmatters.org/parameters/ 
240 
 
[275] Dynamic Light Scattering: Common Terms Defined. Malvern Instruments Limited 
2011  [cited March 2012]; Available from: 
http://www.malvern.com/malvern/kbase.nsf/allbyno/KB003060 
[276] Cho W-S, Duffin R, Thielbeer F, Bradley M, Megson IL, MacNee W, Poland CA, Tran 
CL, Donaldson K. Zeta Potential and Solubility to Toxic Ions as Mechanisms of Lung 
Inflammation Caused by Metal/Metal Oxide Nanoparticles. Toxicol Sci. 
2012;126:469-477. 
[277] Kominami H, Murakami S, Kato J, Kera Y, Ohtani B. Correlation between some 
physical properties of titanium dioxide particles and their photocatalytic activity 
for some probe reactions in aqueous systems. J Phys Chem B. 2002;106:10501-
10507. 
[278] Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, Dawson KA. Time and space 
resolved uptake study of silica nanoparticles by human cells. Mol BioSyst. 
2011;7:371-378. 
[279] Calabrese EJ. Hormesis: Why it is important to toxicology and toxicologists. Environ 
Toxicol Chem. 2008;27:1451-1474. 
[280] Krug HF. Quality Handbook: Standard procedures for nanoparticle testing: 
NANOMMUNE; 2011. Available from: 
http://www.nanosafetycluster.eu/news/51/66/QUALITY-HANDBOOK.html 
[281] Fadeel B, Garcia-Bennett AE. Better safe than sorry: Understanding the 
toxicological properties of inorganic nanoparticles manufactured for biomedical 
applications. Adv Drug Delivery Rev. 2010;62:362-374. 
[282] Wyllie AH, Kerr JF, Currie AR. Cell Death: The Significance of Apoptosis. Int Rev 
Cytol. 1980;68:251-306. 
[283] Elmore S. Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol. 
2007;35:495-516. 
241 
 
[284] Kerr JFR, Wyllie AH, Currie AR. Apoptosis: Basic biological phenomenon with wide-
ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-&. 
[285] Adams DO, Hamilton TA. The Cell Biology Of Macrophage Activation. Annu Rev 
Immunol. 1984;2:283-318. 
[286] Unanue ER. Antigen-presenting function of the macrophage. Annu Rev Immunol. 
1984;2:395-428. 
[287] Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic 
cells and induce class I-restricted CTLs. Nature. 1998;392:86-89. 
[288] Geisow MJ, Hart PD, Young MR. Temporal Changes of Lysosome and Phagosome 
pH during Phagolysosome Formation in Macrophages: Studies by Fluorescence 
Spectroscopy. J Cell Biol. 1981;89:645-652. 
[289] Reagan-Shaw S, Breur J, Ahmad N. Enhancement of UVB radiation-mediated 
apoptosis by sanguinarine in HaCaT human immortalized keratinocytes. Mol 
Cancer Ther. 2006;5:418-429. 
[290] Hsin YH, Chena CF, Huang S, Shih TS, Lai PS, Chueh PJ. The apoptotic effect of 
nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the 
mitochondrial pathway in NIH3T3 cells. Toxicol Lett. 2008;179:130-139. 
[291] Gopinath P, Gogoi SK, Sanpui P, Paul A, Chattopadhyay A, Ghosh SS. Signaling gene 
cascade in silver nanoparticle induced apoptosis. Colloid Surf B-Biointerfaces. 
2010;77:240-245. 
[292] Li N, Xia T, Nel AE. The role of oxidative stress in ambient particulate matter-
induced lung diseases and its implications in the toxicity of engineered 
nanoparticles. Free Radic Biol Med. 2008;44:1689-1699. 
[293] Oberdorster G, Stone V, Donaldson K. Toxicology of nanoparticles: A historical 
perspective. Nanotoxicology. 2007;1:2 - 25. 
242 
 
[294] Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. 
Free Radic Biol Med. 2010;48:749-762. 
[295] Avery SV. Molecular targets of oxidative stress. Biochem J. 2011;434:201-210. 
[296] Halliwell B, Cross CE. Oxygen-derived Species: Their Relation to Human Disease 
and Environmental Stress. Environ Health Perspect. 1994;102:5-12. 
[297] Jezek P, Hlavata L. Mitochondria in homeostasis of reactive oxygen species in cell, 
tissues, and organism. Int J Biochem Cell Biol. 2005;37:2478-2503. 
[298] Forman HJ, Torres M. Redox signaling in macrophages. Mol Asp Med. 
2001;22:189-216. 
[299] Halliwell B. Antioxidant Defence Mechanisms: From the Beginning to the End (of 
the Beginning). Free Radic Res. 1999;31:261-272. 
[300] Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the 
redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 
2001;30:1191-1212. 
[301] Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AMK. Mechanisms 
of Cell Death in Oxidative Stress. Antioxid Redox Signal. 2007;9:49-89. 
[302] Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein 
assay using microplate reader. Free Radic Biol Med. 1999;27:612-616. 
[303] Robinson KM, Janes MS, Pehar M, Monette JS, Ross MF, Hagen TM, Murphy MP, 
Beckman JS. Selective fluorescent imaging of superoxide in vivo using ethidium-
based probes. Proc Natl Acad Sci U S A. 2006;103:15038-15043. 
[304] Monostori P, Wittmann G, Karg E, Turi S. Determination of glutathione and 
glutathione disulfide in biological samples: An in-depth review. Journal of 
Chromatography B-Analytical Technologies in the Biomedical and Life Sciences. 
2009;877:3331-3346. 
243 
 
[305] Gutteridge JMC, Halliwell B. The measurement and mechanism of lipid-
peroxidation in biological systems. Trends Biochem Sci. 1990;15:129-135. 
[306] Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ. Non-cyclooxygenase-derived 
prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad 
Sci U S A. 1992;89:10721-10725. 
[307] Rokach J, Khanapure SP, Hwang SW, Adiyaman M, Lawson JA, FitzGerald GA. The 
Isoprostanes: A Perspective. Prostaglandins Other Lipid Mediat. 1997;54:823-851. 
[308] Roberts LJ, Morrow JD. Products of the isoprostane pathway: unique bioactive 
compounds and markers of lipid peroxidation. Cell Mol Life Sci. 2002;59:808-820. 
[309] Proudfoot J, Barden A, Mori TA, Burke V, Croft KD, Beilin LJ, Puddey IB. 
Measurement of Urinary F2-Isoprostanes as Markers of in Vivo Lipid 
Peroxidation—A Comparison of Enzyme Immunoassay with Gas 
Chromatography/Mass Spectrometry. Anal Biochem. 1999;272:209-215. 
[310] Beck-Speier I, Dayal N, Karg E, Maier KL, Schumann G, Schulz H, Semmler M, 
Takenaka S, Stettmaier K, Bors W, Ghio A, Samet JM, Heyder J. Oxidative stress and 
lipid mediators induced in alveolar macrophages by ultrafine particles. Free Radic 
Biol Med. 2005;38:1080-1092. 
[311] Murphy MP. How mitochondria produce reactive oxygen species. Biochem J. 
2009;417:1-13. 
[312] Choi O, Hu ZQ. Size Dependent and Reactive Oxygen Species Related Nanosilver 
Toxicity to Nitrifying Bacteria. Environ Sci Technol. 2008;42:4583-4588. 
[313] Balkwill FR, Burke F. The Cytokine Network. Immunol Today. 1989;10:299-303. 
[314] Paludan SR. Interleukin-4 and Interferon-γ: The Quintessence of a Mutual 
Antagonistic Relationship. Scand J Immunol. 1998;48:459-468. 
[315] Le JM, Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple 
overlapping biological activities. Lab Investig. 1987;56:234-248. 
244 
 
[316] Balkwill FR. Interferons. Lancet. 1989;1:1060-1063. 
[317] Palladino MA, Patton JS, Figari IS, Shalaby MR. Possible relationships between in 
vivo antitumour activity and toxicity of tumour necrosis factor-α. Ciba Foundation 
Symposia. 1987;131:21-38. 
[318] House RV, Descotes J. Cytokines in Human Health: Immunotoxicology, Pathology, 
and Therapeutic Applications: Humana Press 2007. 
[319] Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T 
helper lymphocyte grows up. Genes Dev. 2000;14:1693-1711. 
[320] Romagnani S. The Th1/Th2 paradigm. Immunol Today. 1997;18:263-266. 
[321] Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, Parente E, Fili 
L, Ferri S, Frosali F, Giudici F, Romagnani P, Parronchi P, Tonelli F, Maggi E, 
Romagnani S. Phenotypic and functional features of human Th17 cells. J Exp Med. 
2007;204:1849-1861. 
[322] Romagnani S. Regulation of the T cell response. Clin Exp Allergy. 2006;36:1357-
1366. 
[323] Hsieh CS, Macatonia SE, Tripp CS, Wolf SF, Ogarra A, Murphy KM. Development of 
TH1 CD4
+ T Cells Through IL-12 Produced by Listeria-lnduced Macrophages. 
Science. 1993;260:547-549. 
[324] Engvall E, Perlmann P. Enzyme-linked Immunosorbent Assay, Elisa: III. Quantitation 
of Specific Antibodies by Enzyme-Labeled Anti-Immunoglobulin in Antigen-Coated 
Tubes. J Immunol. 1972;109:129-&. 
[325] Gessani S, Testa U, Varano B, Dimarzio P, Borghi P, Conti L, Barberi T, Tritarelli E, 
Martucci R, Seripa D, Peschle C, Belardelli F. Enhanced Production of LPS-Induced 
Cytokines during Differentiation of Human Monocytes to Macrophages: Role of 
LPS-Receptors. J Immunol. 1993;151:3758-3766. 
245 
 
[326] Watson RWG, Redmond HP, Bouchierhayes D. Role of endotoxin in mononuclear 
phagocyte-mediated inflammatory responses. J Leukoc Biol. 1994;56:95-103. 
[327] Tamai R, Sugawara S, Takeuchi O, Akira S, Takada H. Synergistic effects of 
lipopolysaccharide and interferon-γ in inducing interleukin-8 production in human 
monocytic THP-1 cells is accompanied by up-regulation of CD14, Toll-like receptor 
4, MD-2 and MyD88 expression. J Endotoxin Res. 2003;9:145-153. 
[328] Malaczewska J. Effect of silver nanoparticles on splenocyte activity and selected 
cytokine levels in the mouse serum. Bull Vet Inst Pulawy. 2011;55:317-322. 
[329] Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses 
inflammatory cytokines and induces apoptosis of inflammatory cells in a murine 
model of allergic contact dermatitis. Br J Dermatol. 2005;152:1235-1242. 
[330] Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of Transendothelial Neutrophil 
Migration by Endogenous Interleukin-8. Science. 1991;254:99-102. 
[331] Eckmann L, Kagnoff MF, Fierer J. Epithelial Cells Secrete the Chemokine 
Interleukin-8 in Response to Bacterial Entry. Infect Immun. 1993;61:4569-4574. 
[332] Babior BM. Phagocytes and oxidative stress. Am J Med. 2000;109:33-44. 
[333] Vanwinkle BA, Bentley KLD, Malecki JM, Gunter KK, Evans IM, Elder A, Finkelstein 
JN, Oberdorster G, Gunter TE. Nanoparticle (NP) uptake by type I alveolar 
epithelial cells and their oxidant stress response. Nanotoxicology. 2009;3:307-318. 
[334] Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of 
particles via the pathways of clathrin-and caveolae-mediated endocytosis. 
Biochem J. 2004;377:159-169. 
[335] Chithrani BD, Ghazani AA, Chan WCW. Determining the Size and Shape 
Dependence of Gold Nanoparticle Uptake into Mammalian Cells. Nano Lett. 
2006;6:662-668. 
246 
 
[336] Jin H, Heller DA, Strano MS. Single-Particle Tracking of Endocytosis and Exocytosis 
of Single-Walled Carbon Nanotubes in NIH-3T3 Cells. Nano Lett. 2008;8:1577-
1585. 
[337] Lunov O, Syrovets T, Loos C, Beil J, Delecher M, Tron K, Nienhaus GU, Musyanovych 
A, Mailander V, Landfester K, Simmet T. Differential Uptake of Functionalized 
Polystyrene Nanoparticles by Human Macrophages and a Monocytic Cell Line. ACS 
Nano. 2011;5:1657-1669. 
[338] Dhawan A, Sharma V. Toxicity assessment of nanomaterials: methods and 
challenges. Anal Bioanal Chem. 2010;398:589-605. 
[339] Elsaesser A, Barnes CA, McKerr G, Salvati A, Lynch I, Dawson KA, Howard CV. 
Quantification of nanoparticle uptake by cells using an unbiased sampling method 
and electron microscopy. Nanomed. 2011;6:1189-1198. 
[340] Wang B, Wang Z, Feng W, Wang M, Hu Z, Chai Z, Zhao Y. New methods for 
nanotoxicology: synchrotron radiation-based techniques. Anal Bioanal Chem. 
2010;398:667-676. 
[341] Paunesku T, Vogt S, Maser J, Lai B, Woloschak G. X-Ray Fluorescence Microprobe 
Imaging in Biology and Medicine. J Cell Biochem. 2006;99:1489-1502. 
[342] Finney L, Mandava S, Ursos L, Zhang W, Rodi D, Vogt S, Legnini D, Maser J, Ikpatt F, 
Olopade OI, Glesne D. X-ray fluorescence microscopy reveals large-scale 
relocalization and extracellular translocation of cellular copper during 
angiogenesis. Proc Natl Acad Sci U S A. 2007;104:2247-2252. 
[343] Vo-Dinh T. Surface-enhanced Raman spectroscopy using metallic nanostructures. 
TrAC, Trends Anal Chem. 1998;17:557-582. 
[344] Lombardi JR, Birke RL. A Unified Approach to Surface-Enhanced Raman 
Spectroscopy. J Phys Chem C. 2008;112:5605-5617. 
[345] Ellis EA. Poststaining Grids for Transmission Electron Microscopy: Conventional 
and Alternative Protocols. Methods Mol Biol. 2007;369:97-106. 
247 
 
[346] Socrates G. Infrared and Raman Characteristic Group Frequencies: Tables and 
Charts. Third ed. Chichester: John Wiley & Sons Ltd 2004. 
[347] Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial 
physicochemical properties on in vivo toxicity. Adv Drug Delivery Rev. 
2009;61:457-466. 
[348] Dhawan A, Sharma V, Parmar D. Nanomaterials: A challenge for toxicologists. 
Nanotoxicology. 2009;3:1-9. 
[349] Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 
Characterization of Nanomaterial Dispersion in Solution Prior to In Vitro Exposure 
Using Dynamic Light Scattering Technique. Toxicol Sci. 2008;101:239-253. 
[350] Kato H, Suzuki M, Fujita K, Horie M, Endoh S, Yoshida Y, Iwahashi H, Takahashi K, 
Nakamura A, Kinugasa S. Reliable size determination of nanoparticles using 
dynamic light scattering method for in vitro toxicology assessment. Toxicol In Vitro. 
2009;23:927-934. 
[351] Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the Cell "Sees" in 
Bionanoscience. J Am Chem Soc. 2010;132:5761-5768. 
[352] Hidalgo E, Dominguez C. Study of cytotoxicity mechanisms of silver nitrate in 
human dermal fibroblasts. Toxicol Lett. 1998;98:169-179. 
[353] Greulich C, Diendorf J, Simon T, Eggeler G, Epple M, Koller M. Uptake and 
intracellular distribution of silver nanoparticles in human mesenchymal stem cells. 
Acta Biomater. 2011;7:347-354. 
[354] Cortese-Krott MM, Munchow M, Pirev E, Hessner F, Bozkurt A, Uciechowski P, 
Pallua N, Kroncke KD, Suschek CV. Silver ions induce oxidative stress and 
intracellular zinc release in human skin fibroblasts. Free Radic Biol Med. 
2009;47:1570-1577. 
[355] Oberdorster G. Toxicology of ultrafine particles: in vivo studies. Philos Trans R Soc 
Lond Ser A-Math Phys Eng Sci. 2000;358:2719-2739. 
248 
 
[356] Donaldson K, Tran CL. Inflammation caused by particles and fibers. Inhalation 
Toxicol. 2002;14:5-27. 
[357] Donaldson K, Stone V. Current hypotheses on the mechanisms of toxicity of 
ultrafine particles. Ann Ist Super Sanita. 2003;39:405-410. 
[358] Brosnan JT, Brosnan ME. The Sulfur-Containing Amino Acids: An Overview. J Nutr. 
2006;136:1636S-1640S. 
[359] Fahey RC, Hunt JS, Windham GC. On the Cysteine and Cystine Content of Proteins: 
Differences Between Intracellular and Extracellular Proteins. J Mol Evol. 
1977;10:155-160. 
[360] Rogers KS. Variable sulfhydryl activity toward silver nitrate by reduced glutathione 
and alcohol, glutamate and lactate dehydrogenases. Biochim Biophys Acta. 
1972;263:309-&. 
[361] Gruen LC. Interaction of amino-acids with silver(I) ions. Biochim Biophys Acta. 
1975;386:270-274. 
[362] Costa CS, Ronconi JV, Daufenbach JF, Goncalves CL, Rezin GT, Streck EL, da Silva 
Paula MM. In vitro effects of silver nanoparticles on the mitochondrial respiratory 
chain. Mol Cell Biochem. 2010. 
[363] Baldi C, Minoia C, Dinucci A, Capodaglio E, Manzo L. Effects of silver in isolated rat 
hepatocytes. Toxicol Lett. 1988;41:261-268. 
[364] Park E-J, Choi K, Park K. Induction of Inflammatory Responses and Gene Expression 
by Intratracheal Instillation of Silver Nanoparticles in Mice. Arch Pharmacal Res. 
2011;34:299-307. 
[365] Hillegass JM, Shukla A, Lathrop SA, MacPherson MB, Fukagawa NK, Mossman BT. 
Assessing nanotoxicity in cells in vitro. Wiley Interdiscip Rev Nanomed 
Nanobiotechnol. 2010;2:219-231. 
249 
 
[366] Pfaller T, Colognato R, Nelissen I, Favilli F, Casals E, Ooms D, Leppens H, Ponti J, 
Stritzinger R, Puntes V, Boraschi D, Duschl A, Oostingh GJ. The suitability of 
different cellular in vitro immunotoxicity and genotoxicity methods for the analysis 
of nanoparticle-induced events. Nanotoxicology. 2010;4:52-72. 
[367] Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. 
Physical–Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo 
Biological Impacts of Nanoparticles. J Am Chem Soc. 2011;133:2525-2534. 
[368] Jackson N, Lopata A, Elms T, Wright P. Engineered nanomaterials: Evidence of the 
effectiveness of workplace controls to prevent exposure: Safe Work Australia, 
Commonwealth of Australia publication; 2009. ISBN 978-0-642-32884-7. Available 
from: 
http://www.safeworkaustralia.gov.au/sites/swa/aboutsafeworkaustralia/whatwed
o/publications/pages/RR200911ENEvidenceOnEffectiveness.aspx 
[369] Gangoli V, Barron A. Measuring the Specific Surface Area of Nanoparticle 
Suspensions using NMR. Connexions 2010  [cited August 2012]; Available from: 
http://cnx.org/content/m34663/1.1/ 
[370] Mottram PL, Leong D, Crimeen-Irwin B, Gloster S, Xiang SD, Meanger J, Ghildyal R, 
Vardaxis N, Plebanski M. Type 1 and 2 Immunity Following Vaccination Is 
Influenced by Nanoparticle Size: Formulation of a Model Vaccine for Respiratory 
Syncytial Virus. Mol Pharm. 2007;4:73-84. 
 
 
